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ABSTRACT 
The Golgi complex, a single -copy organelle, is composed of a ribbon of flattened 
stacks of cisternae during interphase. However, during apoptosis the Golgi is shown 
to fragment and disperse throughout the cytoplasm. Immunoelectron microscopy 
identified these fragments as vesicular -tubular structures that contained the Golgi 
marker n- acetyl -glucosaminyl -transferase -1. Newly- synthesised proteins 
translocated to the endoplasmic reticulum also failed to exit from this organelle and 
reach the Golgi in apoptotic cells. 
Induction of apoptosis by Fas receptor ligation led to the caspase- dependent 
cleavage of GM130, a key Golgi- localised protein involved in tethering incoming 
secretory vesicles to the cis -Golgi. Cleavage of GM130 was prevented by the broad - 
range protein kinase inhibitor staurosporine, suggesting that phosphorylation played 
a role in the regulation of GM130 activity during apoptosis. These morphological and 
functional changes to the early secretory pathway during apoptosis could explain the 
down -regulation of the exocytic pathway in apoptotic neutrophils, which may prevent 
the inappropriate release of proinflammatory agents during resolution of 
inflammation. 
XI 
CHAPTER 1: INTRODUCTION 
1.1 Inflammation & the Neutrophil 
Inflammation is the primary response to tissue damage or infection and an essential 
part of the immune response. Neutrophils are the first cells to be recruited to the 
inflammatory site where they form a first line of defence against invading bacteria 
and fungi. They are terminally differentiated and characteristic of neutrophils are the 
multi -lobed nuclei and dense cytoplasmic granules. During maturation in the bone 
marrow, they pass through six morphological stages: myeloblast, promyeloblast, 
myelocyte, metamyelocyte, non -segmented and segmented neutrophil prior to their 
release into the blood stream (Zajicek et al., 1984). High numbers of neutrophils are 
present in peripheral blood, despite their short life span (4 -6 hours), thus there is 
constant replacement of cells by the bone marrow which produces 1011 neutrophils 
per day in a normal adult (Cannistra & Griffin, 1988). During an inflammatory 
response, large numbers of circulating neutrophils are rapidly recruited to the 
affected site, a process requiring migration across the vascular endothelium. Once 
at the site of injury or infection, inflammatory mediators act to extend the life -span of 
the neutrophil (Haslett et al., 1989). 
Migration of leukocytes from the blood vessels into the site of inflammation is 
dependent on the activation of adhesive molecules, on both the circulating cells and 
the endothelial cells (Wagner & Roth, 2000). Neutrophils bind to the vessel wall 
transiently, a form of adhesion known as `rolling' and this is mediated by the 
reversible binding of selectins to their ligands expressed on both neutrophils and 
vascular endothelial cells (Crockett- Torabi & Fantone, 1995). Selectins are found on 
most circulating leukocytes and on endothelial cells lining the blood and lymph 
vessels (Wagner & Roth, 2000). Rolling adhesion via activated endothelial cell 
selectins allows engagement of neutrophils to integrins, particularly when 
chemokines are present to facilitate 'firm' adhesion to the endothelial cell and arrest 
from vascular flow (Williams & Solomkin, 1999). Following adhesion, neutrophils 
undergo diapedesis and migrate by chemotaxis towards the site of inflammation. At 
the inflammatory site, neutrophils can then phagocytose and destroy invading 
microorganisms by releasing proteolytic enzymes, bactericidal proteins and toxic 
oxygen products into the phagolysosome. 
1 
Necrotic cell death or the inappropriate release of neutrophil granule contents is 
thought to be a major contributing factor to tissue damage occurring during 
inflammatory disease. Oxygen metabolites, produced by neutrophils to exert 
microbicidal function, can also injure surrounding host tissue. Although tissues 
contain protective anti -oxidant enzymes e.g. superoxide dismutase and catalase, 
these enzyme systems may be overwhelmed during intense local production of toxic 
oxygen metabolites. Neutrophil granules also contain a large family of over 20 
enzymes, of which the serine proteases, elastase and the two metalloproteinases 
collagenase and gelatinise, seem to have the greatest potential to act as mediators 
of tissue destruction (Borregaard & Cowland, 1997). Disease states in which the 
inappropriate release of neutrophil granule contents have been implicated, include 
adult respiratory distress syndrome (ARDS), rheumatoid arthritis, chronic bronchitis, 
emphysema and glomerulonephritis (Haslett, 1992; Rossi & Haslett, 1998) 
highlighting the importance of control of secretion. 
For resolution of inflammation to occur and the tissues to return to normal, the 
inflammatory stimulus must be removed, influx of inflammatory cells must cease and 
inflammatory cells already present at the inflammatory site must also be removed. 
The removal of neutrophils has been shown to be mediated by apoptosis (Haslett, 
1992; Haslett et al., 1989; Haslett et al., 1994; Savill et al., 1993; Savill, 1997; Savill 
& Haslett, 1995; Savill et al., 1989; Whyte et al., 1997) and their subsequent 
phagocytosis by macrophages or neighbouring cells, providing a mechanism for the 
safe removal of `unwanted' cells without eliciting an inflammatory response (Savill et 
al., 1993). However, if the inflammatory response becomes overwhelmed and either 
apoptotic neutrophils become too numerous for quick removal by macrophages or 
there is a defect in the phagocytic potential of macrophages then apoptotic 
neutrophils may undergo secondary necrosis and cause tissue damage. This is 
supported by the observation that apoptotic neutrophils incubated in vitro in the 
absence of macrophages, spontaneously release their granule contents (Meagher et 
al., 1992). Nevertheless, the control of secretion must be tightly regulated in the 
neutrophil since there is still a time window for inappropriate granule release between 
the induction of apoptosis and their eventual removal by phagocytes. The induction 
of apoptosis in addition to assigning the cell for removal may also have the built -in 
safety mechanism of inhibiting exocytosis. In support of this, one study has shown 
that apoptotic neutrophils are unable to respond to inflammatory mediators and are 
effectively isolated from their external milieu (Whyte et al., 1993). A possible 
explanation for this could be the shut down of the secretory pathway in the apoptotic 
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cell rendering it incapable of replenishing its cell surface receptors. It is this potential 
inhibition of secretion during apoptosis in the neutrophil that may provide new targets 
for therapeutic manipulation of inflammatory processes. Thus it is essential to 
understand the mechanisms underlying control of secretion during apoptosis in the 
neutrophil. 
1.2 Apoptosis 
Normal cells are thought to survive only in the presence of survival factors and simply 
withdrawing them is often enough to promote apoptosis. These survival factors 
include, cytokines and physical factors such as cell -cell contact and adhesion in the 
case of adherent cells (Raff, 1992). Apoptosis has far reaching implications not only 
in the process of inflammation but also in development, immune regulation, 
degenerative disease and cancer to name a few. Regulation of the apoptotic 
pathways represents a promising new target for control of these processes, either via 
promotion of cell death (e.g. cancer) or inhibition (e.g. Alzheimer's disease). Thus, a 
detailed understanding of regulatory mechanisms and cell type specific differences is 
crucial if this phenomenon is to be exploited to maximum potential for therapeutic 
gain. 
1.2.1 Morphological & Molecular Changes During Apoptosis 
Some of the characteristic morphological features of apoptosis are chromatin 
condensation, DNA fragmentation, cytoplasmic shrinkage and membrane blebbing, 
where the intracellular contents are contained (Kerr et al., 1972; Wyllie et al., 1980). 
Many of these characteristic features are due to an evolutionary conserved apoptotic 
death pathway on which many apoptotic stimuli converge. Common to most models 
of apoptosis is the exposure of phosphatidyl serine (PS) on the outer leaflet of the 
plasma membrane, activation of the caspases, a specific family of proteases that are 
responsible for the disassembly of the cell, including control of DNA fragmentation 
(Strasser et al., 2000). 
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1.2.2 Caspases 
Before the discovery of the cysteinyl aspartate- specific proteinases (caspases), 
apoptosis was known to be distinct from necrotic forms of cell death; however the 
underlying molecular mechanisms remained undefined. Whilst a number of genes 
involved in cell death had been identified in Caenorhabditis elegans their precise role 
in apoptosis had not been elucidated (Thornberry, 1999). The discovery of 
interleukin -1ß converting enzyme (ICE) and its relation to the CED -3 death gene in C. 
elegans by Yuan et al. (1993) led to the connection between caspases and apoptosis 
and the view that the molecular mechanisms of apoptosis were highly conserved. 
The caspase family of proteins contain cysteine residues within their active sites and 
cleave target proteins at aspartic acid residues (Alnemri et al., 1996). Caspases are 
present in the cytosol as zymogens that contain three domains, which become 
activated by specific cleavage at aspartic acids between domains, followed by 
association of the large and small subunits to form a heterodimer (Nicholson, 1999). 
To date, at least 14 mammalian caspases have been identified that can be broadly 
divided into 2 groups: those centrally involved in the cell death program (caspases - 
2, -3, -6, -7, -8, -9, -10, -12, -14) and those involved in cytokine processing ( -1, -4, -5, 
-11, -13) (Nakagawa et al., 2000; Van de et al., 1998; Zimmermann & Green, 2001). 
Those caspases centrally involved in apoptosis may further be divided in terms of 
function into 2 categories: initiator caspases and effector caspases. Initiator 
caspases such as -8 and -10 have long prodomains, containing death effector 
domains (DED), allowing association with adapter molecules such as Fas- associated 
death domain (FADD). The long prodomains of initiator caspases also allow 
oligomerisation, resulting in their activation by autocatalysis by a poorly defined 
mechanism (Kumar, 1999). The preferred cleavage motif of the initiator caspases is 
IETD or LETD a tetrapeptide sequence found in most maturation sites of the initiator 
and effector caspases (Earnshaw et al., 1999). This specificity is consistent with the 
view that initiator caspases are primarily upstream activators of the effector 
caspases. Once activated, initiator caspases process the effector caspases -3, -6, - 
7, whose primary function is thought to be cleavage of cellular proteins to 
disassemble the cell (Nicholson, 1999). Typically, effector caspases have short 
prodomains and lack any `adaptor' domains, suggesting that their activation is 
dependent on cleavage by initiator caspases (Fig. 1.1). The preferred cleavage motif 
of the effector caspases is DExD and has been found in many of the proteins cleaved 
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during apoptosis (Earnshaw et al., 1999). Other caspases such as caspase -2 and 
caspase -9 contain caspase recruitment domains (CARD) that permit interaction with 
other procaspases or adaptor proteins such as inhibitor of apoptosis proteins (IAPs) 
(Kumar, 1999). 
Two caspase activation pathways are well established. One is initiated by caspase- 
8, and -10 upon death receptor ligation, the other is initiated by caspase -9 and is 
mitochondria -dependent. However, there is overlap between the two pathways 
depending on the cell type and apoptotic stimulus used and in many cases the two 
pathways have been shown to converge (see Fig. 1.3) (Kumar, 1999). If the death 
signal is death -receptor- mediated, then caspase -8 may directly process procaspase- 
3 initiating the caspase cascade (Stennicke et al., 1998). On the other hand, 
caspase -9 is central to apoptosis induced by cytotoxic drugs or cellular stress (Slee 
et al., 1999a). Activation of caspase -9 requires the release of cytochrome c and 
apoptosis protease- activating factor 1 (Apaf -1) from the inner mitochondrial 
membrane. Apaf -1 contains multiple WD -40 repeats on its C- terminal domain which 
negatively regulate the oligomerisation and binding of procaspase -9. This was 
shown by deletion of the WD -40 region that allowed binding of procaspase -9 in the 
absence of cytochrome c and dATP (Hu et al., 1999; Srinivasula et al., 1998). 
Binding of cytochrome c and ATP is thought to cause a conformational change in 
Apaf -1, which allows procaspase -9 to interact with its CARD. This complex of 
cytochrome c, ATP and procaspase -9 has been termed the `apoptosome' and is 
believed to allow the proximity- induced processing of caspase -9 (Li et al., 1997; Pan 
et al., 1998b; Saleh et al., 1999). The caspase activation events driven by caspase -9 
appear to be the simultaneous activation of caspases -3 and -7 (Pan et al., 1998a; 
Slee et al., 1999b). Caspase -3 then drives the activation of caspases -2 and -6, 
followed by the activation of caspases -8 and -10 (Slee et al., 1999b). In a cell -free 
system, caspase -3 was shown to be the key caspase involved in cleaving cellular 
proteins. Some of the cellular substrates of caspase -3 are inhibitor of caspase- 
activated DNase (ICAD), receptor- interacting protein (RIP), X- linked inhibitor of 
apoptosis protein (X -IAP), topoisomerase I, Rb and lamin B, but not poly (ADP - 
ribose) polymerase (PARP) or lamin A (Slee et al., 2001). In addition, caspase -3 
was also essential for apoptosis- associated chromatin margination, DNA 
fragmentation, and nuclear collapse in this system. Caspase -6 and -7 however, had 
little impact on any of the parameters investigated, whether this is also the case in 
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Figure 1.1: Model of caspase structure and function. Caspases are divided into 2 subgroups: initiator caspases 
and effector caspases. Initiator caspases such as -8 -9 -10 have long prodomains, containing DED or CARD 
domains, allowing association with adapter molecules. Autocatalytic cleavage of initiator caspases allows the large 
and small subunit to heterodimerise forming the active caspase. Once activated, they cleave the effector caspases - 
3, -6, -7, between domains allowing the heterodimerisation of the large and small subunit. Caspases -1, -2, -4, -5 
have not been fully characterised. 
the whole cell however or whether this is cell type dependent remains to be shown 
(Slee et al., 2001). 
Another pathway resulting in the induction of caspases has recently been discovered. 
Caspase -12 localised to the ER, appears to act as an initiator caspase, although in 
terms of structure, it most closely resembles the subfamily of caspases involved in 
cytokine processing. However, it was shown to be activated in response to ER 
stress signals, such as an accumulation of excess proteins in the ER and initiate the 
apoptotic program (Nakagawa et al., 2000). 
1.2.3 The ER & Apoptosis 
The ER in addition to its role in protein `quality control' has recently been receiving 
attention for its contribution to the apoptotic process. The contribution of the ER to 
apoptosis to date, seems to involve Caz+ signalling and the 'unfolded protein 
response' (UPR) (Ferri & Kroemer, 2001). ER proteins that have been implicated in 
apoptosis include Bcl -2, calreticulin, calnexin and caspase -12 (Ng et al., 1997). 
It has been suggested that in addition to its role of protein folding, calreticulin's role in 
apoptosis may involve Caz+ regulation (Nakamura et al., 2001). The Caz+ 
concentration in the ER of calreticulin- deficient cells is markedly reduced. In cells 
overexpressing Bcl -2, ER Caz+ concentrations are also reduced and it has been 
suggested this is a major contributing factor in the anti -apoptotic effect of Bcl -2 in the 
ER (Ng et al., 1997). Therefore if calreticulin functions as a Caz+ storage protein, 
calreticulin- deficient cells may be more resistant to apoptosis due to the reduced 
Caz+ concentration in the ER. Calnexin is also believed to play a role in the UPR, 
however, Caz+ concentrations in the ER of calnexin- deficient cells are not affected, 
indicating that the role of calnexin in apoptosis is independent of Caz+ concentrations 
(Zuppini et al., 2002). 
The accumulation of misfolded proteins in the ER leads to the activation of two 
separate signaling pathways specific to the UPR. Misfolded proteins bind to the ER 
chaperone BiP, a 70kDa transmembrane heat shock protein and a build -up of 
misfolded protein can result in the competitive disruption of B Cell Immunoglobulin 
Binding Protein/ Inositol requiring 1 -a (BiP/ Ire1 -a) complex and BiP/ Protein Kinase 
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R -like ER Kinase (PERK) (Urano et al., 2000). Ire -a is a type I transmembrane 
protein with a ribonuclease (Rnase) domain on its cytoplasmic tail and a serine/ 
threonine kinase domain that becomes activated upon dimerisation resulting in the 
autophosphorylation and dimerisation of Ire -a (Harding et al., 1999; Urano et al., 
2000). Upon dissociation from BiP, phosphorylated Ire1 -a can recruit TRAF2 via its 
cytoplasmic domain and hence activate the c -Jun N- terminal kinase (JNK) pathway, 
initiating apoptosis (Urano et al., 2000). Upon dissociation of the BiP/ PERK 
complex, PERK oligomerises and is activated by autophosphorylation. Activated 
PERK then mediates the phosphorylation of eukaryotic translation initiation factor 2 
(eIF2a) and eIF2a subsequently inhibits translation (see Fig. 1.2) (Harding et al., 
1999). The cytoplasmic face of the ER is also the intracellular location of caspase- 
12. Procaspase -12 has been shown to be recruited by Ire -a associated TRAF2 
during the UPR, resulting in the processing and activation of caspase -12 (Yoneda et 
al., 2001). It has been shown in yeast that the dimerised RNase domain of Ire -a is 
required for the induction of the UPR (Cox & Walter, 1996). A transcription factor 
was identified, 'homologous to activating transcription factor/ cyclic 3',5'- adenosine 
monophosphate response element binding protein 1 (HAC1) that binds to the UPRE 
and induces the transcription of ER chaperones. HAC1 is constitutively synthesised 
in an unspliced form but is rapidly degraded. Alternative splicing by dimerised and 
phosphorylated Ire1 -a however, generates active HAC1. Active HAC1 can then 
translocate to the nucleus where it binds to the unfolded protein response element 
(UPRE) (see Fig. 1.2). 
ER stress has also been shown to induce the cleavage of activating transcription 
factor (ATF)6, a type II transmembrane protein of the ER, although the exact signal 
for cleavage is unknown. Site -1 protease (Si P) and Site -2 Protease (S2P), involved 
in sterol regulatory binding proteins, were shown to cleave ATF6 during the UPR (Ye 
et al., 2000). Cleavage of ATF6, on the cytosolic region, results in the release of a 
50kDa fragment (p50ATF6) that translocates to the nucleus where it acts as a 
transcription factor and activates transcription of ER chaperone genes (Haze et al., 
1999; Yoshida et al., 2000). In addition, the ATF6 fragment may activate 
CCAAT /enhancer- binding protein beta homologous protein/ growth arrest and DNA 
damage inducible 153 (CHOP/ GADD)153, a transcription factor that decreases the 
expression of Bcl -2 and may therefore promote apoptosis (see Fig. 1.2) (McCullough 
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Figure 1.2: Mechanism of ER stress response. Accumulation of misfolded proteins in the ER results in the 
competitive dissociation of BiP from Ire1. This dissociation leads to the oligomerisation of Ire1, inducing its 
autophosphorylation and activation of endonuclease domains with a subsequent induction of ER chaperone 
genes, via the cleavage of HAC1 pre -mRNA in yeast. A mammalian homologue of HAC1 has yet to be 
identified. In addition, oligomerisation of Ire1 may also lead to the activation of JNK pathways, via the 
recruitment of TRAF2, which in turn can recruit caspase -12 leading to apoptosis. ATF6 is also cleaved, 
although the regulatory ATF6 molecule is unknown and the cytosolic cleavage product is translocated to the 
nucleus, where it acts as a transcription factor and induces the transcription of ER chaperone genes. UPRE = 
unfolded protein response element (yeast), ERSE= endoplasmic reticulum stress element (mammalian cells). 
1.2.4 Inhibitors of Caspases 
The inhibitor of apoptosis (IAP) proteins (X -IAP, C -IAP, C- IAP -2, N -AIP) were initially 
identified as baculovirus products that could inhibit apoptosis. Later, homologous 
mammalian proteins X -IAP (MINA, hILP), c -IAP1 (MIHB), C -IAP -2 (MIHC), N -AIP and 
Survivin were discovered and found to inhibit caspase -3, caspase -7 and caspase -9 
activity (Ekert et al., 1999). Their mode of action appears to be by acting as 
pseudosubstrates for the caspases, binding to active caspases and neutralising their 
activity (Srinivasula et al., 2001). However, upon the induction of apoptosis, the 
inhibitory activity of X -IAP is suppressed by a second mitochondria -derived activator 
of caspase (Smac/ DIABLO), released from the mitochondrial inner membrane space 
(Chai et al., 2000; Du et al., 2000). The role of some IAPs in apoptosis remains 
somewhat controversial however, since C -IAP1 (MIHB), C -IAP -2 (MIHC) and N -AIP 
only inhibited apoptosis at very high concentrations, which probably do not occur in 
vivo (Roy et al., 1997; Ekert et al., 1999). Although, the role of IAPs remains unclear, 
X -IAP and Survivin were demonstrated to be potent inhibitors of caspases at more 
physiological concentrations, thus suggesting that they play a role in regulating the 
apoptotic machinery (Deveraux et al., 1997; 1998; Li et al., 1998). 
1.2.5 Initiation of Apoptosis: Death Receptors 
Apoptosis involves an initiation phase where cells receive a signal to die, a 
commitment phase where pro -apoptotic and anti -apoptotic proteins influence the 
decision to die and an execution phase where the caspases are mobilised to 
disassemble the cell architecture. Initiators of the apoptosis machinery can be 
broadly grouped into two different categories: (1) death receptors (2) stimuli that 
provoke generalised cellular damage or cellular stress. The commitment phase 
involves members of the Bcl -2 family, which may be pro- or anti- apoptotic and in 
many cases act upon the mitochondria. 
The death receptors belong to the tumor necrosis factor (TNF) receptor superfamily, 
with the exception of the nerve growth factor (NGF) receptor (Smith et al., 1994) and 
by definition contain homologous cytoplasmic regions called death domains (DD) 
( Tartaglia et al., 1993). Typically, the TNF family death receptors are present on the 
cell surface as homotrimeric molecules that require three ligands to bind and promote 
clustering of the cytoplasmic death domain (DD) (Smith et al., 1994). In the case of 
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the Fas receptor (FasR), clustering of the DD leads to the binding of FADD through 
its own DD. FADD also contains a region termed the CARD, which recruits 
procaspase -8 and or procaspase -10, promoting the oligomerisation and cleavage of 
caspase -8 (Kischkel et al., 2001; Muzio et al., 1998). Following the activation of 
caspase -8, there are two ways in which the apoptotic machinery can be mobilized 
depending on the cell type (Scaffidi et al., 1998). Type I cell: caspase -8 directly 
activates downstream caspases, initiating the caspase cascade. Type II cell: 
caspase -8 modulates members of the Bcl -2 family of proteins, which influence the 
mitochondrial pathway of caspase activation (Scaffidi et al., 1998). 
In most cell types, TNF binding can result in the activation of three distinct pathways 
and only results in apoptosis in the presence of protein synthesis inhibitors 
(Ashkenazi & Dixit, 1998). TNF binding results in trimerisation of the TNF receptors 
(TNFR), causing association of the cytoplasmic DDs to which TNFR- associated DD 
(TRADD) then binds through its own DD. TRADD binding results in the recruitment 
of TNFR- associated factor -2 (TRAF2) and receptor- interacting protein (RIP) 
(Ashkenazi & Dixit, 1999). TRAF2 and RIP are thought to be involved in activating 
the NF -KB or JNK/AP -1 pathway, leading to the induction of proinflammatory genes. 
NF -KB inducing kinase (NIK) is activated by TRAF2 and RIP, subsequently activates 
inhibitor of KB (I -KB) kinase (IKK) (Ashkenazi & Dixit, 1999). IKK phosphorylates I- 
KB, targeting I -KB for degradation and allowing NF -KB translocation to the nucleus to 
initiate transcription. TRADD also binds to FADD and thereby can activate caspase- 
8 and or -10 and hence apoptosis (Ashkenazi & Dixit, 1998; Kischkel et al., 2001). It 
has also been suggested that ligation of the TNFR results in the recruitment of 
caspase -2, via the adapter molecule RAIDD which binds to the RIP/ TRAF2 complex 
(Duan & Dixit, 1997; Chou et al., 1998; Droin et al., 2001) . However, this is disputed 
since caspase -8 deficient cells are resistant to TNF induced apoptosis (Varfolomeev 
et al., 1998). 
1.2.6 Initiation of Apoptosis: Stress 
The second type of death stimulus includes diverse apoptosis -promoting stimuli such 
as cytotoxic drugs, radiation, heat shock, survival factor deprivation and other cellular 
stresses. Despite the apparent diversity of these stimuli, all the pathways involved 
seem to converge on the mitochondria, where modulation of mitochondrial proteins 
results in the activation of caspases (Strasser et al., 2000). 
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1.2.7 Mitochondria & Bcl -2 Family Proteins 
In addition to the text -book role of mitochondria in cellular respiration, mitochondria 
have in recent years also taken centre stage for their role in apoptosis. In 1994, 
Newmeyer et al., demonstrated that mitochondria were required in cytosols to induce 
nuclear fragmentation characteristic of apoptosis in nuclei isolated from Xenopus 
eggs. Further studies revealed that the release of cytochrome c from mitochondria 
was required for caspase activation (Desagher & Martinou, 2000). Other 
mitochondrial proteins involved in the apoptotic programme including procaspases, 
Smac/ DIABLO and apoptosis inducing factor (AlF) are all released from the 
intermembrane space of mitochondria where many members of the BcI -2 family 
proteins also reside ( Zamzami & Kroemer, 2001). 
Critical to the release of apoptotic proteins from the mitochondrial intermembrane 
space is the permeabilisation of the inner and outer mitochondrial membranes by the 
action of the putative permeability transition pore (PTP). Under normal conditions, 
the PTP facilitates the release of Cat+ from the mitochondrial matrix, through the 
action of adenine nucleotide translocator (ANT) on the inner mitochondrial membrane 
(Li & Weinman, 2002). The voltage- dependent anion channel (VDAC) is located on 
the outer mitochondrial membrane and allows the free exchange of molecules up to 
5kDa, facilitating the exchange of NADH, FADH and ATP /ADP between in the inner 
mitochondrial membrane and the cytosol. Together the ANT/VDAC in conjunction 
with other interacting proteins form the PTP (Li & Weinman, 2002). The permanent 
permeability of the mitochondrial membrane results in the release of cytochrome c 
and other pro -apoptotic molecules and members of the BcI -2 protein family are 
thought to play a key role in regulating the opening of the PTP, but their precise 
mode of action remains controversial (Susin et al., 1996; Zamzami & Kroemer, 
2001). 
Bcl -2 family members can be functionally divided into two classes, those that are 
anti -apoptoptic (e.g. BcI -2, Bcl -xL, McI -1, A -1) and those that promote apoptosis (e.g. 
Bax, Bak, Bcl -xs, Bad, Bid, Bim) (Kelekar & Thompson, 1998). All Bcl -2 family 
members share homology in one of four regions: BH1, BH2, BH3 and BH4, where 
they may share all these domains or are missing one or more domains. However, all 
Bcl -2 family members possess a BH3 domain, a stretch of 16 amino acids, 
necessary for interaction with anti -apoptotic members or to promote cell death 
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(Kelekar & Thompson, 1998). Many of the proteins have a C- terminal region that 
allows them to interact with the outer mitochondrial membrane and the ER (Kelekar & 
Thompson, 1998). For example, Bax, Bak, Bad and Bid are normally cytosolic but 
upon the induction of apoptosis are inserted into the mitochondrial membrane (Kluck 
et al., 1997; Kluck et al., 1999; Murphy et al., 1999b; Nechushtan et al., 2001; Pryde 
et al., 2000; Wei et al., 2001; Wolter et al., 1997). 
Regulation of Bcl -2 family members may be at the transcriptional level or 
posttranscriptional level. Both pro- and anti- apoptotic members can heterodimerize 
with each other which has led to the suggestion that the relative levels of either in a 
given cell may determine the ease with which a cell will activate the apoptotic 
program. Posttranslational regulation, in addition to the formation of heterodimers, 
involves in some cases phosphorylation events. Bcl -2, Bad and Bid have been 
shown to be regulated by phosphorylation (Desagher et al., 2001; Downward, 1999; 
Schurmann et al., 2000; Strasser et al., 2000). Phosphorylation of Bcl -2 has been 
reported to occur via several different kinases including PKC, PKA and CDK1. In the 
majority of studies, Bcl -2 is inhibited by phosphorylation (Adams & Cory, 1998). In 
the case of Bad, survival signals mediate its phosphorylation via protein kinase A 
(PKA) or protein kinase B (PKB or Akt) which results in its release from Bcl -XL at the 
mitochondrion. In type II cells, only the phosphorylated form of Bid is cleaved by 
caspase -8 to yield the pro -apoptotic truncated Bid (tBid) which is then thought to 
translocate to mitochondria and trigger cytochrome c release (Desagher et al., 2001). 
At the transcriptional level, Al and Mcl -1 expression have both been shown to be 
induced by GM -CSF and inflammatory cytokines (Chao et al., 1998; Karsan et al., 
1996). Therefore, a cell may increase the ratio of anti -apoptotic Bcl -2 proteins to pro - 
apoptotic in unfavourable environmental circumstances such as inflammation. See 
Fig. 1.3 for schematic overview of apoptosis. 
1.2.8 Neutrophil Apoptosis 
Evolutionary conservation of death programmes across a diverse range of species 
and tissue types means that in many cases the central pathways leading to cellular 
demise are the same. However, a thorough understanding of the subtle differences 
in the apoptotic program between cell types may be key for selective drug targeting 
strategies for the therapeutic manipulation of disease pathogenesis. While the 
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previous discussion has centred on 'global' apoptotic death programs, this section 
highlights specific neutrophil apoptotic programs. 
Neutrophils undergo constitutive apoptosis during in vitro culture, but IL -113, IL -2, 
TNF -a, IL -15, INF -y, G -CSF, GM -CSF, LPS and hypoxic conditions can inhibit this 
(Akgul et al., 2001; Ward et al., 1999b). It is likely that neutrophils would encounter 
these stimuli at inflammatory sites in vivo, thereby prolonging their life -span and 
allowing them to fulfil their role in clearance of microbes. In contrast, stimulation of 
neutrophils with an antibody against the Fas receptor in vitro has been proposed to 
increase their rate of apoptosis (Liles et al., 1996). In addition, agents that inhibit 
protein synthesis or transcription such as cycloheximide and actinomycin D have 
been shown to promote neutrophil apoptosis (Ward et al., 1999b). While the 
inhibition of protein synthesis may not represent a useful target for in vivo modulation 
of neutrophil apoptosis, the observed induction of apoptosis implies that de novo 
synthesis of survival proteins are required for neutrophil survival. 
The Bcl -2 family members that have been detected in neutrophils are BcI -XL, Mcl -1, 
Al, Bax, Bad, Bak and Bid (Akgul et al., 2001; Chuang et al., 1998; Pryde et al., 
2000). Anti -apoptotic Bcl -2 is not expressed in neutrophils, but Mc1-1 and Al mRNA 
levels, which normally have very short half -lives, have been shown to be increased or 
maintained by inflammatory mediators that inhibit neutrophil apoptosis (Chuang et 
al., 1998; Moulding et al., 1998). In contrast, the pro -apoptotic Bcl -2 family members, 
Bax, Bad, Bak and Bid are constitutively expressed in neutrophils and have a long 
half -life, perhaps explaining why on balance, neutrophils are 'primed' for apoptosis 
(Moulding et al., 2001). Further, during constitutive neutrophil apoptosis Bax 
translocates from the cytoplasm to the mitochondria resulting in caspase -3 activation 
(Pryde et al., 2000). In addition, translocation was not inhibited by z- VAD -fmk, the 
broad range caspase inhibitor, suggesting that Bax redistribution is caspase- 
independent, a topic that is examined in Chapter 3 (Maianski et al., 2002). 
The execution pathway in neutrophils is also mediated by caspases. Effector 
caspases that have been identified in neutrophils are -8 and -3 (Daigle & Simon, 
2001; Yamashita et al., 1999) and mRNA transcripts have been detected for 
caspases -7, -9 and -10 (Santos -Beneit & Mollinedo, 2000). Caspase -3 was shown 
to be critical for the induction of apoptosis in neutrophils, where the active form was 
detected in both constitutive and Fas- induced apoptosis (Daigle & Simon, 2001). 
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Caspase -8 has been shown to be active in freshly isolated neutrophils and 
expression of a FasL/ FasR on the neutrophil cell surface could lead to autocrine/ 
paracrine induction of apoptosis (Iwai et al., 1994; Kiener et al., 1997). This is 
thought not to occur. Recently, it has been reported that soluble FasL acts as a 
chemotactic factor for neutrophils implying that like TNFa, Fas may act to stimulate 
neutrophil function under certain conditions (Ottonello et al., 1999). The function of 
caspase -8 activity in freshly isolated neutrophils is not known and further work is 
necessary to define its role in apoptosis. 
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Figure 1.3: Apoptotic signalling pathways. The death receptor pathway may be triggered by binding of 
Fas ligand (FasL), inducing trimerisation of the Fas receptor (FasR). This results in the recruitment of 
procaspase -8 via the adaptor molecule FADD leading to activation of caspase -8. Caspase -8 (or FLICE) 
can be blocked by FLIP (FLICE- inhibitory protein) present in several viruses. Death receptor induced 
apoptosis may also be blocked through decoy receptors (DcR) that lack the death domain and compete for 
ligand binding without inducing apoptosis. The mitochondrial death pathway is induced by cellular stress 
which can includes cytotoxic drugs, serum withdrawel or DNA damage. The death receptor and 
mitochondria) pathways converge at the point of caspase -3 activation, which results in the cleavage of 
cellular substrates and apoptosis. Crosstalk between the apoptosis- inducing pathways is provided by 
caspase -8 mediated cleavage of Bid, resulting in truncated Bid (tBid) translocating to the mitochondria 
where it promotes the release of cytochrome c. 
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1.3 Neutrophil Granules & Exocytosis 
In addition to the unresponsiveness of apoptotic neutrophils to inflammatory stimuli, 
apoptotic neutrophils have a reduced capacity to degranulate and to bind fMLP to 
surface receptors, suggesting a loss of fMLP receptors (Whyte et al., 1993). 
Surprisingly, few studies have attempted to delineate the underlying mechanism for 
this 'unresponsive state' of the apoptotic neutrophil since it is a key phenomenon that 
prevents the inappropriate release of histotoxic contents from granules before 
apoptotic neutrophils are phagocytosed. 
1.3.1 Neutrophil Granules 
Granules form in the neutrophil during the maturation stage from myeloblast to 
promyelocyte and continue to form until maturation is complete (Borregaard et al., 
1995). Neutrophil granules are divided into myeloperoxidase (MPO) positive and 
MPO negative (Bainton et al., 1971), where MPO positive granules are further 
divided into defensin -rich and defensin -poor granules (Rice et al., 1987). MPO 
negative granules are further divided into `specific' granules and `gelatinase' 
granules, both contain lactoferrin and gelatinase but lactoferrin predominates in 
specific granules and gelatinase predominates in gelatinase granules (Kjeldsen et al., 
1992). Neutrophil storage granules, in addition to containing anti -microbial 
proteases, contain membrane -bound receptors. Secretory vesicles are classified 
separately since their only known content is plasma, although their membranes are 
rich in receptors (see Table 1.1 for known granular content in neutrophils) (Sengelov 
et al., 1993b; Sengelov et al., 1994). Secretory vesicles appear to be mobilised 
when neutrophils are activated e.g. by binding to endothelial cells, by inflammatory 
cytokines or by chemoattractants. (Crockett -Torabi et al., 1995; Crockett -Torabi & 
Fantone, 1995; Patel et al., 1994). Neutrophil activation commonly involves the 
expression of the CD18 (CD11b /CD18 integrin), the fMLP receptor and IL -8. During 
exocytosis, not only are the granule contents released but the neutrophil gains a new 
repertoire of receptors as the granule membrane fuses with the plasma membrane, 
enabling the neutrophil to interact in a new way with its environment (Berger et al., 
1984; Berger et al., 1991; Kuijpers et al., 1991). Mobilisation of secretory vesicles for 
example, enables neutrophil phagocytosis of complement opsonised particles 
(Sengelov et al., 1993b). 
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1.3.2 Regulated Secretion 
Little is known about the sorting of proteins in neutrophils into different granule 
subsets that renders them distinct from each other. The formation of granules must 
involve specificity however, in targeting proteins to the granules and not the plasma 
membrane. Further, specific proteins must be delivered to the different types of 
granule. The transport vesicles destined for the granules through the regulated 
secretory pathway must be sorted from the vesicles containing constitutively secreted 
proteins, destined for the plasma membrane through the constitutive secretory 
pathway (Sossin et al., 1990). Control of granule exocytosis (regulated exocytosis) 
however, appears to be regulated by mechanisms that differentiate between 
azurophilic granules and peroxidase negative granules but not between the subsets 
of those two classes of granule (Sengelov et al., 1993a; Sengelov et al., 1995). 
Differential sensitivity to elevated intracellular Cat+ levels has been shown in 
mobilisation of granules and secretory vesicles (Lew et al., 1986). However, both 
constitutive and regulated secretion play an important role in furnishing the neutrophil 
cell surface with receptors that allow interaction with the extracellular milieu. A 
number of studies have shown that the cell surface receptors are also synthesized de 
novo and therefore by necessity must traffic through the ER to Golgi and from the 
Golgi to the plasma membrane or to granules (Crepaldi et al., 2001; Girard et al., 
1996; Girard et al., 1997; Grenier et al., 1999; Jost et al., 1990; Jost et al., 1991; 
Zhou et al., 2000). 
1.3.3 The SNARE Hypothesis 
Only recently has a hypothesis been put forward to explain the precise targeting of 
vesicles to specific membranes. The SNARE (soluble NSF attachment protein 
receptor where NSF stands for N- ethyl -maleimide- sensitive -fusion protein) family 
proteins consist of v- SNAREs (vesicle- SNARE) and t- SNAREs (target- SNARE) and 
are thought to be part of a conserved group of proteins in mammalian cells (Chen & 
Scheller, 2001). The SNARE hypothesis states that a vesicle contains a membrane 
bound SNARE protein and a partner molecule on the target membrane (Sollner et al., 
1993). Two other known proteins are necessary for vSNARE/ tSNARE mediated 
membrane fusion, known as NSF and a -SNAP (soluble NSF attachment protein), 




CD63 (LAMP -1) 
CD68 (scavenger receptor) 
V -type H- -ATPase 
Granule Contents: 
Acid b- glycerophosphatase 
Acid mucopolysaccharide 
a1- Antitrypsin 
a- Mannosidase (acid hydrolase) 
Azurocidin/ CAP37/ heparin binding protein 
Bactericidal permeability increasing protein 
13- Glycerophosphatase 
f3- Glucuronidase 
Cathepsins (antimicrobial function) 
Defensins (antimicrobial function) 
Elastase 
Lysozyme (antimicrobial function) 
Myeloperoxidase (antimicrobial function) 







Cytochrome b555 (NADPH oxidase component) 
Diacylglycerol- deacylating enzyme 
fMLP -R 
SCAMP 
-Urokinase-type plasminogen activator -R 
VAMP -2 








CD11b/ CD18 (firm adhesion) 
CD15 antigens (rolling) 
CD66 (rolling) 
CD67 (rolling) 
Cytochrome b558 (NADPH oxidase component) 
fMLP -R (chemotaxis) 
Fibronectin 
G- proteina -subunit 
Laminin -R 




SCAMP (membrane fusion) 
Thrombospondin -R (migration) 
TNF-R 
Urokinase -type plasminogen activator -R (migration) 
VAMP -2 (vSNARE) 







Lactoferrin (prevents microbial growth) 
Lysozyme (antimicrobial function) 
NGAL 
Urokinase -type plasminogen activator 
Sialidase 
SGP28 





Cytochrome b558 (NADPH oxidase component) 
CD11b/ CD18 (firm adhesion) 
CD14 
CD16 (Fc receptor) 
fMLP -R 
SCAMP 
Urokinase -type plasminogen activator -R 
V -type H+ -ATPase 




-C1 q- receptor 
DAF (complement regulatory protein) 
Granule Contents: 
Plasma proteins 
Table 1.1: Contents of neutrophil granules and secretory vesicles with some associated functions 
(Borregaard & Cowland, 1997). 
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Different subsets of vSNAREs and tSNAREs in many cases, operate between 
distinct cellular membranes (see Fig. 1.4) (Baumert et al., 1989; Chen & Scheller, 
2001; Hay et al., 1996; Hay et al., 1997; Hay et al., 1998; Subramaniam et al., 1996). 
In addition, vSNAREs and tSNAREs have been identified as part of a complex that 
mediates fusion between a vesicle and its target membrane in almost all fusion 
events studied to date (Scales et al., 2000). However, it is unlikely that the SNARE 
molecules alone are enough to confer specificity, since it was shown that a single 
vSNARE interacted with two separate tSNAREs on separate membrane 
compartments (Gotte & von Mollard, 1998; Rothman, 1994; von Mollard et al., 1997). 
In addition, tetanus toxin exerts its effects by vSNARE proteolysis thereby blocking 
the assembly of SNARES (Hunt et al., 1994). Thus, if SNAREs alone accounted for 
the specificity and targeting of vesicles, then in the presence of tetanus toxin there 
should not be any vesicle association with the target membrane. However, the 
converse was found to be true, with increased numbers of vesicles associated with 
the target membrane, suggesting that vesicles were still targeted correctly. It has 
therefore been proposed that `tethering factors' are required for correct targeting of 
the vesicle. Another family of proteins have been implicated in vesicle targeting, 
adding another layer of specificity to membrane fusion events. The Rab family, 
belonging to the small G protein superfamily, have been shown to be important for 
membrane fusion and different Rab proteins have been shown to localise to specific 
subcellular compartments (see Fig. 1.4) and to control distinct membrane trafficking 
routes (Novick & Zerial, 1997; Zerial & McBride, 2001). However, SNAREs are 
essential for membrane fusion since despite vesicle association to the target 
membrane, no membrane fusion or exocytosis occurred (Hunt et al., 1994). 
Several models have been proposed to account for SNARE -mediated membrane 
fusion (see Hay & Scheller (1997) for review), mainly due to the controversy arising 
over the timing of NSF/ a -SNAP action. However, the model that is currently gaining 
favour is described here (see Fig. 1.5). tSNARE availability to bind vSNAREs should 
be tightly regulated, since not only must vesicle budding from donor organelles be 
regulated, but also their fusion and hence release of vesicle contents. A tSNARE 
regulator called n- Sec -1, was shown to bind to the tSNARE syntaxin -1A, present on 
the plasma membrane, blocking any interaction with its associated vSNARE in 
neuronal cells (Pevsner et al., 1994). Homologues of n -Sec -1 have been identified 
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Figure 1.4: Cellular localisation of vSNAREs, tSNAREs and Rab family of small GTPases in 
the constitutive and regulated secretory pathways. vSNARE family =red text, tSNARE 
family =black text. TGN =trans Golgi network, MG= medial Golgi, CG= cis -Golgi, STX= syntaxin, 
VAMP = vesicle associated membrane protein, SV= secretory vesicles, ER= endoplasmic reticulum, 
























































































































































































































































































However, the tSNARE regulator must also be regulated and possible candidates for 
releasing the tSNARE from n -Sect are the Rab family of small GTPases. Like all 
small GTPases, the Rab proteins cycle between the active GTP bound form and the 
inactive GDP bound form. Release of tSNARE from n- Sec -1, most likely mediated 
by GTP bound Rab, allows vSNARE to bind the tSNARE partner on the target 
membrane. Cat+ is known to be an absolute requirement for fusion to take place 
and is also thought to be the final signal necessary to facilitate `zipping' of the two 
membranes, resulting in fusion (Chen et al., 1999; Lin & Scheller, 1997). A pore 
complex is then thought to allow the release of vesicle contents into the acceptor 
membrane. After fusion, a -SNAP and NSF are recruited from the cytosol and 
hydrolysis of ATP by NSF causes dissociation of the SNARE complex (Chen et al., 
1999). 
Only two studies have looked at SNARE molecules in neutrophils to date. The t- 
SNARE protein, syntaxin -4 was found exclusively on the plasma membrane and the 
v- SNARE, VAMP2 on the membranes of granules and secretory vesicles, although 
VAMP2 was not found on azurophil granules (Brumell et al., 1995). Another study 
showed that the tSNARE syntaxin 6, was localized to the plasma membrane in 
neutrophils and interacted with the vSNARE SNAP -23, located on the gelatinase and 
specific granules. Upon neutrophil activation, SNAP -23 was translocated to the cell 
surface, colocalizing with syntaxin 6 (Martin -Martin et al., 2000). This is in agreement 
with the known secretory characteristics of the MPO +ve and MPO -ve granules. 
Under normal circumstances, the azurophilic granules (MPO +ve) do not contribute 
significantly to extracellular release, whereas specific and gelatinase (MPO -ve) 
granules do and therefore may require high levels of VAMP2 on their membranes 
(Bainton, 1973). Since degranulation is inhibited during neutrophil apoptosis, it is 
feasible that part of the apoptotic process is to shut down membrane trafficking 
events so that receptors can no longer reach the cell surface. However, the shut 
down of the regulated secretory pathway alone would presumably not be sufficient to 
inhibit receptors synthesised de novo from reaching the cell surface. The first 
possible step at which the exocytic pathway could be inhibited during apoptosis 
would be from the ER to the cis -Golgi. 
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1.3.4 Proteins Involved in ER to Golgi Transport & Tethering Factors 
Many of the studies on SNAREs have been performed in neuronal cell lines and 
tissues. However, the most information available to date on the so- called `tethering 
proteins' come from studies of ER to Golgi transport in mammalian cell lines and 
yeast. In contrast to the well -known clathrin- coated vesicles that are involved in the 
endocytic pathway, coatomer (COP) coated vesicles shuttle between the ER and the 
Golgi (COPII) and intra -Golgi (COPI), where COPI is also implicated in retrograde 
trafficking and recycling of `escaped' ER proteins (Barlowe et al., 1994). In yeast, 
COPII subunits Sar1 p, Sec23p /24p complex and Sec13p /31 p complex bind 
sequentially to the ER resulting in the construction of a transport vesicle. Sari p 
belongs to the Ail small GTPase family and is normally in the cytoplasm (Kuehn et 
al., 1998). Sec12p, an integral membrane protein of the ER, recruits Sari p -GDP to 
the ER membrane. Sec12p also functions as a guanine nucleotide exchange factor 
(GEF) ( Barlowe & Schekman, 1993), thereby facilitating the exchange of GDP for 
GTP. In contrast, the disassembly, required for fusion, involves GTP hydrolysis 
activated by Sec23p (a GTPase- activating protein or GAP) (Kaiser & Ferro -Novick, 
1998). Since many of the transport processes are highly conserved, a similar system 
is supposed to operate in the mammalian cell. 
In mammalian cells, ER to Golgi SNAREs (rbetl, membrin, syntaxin 5) project into 
the cytoplasm (Allan et al., 2000). Cytosolic, phosphorylated p115 (Sohda et al., 
1998) is complexed with the 3 SNAREs by the transient action of GTP bound Rab1 
(Allan et al., 2000). Rab1 is essential for p115 recruitment to budding COPII 
vesicles. Although, inhibition of Rab1 prevents pl15 recruitment it does not inhibit 
COPII budding but vesicles can no longer fuse with the cis -Golgi (Wilson et al., 
1994). p115 was originally identified as an essential factor for intra -Golgi transport 
(Waters et al., 1992) however, it was subsequently shown to be necessary for ER to 
Golgi transport for tethering vesicles to the Golgi matrix protein GM130 (Sonnichsen 
et al., 1998). Before vesicles access the cis -Golgi, the intermediate compartment 
(IC) is formed, morphologically described as `clusters of small vesicles or 
tubulovesicular elements' (Saraste & Kuismanen, 1984). Although, COPII is required 
for budding from the ER, it has been shown that during transit to the cis -Golgi the 
COPII vesicles shed their COPII coats and recruit COPI coats, where they undergo 
homotypic fusion to form the IC (Aridor et al., 1995; Balch et al., 1984; Beckers et al., 
1990; Hauri & Schweizer, 1992; Schweizer et al., 1990). In a recent study, the IC 
was further compartmentalised into three stages: 1) tubular elements marked by 
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COPII, 2) tubular clusters marked by COPI and 3) tubular cluster marked by COPI 
juxtaposed to the cis -Golgi but containing cis -Golgi markers (including the p115 
receptor GM130 and GRASP65) but not the cis -Golgi marker mannosidase I (Marra 
et al., 2001). COPI coated vesicles of the middle IC, with giantin and p115 
membrane bound, may then tether to the late IC via a p115 interaction with the Golgi 
matrix protein GM130. p115 may act as a 'bridge' between GM130 on the late IC 
and giantin, present on COPI vesicles (Lesa et al., 2000). GM130 binds GRASP65, 
a structural cis -Golgi membrane protein, via it's extreme C- terminus (Barr et al., 
1998) and both proteins cycle between the late intermediate compartment and the 
cis -Golgi picking up giantin -p115 vesicles (Marra et al., 2001). Giantin-p115- GM130- 
GRASP65 vesicles are then tethered to the cis -Golgi, in a step preceding SNARE 
complex formation bringing the appropriate NSF, SNAP, vSNAREs and tSNAREs 
proteins into close proximity, to promote the formation of the SNARE complex, which 
then drives membrane fusion (Cao et al., 1998). 
In addition to its role in the budding of COPII vesicles, Rab1 GTPase has also been 
shown to bind to GM130, implicating it in the later vesicle tethering stages of ER to 
Golgi transport (Weide et al., 2001). However, further work is needed to elucidate 
the role of Rab1 at this step in ER to Golgi transport. 
1.3.5 The Inhibition of ER to Golgi Transport During Mitosis 
The Golgi complex is a juxtanuclear reticular structure, which in many cell types can 
be visualised by immunofluorescence microscopy during interphase. During mitosis 
however, the Golgi fragments and punctate immunofluorescence staining is seen 
dispersed throughout the cytoplasm of the dividing cell. During telophase, the Golgi 
starts to re- assemble and is equally divided between the two daughter cells (Hiller & 
Weber, 1982). In addition, it was shown that fragmentation of the Golgi complex 
occurs with a concomitant arrest in ER to Golgi and intra -Golgi transport 
(Featherstone et al., 1985). 
Two thirds of the fragmentation that occurs during mitosis, is thought to be due to 
what is known as the COPI- dependent pathway. The COPI- mediated fragmentation 
is linked to the mitotic inhibition of ER to Golgi and intra -Golgi transport (Misteli & 
Warren, 1995). The current view is that COPI vesicles accumulate in mitosis 
because they continue to bud, but no longer dock or fuse with their target membrane. 
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The other pathway, accounting for approximately a third of Golgi fragmentation is the 
so- called COPI- independent pathway (Misteli & Warren, 1995). Only recently have 
some of the underlying mechanisms of Golgi fragmentation during mitosis been 
discovered but the COPI- independent pathway remains poorly defined. 
The transition from G2 to M phase is controlled by CDK1, which forms complexes 
with cyclins of the A and B families (Clarke & Karsenti, 1991). Golgi fragmentation 
had been thought to be dependent on the activity of CDK1 but identification of CDK1 
substrates has only recently been reported (Levine et al., 1996; Mackay et al., 1993; 
Stuart et al., 1993). Lowe et al. (1998) showed that GM130 a peripheral membrane 
protein, was phosphorylated during mitosis and this was later confirmed in 
subsequent studies (Draviam et al., 2001; Lowe et al., 2000). Phosphorylated 
GM130 was shown to have a reduced affinity for p115, potentially inhibiting docking 
of transport vesicles and therefore may contribute to Golgi fragmentation (see Fig. 
1.6). Nevertheless, other events must also take place because inhibition of the 
GM130/p115 interaction was not sufficient to cause a complete halt in intracellular 
transport or total Golgi breakdown. Microinjection of GM130 N- terminal peptide, the 
p115 binding domain, or over expression of the N- terminal peptide, was shown to 
cause an increase in the number of COPI vesicles present in the cytoplasm and a 
reduced rate of intracellular transport. While this study provided support for a model 
of mitotic Golgi fragmentation in which the tethering complex is disrupted by 
phosphorylation of GM130, complete Golgi breakdown or complete inhibition of 
exocytosis did not occur suggesting that other mitotic events were occurring 
(Seemann et al., 2000). A number of other proteins involved in vesicle trafficking 
show altered phosphorylation during the cell cycle. p115 was also found to be 
phosphorylated in a cell cycle- specific manner (Sohda et al., 1998). During 
interphase, dephosphorylated p115 is Golgi- membrane associated and 
phosphorylated p115 is present in the cytosol, having been released from 
membranes by a phosphorylation step involving casein kinase II (CKII) or a CKII -like 
kinase (Dirac -Svejstrup et al., 2000). However, during mitosis only the 
dephosphorylated GM130 binding form was present; although this interaction is 
blocked by GM130 phosphorylation. Further investigation should reveal the 
significance of cell -cycle dependent regulation of p115 (Sohda et al., 1998). 
Interestingly, Rab1 was also shown to be phosphorylated during mitosis, however 










0 0 0 0 o 0 0 0 
O 00 
00000 i0_00 000 0 0 00 
0800 
o8 




Figure 1.6: Protein interactions involved in tethering COPI vesicles to the cis - 
Golgi. During interphase, COPI coated vesicles move from the intermediate 
compartment towards the cis -Golgi. Giantin on the COPI vesicle, binds cytosolic 
phosphoryated p115 present as a homodimer. GM130, bound to the peripheral 
membrane protein GRASP65 acts as a receptor for the p115 molecule bound to the 
COPI vesicle. During mitosis, GRASP65 and GM130 become phosphorylated rendering 
GM130 unable to bind p115 and the Golgi fragments. 
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The GM130 interacting protein, GRASP65 is also phosphorylated during mitosis but 
can still interact with GM130 (Barr et al., 1997; Barr et al., 1998). Both CDK1 and the 
mitotic kinase of the polo -like kinase (Plk) family have been implicated in the 
phosphorylation of GRASP65 although this does not result in the dissociation of the 
GRASP65 -GM130 complex (Lin et al., 2000; Sutterlin et al., 2001). The functional 
significance of GRASP65 phosphorylation has therefore still to be determined. One 
possibility is that if multiple kinases and multiple substrates are involved in Golgi 
structure, the inhibition of any single substrate will not be sufficient to abrogate 
breakdown. 
1.3.6 Mechanism of Golgi Fragmentation During Apoptosis 
During mitosis cells fragment their Golgi complex into thousands of 50nm vesicles 
that are dispersed throughout the cytoplasm and equally divided between the two 
daughter cells (Lucocq et al., 1988; Lucocq & Warren, 1987; Warren, 1989). Golgi 
fragmentation has also been shown to occur with a concomitant arrest of ER to 
Golgi, intra -Golgi and Golgi to plasma membrane protein transport (Barr et al., 1998; 
Stuart et al., 1993; Warren et al., 1983). In addition to sharing morphological 
features with mitotic cells such as chromatin condensation, apoptotic cells also have 
dispersed vesicles throughout the cytoplasm (Chu -Wang I.W., 1978; Philpott et al., 
1996; Sheehan et al., 1997; Watt et al., 1994). Until very recently though, whether 
these vesicles were Golgi derived was not known and hence the question of whether 
Golgi fragmentation accompanied apoptosis also concomitantly with an arrest of 
membrane trafficking had not been addressed. Certainly, this would be one possible 
mechanism to explain the functional down -regulation of apoptotic neutrophils, by their 
inability to secrete cytokines or an inability to transport receptors to their cell surface. 
During the course of this work, studies showing that the Golgi fragments during 
apoptosis have been published and some of the target membrane transport proteins 
affected have been identified in several cell types (Lane et al., 2002; Mancini et al., 
2000; Sesso et al., 1999). Golgi fragmentation during apoptosis was shown to be 
morphologically identical to Golgi fragmentation during mitosis by electron 
microscopy studies. In both cases, 50nm Golgi- associated vesicles are found 
throughout the cytoplasm (Sesso et al., 1999; Warren et al., 1995). Golgin -160 is a 
peripheral Golgi membrane -associated autoantigen. Golgin proteins, to which 
GM130 belongs, are a small group of Golgi associated proteins, which are targets for 
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autoantibodies in some autoimmune diseases (Eystathioy et al., 2000). Golgin -160 
was shown to be cleaved by caspase -2 (Mancini et al., 2000). However, the precise 
role of Golgin -160 in membrane traffic is unknown and therefore it is difficult to 
extrapolate the full implications of this cleavage. Intuitively, the fact that Golgin -160 
undergoes caspase- mediated proteolysis implies that it is a key protein involved in 
intra -Golgi trafficking or structure. However, GRASP65 was recently shown to be 
cleaved by caspase -3 in normal rat kidney (NRK) and HeLa cells during anisomycin 
and staurosporine induced apoptosis (Lane et al., 2002). GRASP65 was shown to 
be cleaved once on the C- terminus region, distal from the GM130 binding region on 
the N- terminus. In cells stably expressing GRASP65, mutated in the caspase -3 
cleavage region, Golgi fragmentation was shown to be inhibited, suggesting that 
GRASP65 plays an important role in maintaining Golgi structure (Lane et al., 2002). 
GRASP65 is also a mitotic target and is phosphorylated by polo -like kinase and 
CDK1, therefore GRASP65 is a common target in mitosis as well as in apoptosis (Lin 
et al., 2000). Further, GM130 was not cleaved and p115, which binds to GM130, 
were both found to be bound to Golgi membranes in apoptotic cells (Lane et al., 
2002). 
29 
1.4 Aims of Thesis 
The principal aims of this thesis were to assess whether transport through the 
constitutive secretory pathway was inhibited during neutrophil apoptosis. While 
neutrophil granules are a major source of cell surface receptors, the constitutive 
secretory pathway also transports receptors to the cell surface. Therefore, an arrest 
of ER to Golgi transport during apoptosis would effectively prevent receptors 
synthesised de novo from reaching the cell surface, contributing to the environmental 
isolation of apoptotic neutrophils. Using the hypothesis that `the constitutive 
secretory pathway is inhibited during apoptosis', the key issues to be addressed 
were: 
To investigate whether ER to Golgi transport is inhibited during apoptosis, using 
fragmentation of the Golgi complex as an indicator of arrest of membrane 
trafficking. 
To identify potential mechanisms of inhibition of ER to Golgi transport. 
To assess directly the progress of viral protein through the secretory pathway in 
apoptotic cells. 
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CHAPTER 2: MATERIALS & METHODS 
2.1 Methods 
2.1.1 Isolation of Human Peripheral Blood Neutrophils 
Human neutrophils were isolated according to previously described methods (Haslett 
et al., 1985). Venous blood (36 ml) was collected into 50 ml polypropylene tubes, 
each containing 4 ml of sterile 3.8% sodium citrate solution to prevent coagulation. 
Following collection of venous blood, all neutrophil isolation procedures were 
performed under sterile conditions. The tubes were gently inverted to mix the sodium 
citrate and blood, before centrifuging the tubes at 350gav for 20 min at 20 °C. 
Centrifugation results in two fractions: the upper layer is rich in plasma and platelets 
whilst the lower layer contains erythrocytes and leukocytes. 
The upper platelet -rich plasma layer was removed for preparation of autologous 
serum and 15 ml mixed with 330 pl of CaCl2 (final concentration 20 µM). The fraction 
containing erythrocytes and leukocytes suspended in 5 ml of pre -warmed to 37 °C 6% 
dextran (2.5 ml T500 dextran/ 10 ml cells) and the volume adjusted to a total of 50 ml 
by the addition of 0.9% saline, also pre- warmed to 37 °C. After 30 min at 20 °C, 
leukocytes and erythrocytes had sedimented differentially into two layers. The upper 
layer containing leukocytes and the bottom layer containing erythrocytes. 
The leukocyte -rich layer was subsequently removed from the sedimented 
erythrocytes, centrifuged at 235gav for 6 min and then resuspended in 2.5 ml of 55% 
isotonic Percoll (9:1 v/v Percoll: 10 x PBS) in 1 x PBS without Cat + / Mg2 +. 
Discontinuous Percoll gradients were prepared by overlaying 2.5 ml of 70% isotonic 
Percoll onto 2.5 ml of 81% isotonic Percoll in a 15 ml Falcon tube and the 
resuspended cell fraction overlayed to form the final layer of the gradient. 
These gradients were centrifuged at 720g for 20 min at room temperature. 
Neutrophils were harvested from the 70%! 81% interface. Cells were then washed 2 
x in 1 x PBS without Cat + / Mg2 +. Neutrophil yield was assessed by flow cytometry 
where typically -98% of cells isolated were neutrophils (see Fig. 3.1). 
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2.1.2 Cell Culture 
2.1.2.1 Neutrophils 
Neutrophils were routinely suspended at a density of 2.5 x 106 cells/ ml in lscoves's 
Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% autologous 
serum and 50 U/ ml penicillin and 50 U/ ml streptomycin. Cells were cultured in flat - 
bottomed 96 -well Falcon Flexiwell plates (Becton- Dickenson, UK) at 37 °C in a 
humidified 5% CO2 atmosphere. 
2.1.2.2 Cell Lines 
NRK and HeLa cells were routinely maintained in Minimal Essential Medium (MEM), 
COS -7 cells in DMEM and J.CaM1.6 cells in RPMI -1640 containing 10% FCS, 100U/ 
ml of penicillin /streptomycin, 2 mM L- glutamine, and 1% non -essential amino acids. 
Cells were grown in a 5% CO2 humidified incubator at 37 °C. J.CaM1.6 cells are a 
mutant derivative of Jurkat Human T cells, which constitutively express FasR. 
2.1.2.3 Hybridomas 
The hybridoma 1B2, raised against rat liver Golgi membranes (J.Pryde - unpublished 
results), was maintained in DMEM containing 20% FCS, 100U/ ml of 
penicillin /streptomycin, 2mM L- glutamine, and 1% non -essential amino acids in a 5% 
CO2 humidified incubator at 37 °C. Cell density was maintained between 5 x 105 and 
8 x 105 cells/ ml. To harvest the monoclonal anti -Golgi antibody, cell density was 
allowed to increase to 2 x 105 cells/ ml, after which the supernatant was collected. 
2.1.3 Induction of Apoptosis 
NRK or HeLa cells grown on glass coverslips in a 6- well -plate were incubated in 2 ml 
serum -free DMEM containing 1000/ ml of penicillin /streptomycin per dish overnight. 
Apoptosis was induced by the addition of 2 pM staurosporine (SSP) solubilised in 
dimethyl sulphoxide (DMSO) for various time points and control cells were treated 
with <1% DMSO. 
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COS -7 cells were grown on glass coverslips in a 6- well -plate in 2 ml whole DMEM 
per dish. Cells were incubated overnight with 2-(4-morpholinyl)-S- phenyl -4H -1- 
benzopynan -4 -one (LY294002) and apoptosis was induced by the addition of 2 pM 
SSP solubilised in DMSO for various time points and control cells were treated with 
<1% DMSO. 
J.CaM1.6 cells were incubated in 96- well -plates at 2.5 x 106 cells/ ml in a total 
volume of 150 pl. Stock SSP (2mM in DMSO) and stock CH11 (5 µg/ ml) were 
diluted 1/ 100 in complete medium and further diluted 1/ 10 by adding 15 pl into the 
appropriate wells. Z -VAL- ALA -DL- Asp -fluoromethylketone (z- VAD -fmk, 100 p.M) was 
added to appropriate wells in both SSP and CH11 (monoclonal antibody, 500 ng/ ml) 
assays and ZB4 (monoclonal antibody, 500 ng/ ml) was added to appropriate wells in 
CH11 assays. 
2.1.4 Assessment of Apoptosis 
2.1.4.1 Nuclear Morphology: 
Nuclei were stained with Hoechst 33258 and examined by fluorescence microscopy. 
Apoptotic cells were identified by characteristic fragmented or `pebbled' nuclei (Wyllie 
et al., 1980) (Fig. 3.9C). In the case of neutrophils, apoptotic cells were defined as 
those containing one or more darkly stained pyknotic nuclei (see Fig. 3.4E). 
2.1.4.2 Fractional DNA Content 
DNA content of cells was assessed by flow cytometry, where cells with fragmented 
DNA can be identified by their location to the left of the G1 peak representing G1 
cells (Bedner et al., 1999). Cells were fixed and permeabilised in ice -cold 70% 
ethanol over 10 min and pelleted (200 gay, 3 min, 4 °C). The cell pellet was then 
washed 3 x in PBS without Cat + / Mgt+ and were then incubated with 60 pl of 50 µg/ 
ml RNase A at 20 °C for 30 min. Cells were subsequently stained with 1 mg/ ml 
propidium iodide (PI) for 25 min and covered in foil. Fractional DNA content was 
assessed by flow cytometry on a Coulter EPICS (Beckman Coulter (UK) Ltd) and 
analysed on associated EXPO software. All experiments were assessed in triplicate. 
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2.1.4.3 Annexin -V Binding 
Apoptosis in J.CaM1.6 cells and neutrophils was also assessed by flow cytometry. 
Externalisation of phosphatidylserine was monitored by FITC -labelled recombinant 
human Annexin -V binding. Stock Annexin -V -FITC was diluted 1/ 3000 with Annexin- 
V binding buffer (500 ml Hanks Balanced Salt Solution containing 5 µM CaCl2 ). 20 
pl of cells (5 x 106 cells/ ml) were added to 280 pi of the diluted Annexin -V -FITC 
solution and incubated on ice for 10 min. Annexin -V binding was assessed by flow 
cytometry on a Coulter EPICS (Beckman Coulter (UK) Ltd) and analysed on 
associated EXPO software. All experiments were assessed in triplicate. 
Alternatively, adherent cell lines grown on glass coverslips, were inverted onto 100 pl 
of Annexin -V -Alexa 488 (green), diluted 1/ 200 with Annexin -V binding buffer 
containing 2 µg/ ml Hoechst 33258 to stain the nuclei. Cells were incubated at room 
temperature for 15 min before samples were fixed with 3% (w /v) PFA in PBS and 
mounted with Moviol *. 
2.1.5 Indirect Immunofluorescence 
The indirect immunofluorescence protocol was adapted from the method of (Ash et 
al., 1977). Cells were grown on 1.5 x 22 x 22 -mm glass coverslips in a 6 -well Greiner 
dish or non -adherent cells were cytocentrifuged (300rpm for 3 min) onto 1.5 x 22 x 
22 -mm glass coverslips and fixed in methanol -free 3% (w /v) PFA/ PBS containing 
1mM CaCl2 and 1mM MgCl2 for 20 min at 20 °C. All subsequent steps were carried 
out at room temperature. The aldehyde groups were then quenched with 50 mM 
NH4CI for 10 min. If required, cells were permeabilised with 0.1% (w /v) Triton X -100 
and non -specific binding blocked with 10% (v /v) sheep serum (SS) in 0.2% (w /v) fish 
skin gelatin (FSG). To apply the antibodies to the cells, the coverslips were drained 
on Whatmann 3mm filter paper and inverted onto a 100 µi drop of antibody diluted in 
10% (v /v) SS/ 0.2% (w /v) FSG, placed on a sheet of parafilm. Primary antibodies 
used were: Rabbit anti -active -caspase -3 rabbit polyclonal antibody 1/ 3000. Mouse 
anti -rat GM130 monoclonal antibody (stock solution 250 µg/ ml diluted 1/ 200). 
Mouse anti -rat p115 monoclonal antibody (stock solution 250 µg/ ml diluted 1/ 200). 
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Rabbit anti -human Bax polyclonal antibody (stock solution 1 mg/ ml diluted 1/ 200). 
Mouse anti -Bax monoclonal antibody (mouse ascites fluid diluted 1/ 200). Mouse 
anti -Golgi (1 B2) monoclonal antibody neat supernatant from hybridoma culture. 
Rabbit anti -Golgi (JPR3) polyclonal antibody 1/ 200 (Pryde, 1994). Mouse anti- 
human MPM2 monoclonal antibody (stock solution 1 mg/ ml diluted 1/ 500). The 
slides were incubated with the secondary antibodies AlexaTM 488 (green) goat anti - 
mouse IgG (highly cross -adsorbed) and AlexaTM 568 (red) goat anti -rabbit (highly 
cross -adsorbed), (stock solutions 2 mg/ ml diluted 1/ 400) for 20 min and washed 
three times in PBS. Nuclei were stained with 2 µg/ ml Hoechst 33258 for 10 min for 
fluorescence microscopy or with 1 µM TO -PRO3 for 45 min for confocal microscopy. 
For confocal microscopy the cells were immediately rinsed in dH2O following 
incubation with TO- PRO -3, drained on filter paper and inverted onto a drop of Moviol* 
on a glass slide. Cells stained with Hoechst 33258 were further washed 3 x in PBS, 
rinsed in dH2O and mounted in Moviol *. 
*Moviol: 6g of analytical grade glycerol, 2.4g of Moviol 4 -88 (Hoechst), add 6 ml of 
water and leave solution for 2 h at room temperature. Add 12 ml of 0.2 M Tris -HCI 
pH 8.5 and incubate solution at 50 °C for 10 min with occasional stirring to dissolve 
the Moviol. The mixture is clarified by centrifugation at 5000 gay for 15 min. 
2.1.5.1 Immunofluorescence Staining of VSVG 
The monoclonal antibody clone 8G5 was shown to only stain the correctly folded 
VSVGts045. In contrast the monoclonal antibody raised against VSVGts045, clone 
P5D4 recognised both the misfolded and correctly folded (32 °C) VSVGts045 (Fig. 
2.1). To ensure that VSVGts045 was labelled a mixture of both antibodies was used 
in subsequent experiments. Both antibodies were used at a working dilution of 1/200 
(P5D4 mouse ascites fluid, 8G5 stock solution 1 mg/ ml). 
2.1.6 Microscopy 
For fluorescence microscopy, cells were observed using a x63 oil immersion 
objective lens on a Zeiss Axiovert S100. Images were captured using a colour 
CooISNAP camera (Zeiss) and Openlab 3.0 (Zeiss) software. Images were then 
digitally processed using Adobe Photoshop 5.02 and Paint Shop Pro 5. 
35 
For confocal microscopy cells were observed using an x63 oil immersion objective 
lens on a Leica TCS NT confocal laser scanning microscope system (Heidelberg, 
GMBH). Single optical sections of the images captured with Leica TCS software 
were digitally processed using Adobe Photoshop 5.02 and Paint Shop Pro 5. 
2.1.7 Statistical Analysis 
Results are reported either as pooled data from a series of n separate experiments 
(mean ± S.E.M) or as individual representative experiments (mean ± S.E.M., each 
slide counted 3 x/ condition or 3 replicates/ condition). Statistical significance was 
assessed by one -way analysis of variance with comparisons between groups made 
using the Tukey procedure. 
2.1.8 Preparation of Samples for EM 
HeLa cells were treated with 2µM SSP for 5 h in 75cm2 tissue culture flasks and then 
fixed in 0.5% (v /v) -glutaraldehyde -200mM PIPES [piperazine-N,N'-bis(2- 
ethanesulfonic acid)] -KOH, pH 7 for 1 hour and stored in PBS. All subsequent 
procedures were carried out by J. Lucocq, The University of Dundee, U.K. Cells 
were then scraped from 75 cm2 tissue culture flasks and centrifuged at 13,000ga, for 
15 min. Pellets were cryoprotected by infusion with 2.1M sucrose and frozen in liquid 
nitrogen and ultrathin cryosections were prepared and immunolabelled with the 
monoclonal antibody raised against n- acetyl -glucosaminyl -transferase -1, a resident 
Golgi enzyme, followed by protein -A -gold. For quantitative methods see Pryde et al. 
(1998). 
2.1.9 Transport Assay in Transfected COS -7 cells 
COS -7 cells (5 x 106 cells/ ml) were transiently transfected with the mammalian 
expression vector JC119/ ts045 by double pulse (750 V, 25 pF and 100V, 1500 NF) 
on the EasyJect Electroporator (Flowgen, Leicestershire, UK). Following 
electroporation, cells were immediately transferred to whole DMEM, pre- warmed to 
37 °C and incubated at 37 °C for 12 h to allow the cells to adhere. Cells were then 
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washed 2 x in PBS without Caz +/ Mgt+ to remove dead cells and trypsinised. The 
cells were then counted and the % cell survival was typically 40 -50 %. The remaining 
cells were subsequently grown on 1.5 x 22 x 22 -mm glass coverslips in a 6 -well 
Greiner dish, containing 2 ml of whole DMEM and left overnight. The medium was 
then replaced with serum -free DMEM containing 100U/ ml of penicillin /streptomycin 
and 20 .tM LY294002 and returned to 37 °C. Cells were subsequently shifted to the 
restrictive temperature (40 °C) 12 h prior to the induction of apoptosis to allow an 
accumulation of VSVGts045 in the ER. 
2 µM SSP was added to the appropriate wells and the cells incubated for 8 h at 40 °C. 
30 min prior to shifting to the permissive temperature of 32 °C, 50 µg/ ml CHX was 
added to halt further translation of VSVG and 100 µM z- VAD -fmk to prevent 
progression of apoptosis during the transport of VSVGts045 to the cell surface. The 
cells were then shifted to the permissive temperature (32 °C) for 2 h to allow 
progression of VSVGts045 to the cell surface. Cells were then immediately fixed and 
immunofluorescently labelled for confocal microscopy as described above. 
2.1.10 Western Blotting 
2.1.10.1 Western Blotting for GM130 
Detection of GM130, a 130kDa peripheral Golgi membrane protein, required that 
adjustments were made to the standard method of sample preparation to optimise 
detection by western blotting in J.CaM1.6 cells. Various different lysis buffers were 
tested: 
1) Standard Lysis Buffer: 10 mM Tris -HCI pH 6.8, 1% (w/ v) NP -40, 1% (w/ v) 
deoxycholate, 1/ 5000 protease inhibitor cocktail (87 mg phenylmethylsufonyl 
fluoride, 160 mg benzamidine, 10 mg leupeptin and aprotinin, 5 mg of bestatin, 
antipain, chymostatin and pepstating A solubilised in 1 ml DMSO). 
2) Standard Lysis Buffer containing 1% SDS: 10 mM Tris -HCI pH 6.8, 1% (w/ v) NP- 
40, 1% (w/ v) deoxycholate, 1% (w/ v) SDS, 1/ 5000 protease inhibitor cocktail. 
3) Immunoprecipitation buffer: 50 mM Tris -HCI pH 8, 0.4M NaCI, 1% (w/ v) 
deoxycholate, 1% (w/ v) NP40, 5 mM EDTA, 1/ 5000 protease inhibitor cocktail. 
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60 µl of lysis buffer was added to the cell pellet (either 2.5 x 106 cells or 5 x 106 cells), 
pre- washed in ice -cold PBS containing 1/ 5000 protease inhibitor cocktail and 
incubated on ice for 10 min. Samples were then centrifuged at 18,000 gav for 3 min 
and the post -nuclear supernatant added directly to pre- heated (95 °C) sample buffer. 
Figure 2.2 shows the efficiency of GM130 extraction using the different lysis 
methods. The lysis buffer containing 10 mM Tris -HCI pH 6.8, 1% (w /v) NP -40, 1% 
(w/ v) deoxycholate, 1% (w/ v) SDS 1/ 5000 protease inhibitor cocktail was the most 
efficient lysis buffer for the extraction of GM130 from J.CaM1.6 cells and 2.5 x 106 
cells/ sample were adequate for it's detection (Fig. 2.2, lanes 3 & 4). 
2.1.10.2 Sample Preparation 
Proteins analysed by western blot were: procaspase -3, GM130, pl 15 and actin. The 
standard lysis buffer containing 1% (w /v) SDS was efficient at extracting all proteins 
of interest and was therefore used as standard in all subsequent experiments. 
J.CaM1.6 cells were harvested, put into pre -chilled eppendorfs and pelleted (100 gay, 
5 min, 4 °C) and washed 1 x in ice -cold PBS without Cat + / Mgt+ containing a 1/ 5000 
dilution of protease inhibitor cocktail and incubated on ice for 30 min. Cells were 
pelleted again and resuspended in 6011I lysis buffer (10mM Tris -HCI, 1% (w/ v) SDS, 
1% (w/ v) NP -40, 1% (w/ v) deoxycholate and incubated on ice for 10 min before 
being centrifuged (18,000 gay, 3 min, 4 °C) to pellet the nuclei. Post -nuclear 
supernatants were then transferred to eppendorfs containing 2 x pre -heated (95 °C) 
sample buffer (4 x sample buffer is 1 M Tris -HCI pH 6.8, 10% (w/ v) SDS, 40% (w/ v) 
glycerol, 5µM DTT and 0.01 % (w/ v) bromophenol blue) and heated at 95 °C for 3 
min. Samples were then cooled and 10 mM iodoacetamide added prior to 
centrifuging (20,000 ga,,, 1 min, 20 °C). 
2.1.10.3 Protein Separation By Polyacrylamide Gel Elecrophoresis 
(PAGE) 
Proteins were separated on polyacrylamide gels (Laemmli, 1970) (1 M Tris -HCI pH 
8.8, 8% acrylamide) and the stacking gel used was 50 mM Tris -HCI pH 6.8 with 4% 
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(w/ v) acrylamide. Samples were then resolved on gels, 16 x 20 cm plates, 1 mm 
thick (Bio -Rad Protean II) overnight at 62V and electrophoreticallly transferred to 
nitrocellulose at a constant current of 0.85 mA for 90 min at 4 °C alongside molecular 
weight markers. The transfer buffer used was 50 mM Tris -HCI, 0.4 M glycine and 
20% (v /v) methanol (Towbin et al., 1979). To check protein transfer the nitrocellulose 
was stained with Ponceau S. Non -specific protein binding sites on the nitrocellulose 
membrane were blocked by incubation of the membranes in blocking buffer (Tris 
Buffered Saline (TBS) is 20 mMTris -HCI pH 7.4, 15 mM NaCI containing 5% (w/ v) 
casein) for one hour at 37 °C. The blots were probed with mouse monoclonal 
antibodies to procaspase -3 (stock solution 250 mg/ ml diluted 1/ 1000), GM130 
(stock solution 250 lug/ ml diluted 1/ 500), p115 (stock solution 250 µg/ ml diluted 1/ 
500) and actin (ascites fluid diluted 1/ 5000) for 90 min at 20 °C with constant 
shaking. This was followed by 3 sequential washes (5 min, 20 °C) in TBS buffer. 
Membranes were then incubated with the horse -radish peroxidase (HRP)- conjugated 
secondary antibody HRP -Goat anti mouse IgG diluted 1/ 10,000 in blocking buffer for 
one hour at room temperature with gentle shaking. Membranes were washed a 
further 3 times with Tris Buffered Saline (TBS is 20 mM Tris -HCI pH 7.4, 15 mM 
NaCI) before 1 min incubation with ECL reagent. The membrane was placed under 
BioMax MS -1 X -ray sensitive film and processed through an X -ray developer (X- 
Ograph Imaging Systems, Wilts, U.K.) with a typical exposure time of 5, 10 or 20 min. 
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Figure 2.1: Indirect Immunofluorescence staining of VSVGts045 in COS -7 cells. Cells 
were transfected with JC119/ts045 and held at the restrictive temperature for 12 hours to 
allow VSVG to accumulate in the ER. (A) cells held at the restrictive temperature (40 °C), 
stained with the monoclonal antibody 8G5. Only the ER (red) was stained with an antibody 
raised against calnexin. There is no detectable VSVGts045 staining (green). (B) COS -7 
cells shifted to the permissive temperature where VSVGts045 is detected on the cell surface 
with the 8G5 antibody. (C) JC119/ ts045 transfected cell held at the restrictive temperature 
(40 °C), stained with the monoclonal antibody P5D4. VSVGts045 was detected and co- 
localised (yellow staining) with the ER. In addition, this antibody also detected the properly 
folded VSVGts045 detected on the cell surface after incubation at the permissive 
temperature (D). Data are representative of 2 separate experiments. Scalebar represents 
10µm. 
Figure 2.2: Optimisation of lysis buffer used to extract GM130 from J.CaM1.6 
cells for western blotting. Lane 1: positive control. Lane 2: Standard Lysis Buffer, 2.5 
x 106 cells. Lane 3: Standard Lysis Buffer, 5 x 106 cells. Lane 4: Standard Lysis Buffer 
+ 1% SDS, 2.5 x 106 cells. Lane 5: Standard Lysis Buffer + 1% SDS, 5 x 106 cells. 
Lane 6: immunoprecipitation buffer, 2.5 x 106 cells. Lane 7: immunoprecipitation buffer, 
5 x 106 cells. Data are representative of 2 experiments. 
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2.1.11 Molecular Biology Methods 
2.1.11.1 Agarose Gels 
DNA was typically run on a TBE (90 mM Tris- borate, 2 mM EDTA) agarose gel, with 
an agarose percentage ranging from 0.7% to 1% (w/ v) depending on the size of 
DNA fragments to be resolved. 
2.1.11.2 Sub -cloning of VSVGts045 
pcDNA3 was linearised with the restriction enzyme Xhol in the buffer supplied by the 
manufacturer (Promega, UK) and run on a 1% (w/ v) agarose gel. Cut pcDNA3 was 
then gel purified and treated with shrimp alkaline phosphatase (SAP) according to the 
manufacters instructions to prevent self -ligation of the vector. 
JC119/ ts045 was digested with Xhol and the 1.7 Kb insert gel purified using the 
QIAEX Il Kit (Qiagen, UK). Ligation reactions were carried out with various ratios 
(1:3, 1:5, 1:7, 1:10) of SAP treated pcDNA3 and 1.7 Kb ts045 were then incubated 
with T4 DNA ligase, in the buffer supplied, at 16 °C overnight. 
2.1.11.3 Transformation of Competent Bacterial Cells 
50 µl of E.coli DH5a cells (Gibco, UK) were mixed with 3 cf ligation reaction in pre - 
chilled eppendorfs and left on ice for 30 min. The cells were heat -shocked for 35 sec 
at 45 °C and further incubated on ice for 2 min. The cells were then incubated in 400 
IA of S.O.C. medium for 60 min at 37 °C before being plated onto Lauria Broth (LB) 
Agar containing 50 µg/ ml ampicillin. The cells were incubated overnight at 37 °C. 
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2.1.11.4 Screening of Transformed Cells for pcDNA3/ VSVGts045 
Transformed cells were picked and grown overnight in 5 ml of LB containing 50 µg/ 
ml ampicillin at 37 °C. Plasmid purification was carried out using the Mini -Prep DNA 
Purification Kit (Promega, UK) and initially, the DNA digested either with Xhol to 
screen for clones containing the pcDNA3/ ts045 or EcoRV to check the orientation of 
the 1.7Kb ts045. Subsequent double digests were performed with Xbal and Notl to 
ensure that the 1.7Kb ts045 had inserted as a single copy into pcDNA3. 
2.1.11.5 Transfections 
Cells were transiently transfected with VSVGts045 in the expression vectors JC119 
or pcDNA3 by electroporation using either single pulse at 400 V, 25 pF or double 
pulsed at 750 V, 25 pF and 100 V, 1500 pF on the EasyJect Electroporator 
(Flowgen, Leicestershire, UK) according to the manufacturers instructions. Cells 
were initially transfected in phosphate buffered sucrose (272 mM sucrose, 7 mM 
sodium phosphate pH 7.4, 1 mM MgCl2). To optimise transfection efficiencies, the 
transfection buffer used was 50 mM Glutathione, 200 mM ATP in Hank's Balanced 
Salt Solution, based on the recommended transfection buffer by the manufacturers: 
OptiMixTM (Flowgen, Leicestershire, UK). 
5 x 106 cells were pelleted and resuspended in 800 µl transfection buffer containing 
20 pg of expression vector/ VSVGts045 DNA and immediately transferred to 
GenePulser electroporation cuvettes (0.4 mm gap, Bio -Rad). Cells were then 
electroporated at the voltages and number of pulses indicated (see Chapter 5) and 
immediately transferred to a 75 cm2 tissue culture flask, containing pre- warmed 
(37 °C) whole DMEM. Cells were then left for 12 h before the dead cells were rinsed 
off with PBS (Ca2 +, Mg2+ free) and then trypsinised and transferred to 6- well -plates 
containing glass coverslips. Cells were then left for a further 36 h to allow for 
maximal protein expression before cells were fixed with 3% (w/ v) PFA in PBS and 
stained by indirect immunofluorescence. 
Transfection efficiency was estimated by counting 100 cells, stained with the 
monoclonal antibodies P4D5 and 8G5 raised against VSVG protein. 
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2.2 Materials 
Amersham Pharmacia Biotech, UK Ltd (Buckinghamshire, UK): Hybond C 
nitrocellulose membrane. 
Bachem (Saffron Walden, UK): z- Val -Ala -DL- Asp- fluoromethylketone (z- VAD -fmk) 
dissolved in DMSO and stored at -20 °C at a stock concentration of 100mM. 
Bender MedSystems, (Vienna, Austria): Fluorescein isothianate (FITC) -labelled 
recombinant human Annexin -V. 
Bio -Rad (UK): GenePulser cuvettes (0.4cm gap). 
Boehringer Corporation (UK): Triton X -100. 
Calbiochem Novabiochem Ltd (Nottingham, UK): Staurosporine (dissolved in 
DMSO at 2mM and stored at 4 °C). 
European Collection of Animal Cell Cultures (Porton Down, UK): COS -7. HEK- 
293. HeLa. J.CaM1.6. NRK. Spinner HeLa. 
Gibco Life Technologies (Paisley, UK): Heat -inactivated Fetal Calf Serum. RPMI- 
140. L- Glutamine. Penicillin (50 U/ ml). Streptomycin (50 U/ ml). 1M Hepes (tissue 
culture grade). Non -essential amino acids. Trypsin /EDTA. Competent Escherichia 
coli DH5. 
Hoechst (Frankfurt, Germany): Moviol 4 -88. 
Invitrogen (UK): Mammalian expression vector pcDNA3. 
Molecular Probes (Netherlands): Hoescht 33258. Propidium Iodide. Annexin -V- 
Alexa 488 (green). 
MWG- Biotech AG (UK): Oligonucleotides for sequencing: 5' -TTG TTG ATG AAT 
ACA CAG GAG A -3', 5' -TTG AGA GGA TCT ATT ATT C -3', 5' -ATC TTC ATC TTA 
GCT CAA AGG C -3'. 
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Promega (UK): Restriction enzymes (BamHI, EcoRI, EcoRV, Kpnl, Hindlli, Notl, 
Smal, Xbal, Xhol). T4 DNA Ligase. BenchTop 1kb DNA Ladder. Wizard® Plus SV 
Minipreps DNA Purification System 
Qiagen (UK): Endotoxin -Free MaxiPrep. SuperFectTM 
Roche (UK): FuGeneTM6. Shrimp Alkaline Phosphatase (SAP). 
Scottish Antibody Production Unit: Sheep serum. 
Sigma (UK): Ampicillin. Cycloheximide (dissolved in DMSO at 20mM). Dimethyl 
sulphoxide (DMSO). Dithiothreitol (DTT). Dulbecco's Phosphate buffered saline 
(PBS) sterile, endotoxin -free, pH7.4. Dulbecco's Minimal Essential Medium (DMEM). 
Ethidium bromide. Sodium azide. Kodak BioMax Film. Methanol -free 
paraformaldehyde. Minimal Essential Medium (MEM). 
Sykem (UK): Agarose. 
JC119/ ts045 was a kind gift from J.Rose, Yale University. 
All other chemicals were of molecular, reagent or cell culture grade and were 
obtained from BDH (Leicestershire, UK). 
2.2.1 Antibodies 
Idun Pharmaceuticals (USA): Rabbit anti -active -caspase -3 polyclonal 
antibody (clone CM1). 
Molecular Probes (Netherlands): Goat anti -mouse IgG antibodies AlexaTM 488 
(Green) (Highly Cross Adsorbed). Goat anti - 
rabbit IgG antibodies AlexaTM 568 (Red) 
(Highly Cross Adsorbed). 
PharMingen (Europe): Mouse anti -human procaspase -3 monoclonal 
antibody (clone 19). 
Mouse anti -VSV Glycoprotein (clone P5D4) Sigma (UK): 
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monoclonal antibody. 
Mouse anti -f3 -actin monoclonal antibody (clone 
AC -74). 
TCS Biologicals (UK): Mouse anti -human FasR (clone CH11) 
monoclonal antibody. 
Mouse anti -human FasR (clone ZB4) 
monoclonal antibody. 
Mouse anti -human MPM -2 monoclonal 
antibody. 
Mouse mitochondrial heat shock protein 70 
(mtHSP70) monoclonal antibody (clone JG1). 
Rabbit anti -human Bax polyclonal antibody. 
Transduction Laboratories (San Mouse anti -rat GM130 (clone 35) monoclonal 
Diego, USA): antibody. 
Mouse anti -rat p115 (clone 46) monoclonal 
antibody. 
Leo Lefransçois, University of Hybridoma clone 8G3 (VSVG) 
Connecticut Health Center 
Graduate School, USA. 
Brian Burke, University of Polyclonal rabbit calnexin polyclonal antibody 
Calgary, Canada. Mouse VSV Glycoprotein (clone VG1) 
monoclonal antibody 
James G. Pryde, The University Hybridoma clone 1B2 (Golgi) 
of Edinburgh, UK. 
Herman Schagger, University of Rabbit polyclonal anti -ubiquinol- cytochrome c 
Frankfurt-am -Main oxidoreductase (complex Ill) 
Ian Dransfield, The University of Monoclonal antibody BOB78 
Edinburgh, UK. 
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CHAPTER 3: GOLGI MORPHOLOGY DURING APOPTOSIS 
3.1 Introduction 
Morphologically, the Golgi apparatus is organised juxtanuclearly in a series of stacks 
of flattened discs linked by filamentous structures in interphase cells. Proteolysis of 
Golgi stacks in cell -free studies leads to the disorganisation of the flattened discs, 
giving rise to single cisternae (Cluett & Brown, 1992). This finding suggested that 
these connecting filamentous structures were proteinaceous and were required for 
stacking of the Golgi cisternae (Cluett & Brown, 1992), leading to the idea of the 
intercisternal Golgi matrix; a group of proteins involved in interconnecting the Golgi 
cisternae. Reassembly of mitotic Golgi membranes in cell -free experiments, required 
NSF, SNAPs, p115 and p97 to give rise to single cisternae (Rabouille et al., 1995). 
However, for the stacking of cisternae, GRASP65, GRASP55, giantin and GM130 
are required (Barr et al., 1997; Shorter et al., 1999; Shorter & Warren, 1999). 
Therefore, the main candidates involved primarily in stacking of single Golgi 
cisternae are GRASP65, GRASP55, giantin and GM130. 
During mitosis, the Golgi complex fragments into thousands of -50nm vesicles 
dispersed throughout the cytoplasm of the cell with a concomittant inhibition of ER to 
Golgi transport and intra -Golgi transport (Lucocq et al., 1988; Lucocq & Warren, 
1987; Mackay et al., 1993; Stuart et al., 1993; Warren et al., 1983). Golgi 
fragmentation also occurs when cells are treated with nocodazole, okadaic acid, 
brefeldin A and ilimaquinone (Lowe et al., 2000). In the case of nocodazole, Golgi 
fragmentation ocurs without a concomittant arrest of ER to Golgi transport. However, 
Golgi fragmentation occurred without phosphorylation of GM130 by CDK1 in 
nocodazole, okadaic acid or ilimaquinone treated cells, as occurs during mitosis 
(Lowe et al., 2002). Therefore, these models of Golgi fragmentation have no known 
physiological relevance. Recently, it was shown that the Golgi also fragments during 
apoptosis, in a manner that is morphologically similar to fragmentation during mitosis 
(Sesso et al., 1999). It is therefore tempting to hypothesise that the mitotic targets of 
key Golgi proteins may also be targets during apoptosis. 
Golgi fragmentation during mitosis is CDK1 dependent. Interestingly, there have 
been numerous reports recently showing acitivation of CDKs during apoptosis (Choi 
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et al., 1999; Hakem et al., 1999; Jin et al., 2000; Kim et al., 2001; Schroter et al., 
1996; Shi et al., 1994; Zhou et al., 1998). Inhibitors of CDKs were shown to reduce 
DNA fragmentation in many models of cell death. Activation of CDK2 during 
apoptosis was shown to be caspase- dependent in HeLa cells treated with a variety of 
death inducing stimuli. Inhibition of CDK2 activity was shown to affect chromatin 
condensation, cell shrinkage and loss of adhesion, features that are also common to 
mitosis (Harvey et al., 2000). Interestingly, the CDK1 regulatory kinase Wee1 has 
been shown to be cleaved by caspases -3, -7 and -8 in apoptotic Jurkat cells, while 
cdc25 was not affected (Zhou et al., 1998). Wee1 phosphorylates threonine 14 and 
tyrosine 15 on CDK, thereby inhibiting CDK1 activity. Removal of those phosphates 
by the phosphatase cdc25, results in activation of CDK1 (Obaya & Sedivy, 2002). 
Also shown in this study was that total CDK1 and CDK2 levels remained constant but 
there was a dramatic decrease in phosphorylation at tyrosine 15 argueing against the 
need for de novo protein synthesis. However, the MPM -2 antibody, a monoclonal 
antibody reacting specifically with over 40 mitotic phosphorylated proteins 
( Westendorf et al., 1994), did not react with apoptotic cells, suggesting that the 
widespread phosphorylation of mitotic substrates did not occur. Nevertheless, it is 
possible that potential substrates include those contributing to the morphological 
similarities between mitosis and apoptosis, one of which may be the fragmentation of 
the Golgi complex. 
Neutrophils have been shown to become environmentally isolated during apoptosis, 
failing to respond to inflammatory stimuli (Whyte et al., 1993). One mechanism that 
may account for this environmental isolation is an inhibition of the secretory pathway, 
where receptors would fail to reach the cell surface. During mitosis, an inhibition of 
ER to Golgi transport is known to coincide with the fragmentation of the Golgi 
complex into thousands of -50nm vesicles dispersed throughout the cytoplasm of the 
cell (Lucocq et al., 1988). Therefore, Golgi fragmentation during apoptosis may 
reflect inhibition of the secretory pathway. No studies to date have looked at Golgi 
morphology in the neutrophil. However, by EM the Golgi can be seen in neutrophils 
as a relatively small juxtanuclear structure (J.Pryde - unpublished). Golgi 
morphology may easily be visualised by immunofluorescence and therefore the fate 
of the Golgi complex was followed during apoptosis using this technique. 
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3.2 Results 
3.2.1 Induction of Neutrophil Apoptosis by the Activity of Anti -FasR (CH11) 
Neutrophils were isolated from whole blood and were typically >95% pure as 
assessed by forward and side scatter flow cytometry profiles (Fig. 3.1). To induce 
apoptosis, neutrophils were treated with CH11 (500ng/ ml) (Iwai et al., 1994) for 4 h 
and apoptosis assessed by Annexin -V -FITC binding. Only 1.8% of neutrophils were 
apoptotic in untreated samples (Fig. 3.2 A &B) compared to 29.9% of CH11 treated 
cells (Fig. 3.2 C &D). Apoptosis was also assessed by DNA content using PI staining 
(Bedner et al., 1999). Again, there was a low number (2.9 %, Fig. 3.3A &B) of 
apoptotic cells in untreated samples and 32.3% apoptotic cells (Fig. 3.3C &D) in 
CH11 treated cells, as is characteristically shown in Fig. 3.3, by the sub -G1 peak to 
the left of the G1 peak. 
3.2.2 Indirect Immunof/uorescence Staining of Bax in Neutrophils 
In addition to inducing apoptosis in neutrophils by a direct receptor- mediated 
pathway, neutrophils were also treated with 2014/ ml cycloheximide (CHX), a protein 
synthesis inhibitor, to induce apoptosis by the stress -mediated pathway (Ward et al., 
1999a). To find a marker of apoptosis by immunofluorescence, neutrophils were 
stained with a polyclonal antibody raised against Bax. Since Bax has been reported 
to translocate from the cytoplasm to the mitochondria during apoptosis (Goping et al., 
1998; Murphy et al., 1999; Narita et al., 1998; Pryde et al., 2000), mitochondria were 
stained with a monoclonal antibody raised against the mitochondrial heat shock 
protein 70 (mtHSP70). 
Freshly isolated neutrophils showed little non -specific fluorescence when stained with 
secondary antibodies only (Fig. 3.4A) or with non -specific mouse and rabbit IgG and 
followed by secondary antibodies (Fig. 3.4B). Bax and mtHSP70 were not detected 
in freshly isolated neutrophils (Fig. 3.4C). However, in CHX treated cells with 
classical apoptotic nuclear morphology, large structures were shown to be 
aggregated in the cytoplasm in neutrophils stained with antibodies to mitochondria 
(Fig. 3.4D) and Bax (Fig. 3.4E). When these photomicrographs were merged, many 
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of these large structures were shown to co- localise (Fig. 3.4F, yellow), but some Bax 
clusters were present where there was no detectable mitochondrial staining. 
Clusters of mitochondria and Bax were all closely associated with nuclei (Fig. 3.4D -F) 
and interestingly, when mitochondrial clustering was inhibited by z- VAD -fmk (Fig. 
3.4G), not only did Bax still cluster but translocation was still to the same cellular 










Figure 3.1: Isolated neutrophils from whole blood. Approximately 1.52% of cells were 
contaminating monocytes and lymphocytes. FS = forward scatter, SS = side scatter. Data 
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Figure 3.2: Activity of anti -FasR monoclonal antibody (CH11) induces apobptosis, assessed by 
Annexin -V -FITC binding, in human neutrophils. Human neutrophils (5 x 10°/m1) were cultured at 
37 °C in Iscove's DMEM containing 10% autologous serum and treated with or without 500ng /ml anti - 
FasR (CH11). After 4 hours, cells were incubated with Annexin -V -FITC for 10 min on ice and analysed 
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Figure 3.3: Activity of anti -FasR monoclonal antibody (CH11) induces apoptosis, assessed by 
analysis of DNA content by Pl, in human neutrophils. Human neutrophils (5 x 106/ ml) were 
cultured at 37 °C in Iscove's DMEM containing 10% autologous serum and treated with or without 500 
ng /ml anti -FasR (CH11). After 4 hours, cells were fixed and permeabilised with ethanol and stained 
with Pl and analysed by flow cytometry. FS = forward scatter, SS = side scatter. Data are from 1 
representative experiment of 2. 
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Figure 3.4: Bax aggregates in apoptotic neutrophils by indirect immunofluorescence but aggregation is not 
inhibited by z- VAD -fmk. Human neutrophils (5 x 106 /m1) were cultured at 37 °C in Iscove's DMEM containing 10% 
autologous serum and treated with 20pg /m1 CHX (D -I). Neutrophils were stained with mouse -anti- mtHSP70 (green), 
rabbit -anti -bax (red) and the nuclei were stained with TO -PRO -3 (blue). Freshly isolated neutrophils showed minimal 
non -specific fluorescence when stained with Alexa -488 (green) and Alexa -568 (red) (A) or goat- anti -mouse (green) 
and goat- anti -rabbit antibodies (red) (B). Bax and mtHSP70 were not detected in freshly isolated neutrophils (C). 
However, in apoptotic neutrophils stained with mouse -anti- mtHSP70 (D, green) and rabbit -anti -Bax (E, red), large 
structures were aggregated in the cytoplasm, which co- localised (F, yellow) with many of the clusters revealed my 
mitochondrial staining. z- VAD -fmk inhibited the aggregation of structures stained with anti- mtHSP70 (G) but did not prevent the aggregation of structures in cells stained with anti -Bax (H), where (I) is the composite photomicrograph. 
Data are representative of 3 experiments. Scalebar represents 101.1m. 
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3.2.3 Indirect Immunofluorescence Staining of Golgi in NRK Cells 
To validate immunofluorescence staining of the Golgi apparatus using several 
antibodies raised against Golgi membranes, we used normal rat kidney (NRK) cells 
as these cells are known to have large Golgi complexes. There was minimal non- 
specific staining by cells stained with mouse (Fig. 3.5A) and rabbit IgG (Fig. 3.5B). 
NRK cells were stained with polyclonal rabbit JPR3 (Fig. 3.5C) raised against rat liver 
Golgi membranes, mouse monoclonal to mannosidase II 53FC3 (Burke et al., 1982) 
(Fig. 3.5D), mouse monoclonal 1b2 (Fig. 3.5E), mouse monoclonal GM130 (Fig. 
3.5F) and mouse monoclonal p115 (Fig. 3.5G). All antibodies used showed specific 
juxtanuclear reticular Golgi staining, demonstrating that these antibodies detect the 
Golgi complex in NRK cells. 
3.2.4 Indirect Immunofluorescence Staining of Golgi in Neutrophils 
Apoptosis in neutrophils may be assessed by morphological criteria such as 
chromatin condensation, cytoplasmic shrinkage (Savill et al., 1989) and by indirect 
immunofluorescence, Bax redistribution as a marker of the initiation stages of 
apoptosis and mitochondria) clustering as a marker of the execution phase (section 
3.2.2). In addition, apoptosis could be assessed by Annexin -V -FITC binding and by 
loss of DNA content as measured by flow cytometry analysis of cells fixed and 
stained with Pl. 
To assess the fate of the Golgi complex in models of neutrophil apoptosis, the Golgi 
complex was stained by indirect immunofluorescence. To optimise Golgi staining, 
freshly isolated neutrophils were fixed and permeabilised and stained with various 
antibodies raised against Golgi- membrane proteins. Fig. 3.6A shows neutrophils 
stained with non -specific rabbit and mouse IgG, followed by Alexa green (goat anti - 
mouse) and Alexa red (goat anti -rabbit). No non -specific staining was detected. As 
a positive control, neutrophils were stained with the antibody BOB78 that recognises 
a 90 kDa antigen localised in intracellular granules (Hart et al., 2000) (Fig. 3.6B). 
Neutrophils did not show specific staining with the Golgi markers anti -1 b2 (Fig. 3.6C), 
53FC3 (Fig. 3.6D) and anti -GM130 (Fig. 3.6E), but only diffuse cytoplasmic staining. 
However, anti -p115 antibody (Fig. 3.6F) showed specific staining of the Golgi 
(arrows). The Golgi staining shows a distinct aggregate of fluorescence that always 
stained juxtanuclearly. Serial sections of neutrophils stained with the monoclonal 
55 
anti -p115 antibody showed that the fluorescence was through several layers of the 
cell. As far as is known, the Golgi complex has not been identified by indirect 
immunofluorescence in neutrophils but has been by EM. 
Although, the data demonstrated that the Golgi complex was present in neutrophils, 
resolution of typical interphase Golgi structures and fragmented Golgi was likely to be 
difficult in view of the low level of signal seen. Therefore, it was decided to use cell 
lines to establish whether the Golgi fragments during apoptosis and investigate 
possible mechanisms of Golgi fragmentation. 
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Figure 3.5: Indirect immunofluorescence of the 
Golgi complex in NRK cells using different Golgi 
markers. NRK cells were grown on coverslips and 
fixed in 3% PFA and stained with 5 different Golgi 
markers and the nucleus was stained with TO -PRO -3 
(blue). There was minimal non -specific staining by 
mouse (A) and rabbit IgG (B) antibodies. NRK cells 
were stained with polyclonal rabbit JPR3 (C) raised 
against rat liver Golgi membranes, mouse 
monoclonal 53FC3 (D), mouse monoclonal 1b2 (E), 
mouse monoclonal GM130 (F) and mouse 
monoclonal p115 (G). Scalebar represents 10µm. 
Figure 3.6: Indirect immunofluorescence staining of the Golgi complex (green) in freshly 
isolated neutrophils. Freshly isolated neutrophils were cytocentrifuged onto glass coverslips and 
fixed in 3% PFA. The nuclei (blue) were stained with TO- PRO -3. (A) Neutrophils stained with 
non -specific mouse IgG antibodies showing that non -specific binding was minimal. Cells stained 
with the granule -specific BOB78 antibody (B), demonstrating specific binding in neutrophils. There 
was no specific staining when neutrophils were incubated with the anti-1b2 (C), anti -53FC3 (D) 
and anti -GM130 (E) anti -Golgi antibodies. However, anti -p115 antibody (F) showed specific 
staining of the Golgi (arrows). Data are representative of 2 separate experiments. Scalebar 
represents 10pm. 
3.2.5 The Golgi Complex During Mitosis in NRK Cells 
During mitosis the Golgi complex fragments into thousands of vesicles coinciding 
with an arrest of intracellular transport. NRK cells were stained with 53FC3, a 
monoclonal antibody raised against mannosidase II (Burke et al., 1982) and the 
nuclei stained with Hoechst 33258. The Golgi structure during interphase is 
juxtanuclear and reticular (Fig. 3.7A). During prometaphase the chromatin 
condenses and the Golgi starts to lose its reticular structure (Fig. 3.7B). By 
metaphase (Fig. 3.7C) through to anaphase the Golgi complex is completely 
fragmented and dispersed throughout the cytoplasm. During telophase (Fig. 3.7D) 
the Golgi complex is equally divided between the two daughter cells and re- 
assembles juxtanuclearly. 
3.2.6 The Golgi Fragments in SSP Induced Apoptosis in NRK Cells 
NRK cells were treated with 2µM SSP over 6 h to induce apoptosis and the nuclei 
stained with TO -PRO -3 and the Golgi complex with the monoclonal 1B2 antibody. 
The Golgi complex of interphase NRK cells, stained with 1B2, was juxtanuclear and 
reticular in structure (Fig. 3.8A). At 6 h, cells that had been incubated with SSP were 
fixed and permeabilised. In those apoptotic cells that had fragmented or pebbled 
nuclei, typical of classical apoptosis (Leist & Jaattala, 2001), the Golgi had lost its 
juxtanuclear reticular structure and had fragmented and dispersed throughout the 
cytoplasm (Fig. 3.8B). The staining pattern of the apoptotic Golgi morphology was 
similar to that of mitotic cells (Fig. 3.7C). 
However, fragmentation of the Golgi in NRK cells where the nucleus was condensed 
(Fig. 3.9B) also occurred, compared to interphase nuclei (Fig. 3.9A) but was not 
fragmented or pebbled (Fig. 3.9C). In addition, for those cells that had `condensed 
nuclei', the associated Golgi morphology was not always completely fragmented (Fig. 
3.9E) but was not similar to the interphase structure either (Fig. 3.9D). The Golgi 
appeared to have partially fragmented in these cells but a large aggregate of 
fluorescence was still visible. This was named 'condensed clustered Golgi' (Fig. 
3.9F). It was thought that these different nuclear and Golgi morphologies may 
represent intermediate stages of apoptosis and Golgi fragmentation and that different 
nuclear morphologies might be correlated with distinct Golgi morphologies. To 
59 
further investigate that these observations were correct, a time -course over 10 h was 
carried out, with samples taken at 0, 2, 6 and 10 h and the various morphologies 
counted to follow the kinetics of Golgi fragmentation in NRK cells treated with 21.t.M 
SSP. 
3.2.7 Kinetics of Golgi Fragmentation in NRK Cells Treated with SSP 
Five different Golgi morphologies correlated to nuclear morphology were observed 
during SSP induced apoptosis in NRK cells: 1) Interphase nucleus & Juxtanuclear 
Reticular Golgi, 2) Condensed Nucleus & Clustered Golgi Membrane, 3) Condensed 
Nucleus & Fragmented Golgi, 4) Pebbled Nucleus & Clustered Golgi membrane and 
5) Pebbled Nucleus & Fragmented Golgi. 
Examination of untreated NRK cells showed that the majority of cells ( -90 %) had 
'Interphase Nuclei & Juxtanuclear Reticular Golgi' (Fig. 3.10). However, after 2 h 
incubation with 2µM SSP, this morphology was largely replaced by two dominant 
morphologies: 'Condensed Nuclei & Clustered Golgi Membranes', and 'Condensed 
Nucleus & Fragmented Golgi', which represented -50% and -46% of the total 
population respectively (Fig. 3.10). The increase in the proportion of cells with 
'Condensed Nuclei & Clustered Golgi Membranes' and 'Condensed Nucleus & 
Fragmented Golgi' compared to control values was statistically significant (p < 
0.001). These observations raised the possibility that the 'Condensed Nucleus & 
Clustered Golgi Membrane' morphology was an intermediate morphology during the 
apoptotic program and that these cells would ultimately progress to the 'Condensed 
Nucleus & Fragmented Golgi' morphology as apoptosis proceeded. 
After 6 h, the 'Condensed Nucleus & Clustered Golgi Membrane' morphology was no 
longer a dominant morphology (Fig. 3.10). However -50% of the cell population had 
'Condensed Nuclei & Fragmented Golgi' which was not significantly different from the 
proportion of cells showing this morphology at 2 h (p > 0.05). Furthermore, at this 
time point -40% of cells had a 'Pebbled Nucleus & Fragmented Golgi' morphology. 
A significant increase (p < 0.001) compared to 0 and 2 h. This confirms that in NRK 
cells, nuclear condensation occurs prior to pebbling and similarly the Golgi apparatus 
becomes clustered prior to fragmenting during SSP induced apoptosis. The 'Pebbled 
Nucleus & Clustered Golgi Membrane' morphology was only observed in a small 
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proportion of cells, with the highest count at 6 h of just -5% (Fig. 3.10). Since the 
nuclei appeared to pebble after condensing and that `Condensed Nuclei & 
Fragmented Golgi' were a dominant morphology at 2 and 6 h, it appeared that the 
Golgi fragmented after nuclear condensation but prior to nuclear pebbling. 
At the latest time point of 10 h, -25% of cells had `Condensed Nuclei & Fragmented 
Golgi Membranes' (Fig. 3.10), which was significantly reduced compared to 2 and 6 h 
(p <0.001), whilst -75% of NRK cells belonged in the `Pebbled Nucleus & 
Fragmented Golgi' category confirming that the end -stage of Golgi morphology 
during SSP induced apoptosis in NRK cells is fragmentation. 
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Figure 3.7: The Golgi complex during interphase and mitosis. NRK cells were grown on glass coverslips and 
fixed with 3% PFA. The nuclei were stained with TO -PRO -3 (blue) and the Golgi complex with the anti -Golgi 
monoclonal antibody 1B2 (red). (A) Typical nuclear and juxtanuclear reticular Golgi structure during interphase. 
During prometaphase the chromatin condenses and the Golgi starts to lose its reticular structure (B). By metaphase 
(C) through to anaphase the Golgi complex is completely fragmented and dispersed throughout the cytoplasm. 
During telophase (D) the Golgi complex is equally divided between the two daughter cells and re- assembles 
luxtanuclearly. Scalebar respresents 5µm. 
Figure 3.8: The Golgi Fragments During SSP Induced Apoptosis in NRK Cells. NRK were 
grown on glass coverslips in serum -free medium and treated with or without 2pM SSP over 6 
hours. Cells were fixed in 3% PFA. The nuclei are stained with TO -PRO -3 and the Golgi with the 
monoclonal anti -mouse 1B2 antibody followed by Alexa -568 red (goat anti -mouse). (A) Untreated 
interphase cells with interphase nuclei and typical interphase juxtanuclear reticular Golgi. A 
mitotic cell where the Golgi is fragmented (arrow). After 6 hours, apoptotic cells (by nuclear 
morphology) have fragmented and dispersed Golgi staining (B). Data are representative of at 
least 5 separate experiments. Scalebar represents 10µm. 
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Figure 3.9: Nuclear and Golgi morphologies observed during SSP induced apoptosis in NRK cells. (A) 
Untreated cells, normal interphase nuclei. (B) NRK cells treated with 2pM SSP over 2 hours. The nuclei are reduced 
in size. (C) NRK cells treated with 2pM SSP for 6 hours. The nuclei have fragmented resulting in the appearance of 
pebbles, hence 'pebbled nuclei'. (D) normal interphase juxtanuclear Golgi structure (E) NRK cells treated with 2pM 
SSP over 2 hours. Arrow indicates a cell where the Golgi has lost its characteristic interphase morphology, however 
a large part of the Golgi remains intact hence 'clustered Golgi'. (F) NRK cells treated with 2pM SSP over 6 hours. 
The Golgi is completely fragmented in these cells resulting in a dispersed fluorescence signal distributed throughout 
the cytoplasm, similar to the fragmentation during mitosis by indirect immunofluorescence. Data are representative 
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Figure 3.10: Kinetics of Golgi fragmentation in SSP treated NRK cells. NRK cells were treated with 2pM SSP 
over 10 hours. The nuclei were stained with Hoescht 33258 and the Golgi with the monoclonal anti -mouse 1B2 
antibody. Five different morphologies were observed in control cells and SSP treated cells over 10 hours. Data 
represent the mean ± SEM of a typical experiment, where 500 cells were counted at random 3x/ slide. Data are 
representative of 2 experiments. 
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3.2.8 Annexin -V Alexa -488 Binding Correlated to Nuclear Morphology 
From kinetic studies of Golgi fragmentation during SSP induced apoptosis in NRK 
cells it appeared that the Golgi fragmented prior to the classical 'pebbled' morphology 
of apoptotic nuclei in this system. The 'condensed nucleus & fragmented Golgi' was 
a major morphology observed prior to the 'pebbled nucleus & fragmented Golgi', 
suggesting that Golgi fragmentation was an early event during apoptosis. However, 
to ascertain that a 'condensed nucleus' was also part of the apoptotic process and 
not simply a reflection of inhibition of kinase activity within the cells, a second marker 
of apoptosis that coincided with the appearance of a 'condensed nucleus' was 
sought. 
Since the externalisation of PS is considered an early marker of apoptosis (Fadok et 
al., 1992), NRK cells were grown on glass coverslips and treated with SSP over 2 h 
and incubated with Annexin -V Alexa -488 and hoechst 33258 (nuclear stain) for 15 
min at room temperature before they were fixed with 3% PFA and mounted onto 
slides with Moviol. Although some cells bound Annexin -V Alexa -488, the binding did 
not appear to be consistently correlated to nuclear morphology characteristic of 
apoptosis. In contrast, HeLa cells treated with SSP for 3 h there appeared to be a 
correlation between nuclear morphology and Annexin -V Alexa -488 binding. To 
ascertain whether there was a true correlation between nuclear morphology and PS 
exposure in SSP treated HeLa cells, Annexin -V Alexa -488 binding in relation to 
nuclear morphology was assessed by microscopy over a time course. 
HeLa cells were treated with 2 pM SSP over 5 h and the nuclear morphologies 
categorized into 1) interphase nucleus (Fig. 3.11A), 2) condensed nucleus (Fig. 
3.11C) or 3) pebbled nucleus (Fig. 3.11C). Cells with one of three categories of 
nuclear morphologies were then assessed for Annexin -V Alexa -488 binding. The 
majority of untreated cells had interphase nuclei and were Annexin -V Alexa -488 
negative (Fig. 3.12A). After 2 h and 3 h, this changed where the dominant nuclear 
morphology was of the condensed nucleus category. Cells with this morphology did 
not however expose PS on their cell surface (Fig. 3.126 &C). After 4 h, cells with 
'pebbled nuclei' started to appear, of which the majority bound Annexin -V Alexa -488 
(Fig. 3.12D). PS exposure did not mark those cells with condensed nuclei as 
apoptotic. This suggests that PS exposure is a later event than nuclear 
condensation in the apoptotic process in SSP treated HeLa cells. However, the 
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question remained whether nuclear condensation represented an event specific to 
apoptosis or whether it was due to the inhibition of kinase activity in the cells. 
3.2.9 Ultrastructure of the Golgi in SSP Treated HeLa Cells 
By EM, the cytoplasm of mitotic cells contains thousands of -50nm vesicles derived 
from the Golgi complex (Lucocq et al., 1988). To determine if the fragmentation of 
the Golgi complex during apoptosis also produced similar vesicles at the 
ultrastructural level, we treated HeLa cells with SSP over 5 h and fixed them with 2% 
glutaraldehyde. EM was performed by J. Lucocq. HeLa cells were labelled with a 
Golgi marker, n- acetyl -glucosaminyl -transferase -1 conjugated to Protein -A -Gold. 
The gold particles can be seen to localise to small vesicles within the cytoplasm (Fig. 
3.13, arrows indicate gold labelling) and the vesicles were reported to be -50nm in 
size, similar to those observed in mitotic cells (J.Lucocq - personal communication). 
Quantitation of Golgi cisternae or stacks versus Golgi- derived vesicles in untreated 
cells and SSP treated cells showed a dramatic loss of Golgi stacks and increase in 




Figure 3.11: Annexin -V binding in SSP treated HeLa cells. HeLa cells were grown on 
glass coverslips in serum -free medium and were either untreated or incubated with 2 pM 
SSP over 5 hours. Cells were then stained with annexin -V conjugated to Alexa -488 (green) 
at room temperature over 15 minutes and fixed in 3% PFA. The nuclei were stained with 
Hoechst 33258. Non -apoptotic (A) cells did not bind annexin -V (B). HeLa cells treated with 
SSP over 5 hours that had condensed but not fragmented nuclei (C) also did not bind 
annexin -V (D). Only the cells which had fragmented nuclei (E) appeared to bind annexin -V 
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Figure 3.12: % Annexin -V -Alexa 488 binding correlated to nuclear morphology in HeLa cells treated with 21.LM 
SSP over 5 hours. (A) Untreated cells had typical interphase nuclei and did not bind Annexin -V. (B) After 2 hours, 
the nuclei had mostly condensed but still did not bind Annexin -V (79.8 ± 7.6 %SEM). (C) After 3 hours the majority of 
cells had condensed nuclei and there was a slight increase in cells with pebbled nuclei, the majority of which bound 
Annexin -V (pebbled nuclei: 6.6% ± O.6SEM Annexin -V +ve, 2.7% ± O.3SEM Annexin -V -ve). (D) After 4 hours there 
was an increase in cells with pebbled nuclei (-41 %) of which 32.8% ± 4SEM bound Annexin -V. Cells with condensed 
nuclei (58.5% ± 5.9SEM) did not bind Annexin -V. (E) the majority of cells had condensed nuclei and there was a slight 
increase in cells with pebbled nuclei, the majority of which bound Annexin -V (pebbled nuclei: 6.6% ± O.6SEM Annexin - 
V +Ve, 2.7% ± 0.3% Annexin -V -ve). Data represent the mean ± SEM of a typical experiment, where 500 cells were 
counted at random 3 x / slide. 
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Figure 3.13: Golgi- derived vesicles in apoptotic SSP treated HeLa cells are 
morphologically similar to mitotic Golgi fragments. Ultrathin frozen sections of HeLa 
cells treated with 2pM SSP over 5 hours, labelled with n- acetyl -glucosaminyl -transferase -1 
conjugated to Protein -A -Gold. An apoptotic cell where the Golgi stack has fragmented into 
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Figure 3.14: Quantitation of Golgi cisternae (stack) versus Golgi 
vesicles in SSP treated HeLa cells. Bars represent ± SEM. (Data by John 
Lucocq). 
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3.2.10 The Golgi Fragments During CHX Induced Apoptosis in NRK Cells 
Using SSP to induce apoptosis in NRK and HeLa cells we have shown that in both 
cell types, the Golgi fragments during SSP induced apoptosis. Inhibition of ER to 
Golgi transport during apoptosis would render the dying cell environmentally isolated 
by preventing delivery of cell surface receptors. While Golgi fragmentation during 
apoptosis is also a strong indicator of the inhibition of ER to Golgi transport during 
apoptosis, its fragmentation may also serve a physical need. Just like mitotic cells 
are able to divide the Golgi, which is present as a single -copy organelle, equally 
between the two daughter cells; an apoptotic cell must surely fragment its Golgi for 
eventual enclosure into apoptotic bodies. 
I therefore investigated whether Golgi fragmentation also occurred with other agents 
that induce apoptosis. NRK cells were treated with 10µg/ ml CHX, a protein 
synthesis inhibitor, over 4 h and cells were stained with the anti -GM130 antibody to 
mark the Golgi complex and an antibody that recognises only the active form of 
caspase -3. It is important to note that in untreated cells with juxtanuclear reticular 
Golgi structures and in dividing cells where the Golgi is completely fragmented 
throughout the cytoplasm, that there is no caspase -3 activity (Fig. 3.14A). However, 
a very early apoptotic cell was observed where the nucleus had condensed but not 
yet pebbled and the cell was still adherent (Fig. 3.14B). The caspase -3 activity was 
present throughout the cytoplasm of the cell and importantly, the Golgi was still 
intact, raising the possibility that Golgi fragmentation may be downstream of the early 
execution phase of apoptosis. In addition, at least in the model of CHX nduced 
apoptosis, the morphology of `condensed nucleus' appears to be specific to the very 
early stages of apoptosis. After 4 h many of the cells had rounded up and the nuclei 
become pebbled, characteristic of apoptosis and stained positive for anti -active 
caspase -3. In these cells the Golgi was completely fragmented and dispersed 
throughout the cytoplasm (Fig. 3.15C) and the insert in Fig. 3.15C shows apoptotic 
cells with only Golgi staining to demonstrate the punctate Golgi staining more clearly. 
Importantly, Golgi fragmentation was completely inhibited by z- VAD -fmk, the broad - 
range caspase inhibitor (Fig. 3.15D), demonstrating that Golgi fragmentation during 
apoptosis is caspase- dependent. 
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Figure 3.15: Caspases are required for the fragmentation of the Golgi complex during 
apoptosis. NRK cells were grown on glass coverslips in serum -free medium and treated with or 
without 10µg /ml CHX for 4 hours. Cells were then fixed with 3% PFA. Immunofluorescence 
staining of the Golgi apparatus was with the monoclonal antibody against GM130 (green) and the 
polyclonal antibody against active caspase -3 (red). (A) Untreated NRK cells with typical interphase 
nuclei and juxtanuclear reticular Golgi. Amongst the cells are two mitotic cells where the Golgi is 
fragmented (arrows). There is no detectable caspase -3 activity. (B) NRK cells were incubated with 
CHX for 1 hour and here is an early example of an apoptotic cell that is positively stained for 
caspase -3 activity, yet the nucleus has not yet pebbled and the Golgi is still intact. (C) NRK cells 
were treated with CHX for 4 hours after which the nuclei show classical apoptotic nuclear pebbling 
and are positive for caspase -3 staining; in those cells the Golgi is fragmented. The bottom left 
picture insert is of NRK cells under the same conditions, without anti -caspase -3 staining to show 
Golgi fragmentation more clearly. (D) Cells were incubated with 100pM z- VAD -fmk, the broad - 
spectrum caspase inhibitor, 30 minutes prior to the addition of CHX for 4 hours and the cells have 
retained their interphase nuclear and Golgi morphology. Data are representative of 2 separate 
experiments. Scalebar represents 10µm. 
3.2.11 Golgi Fragmentation is Specific to Apoptosis 
Since apoptosis shares many of the morphological features of mitosis e.g. chromatin 
condensation, Golgi fragmentation, NRK cells were again treated with 10µg/ ml CHX 
over 4 h to induce apoptosis and stained with the MPM -2 monoclonal antibody and 
the polyclonal JPR3 antibody raised against rat liver Golgi membranes. Untreated 
interphase cells had the characteristic juxtanuclear reticular Golgi staining and mitotic 
cells stained positively with the MPM -2 monoclonal antibody (Fig. 3.16A &B). In 
apoptotic cells (identified by nuclear morphology), where the Golgi was fragmented, 
the MPM -2 antibody did not recognise any mitotically phosphorylated antigens (Fig. 
3.16C). Therefore, while CDK activity may occur in apoptotic cells (Harvey et al., 
2000; Zhou et al., 1998), not all of the mitotic antigens are phosphorylated in this 
model of apoptosis. Thus, Golgi fragmentation appears to be specific to apoptosis in 
addition to mitosis although the mechanism of Golgi fragmentation may be different 
in apoptosis. 
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Figure 3.16: The monoclonal antibody MPM -2 does not stain apoptotic NRK cells where the Golgi 
is fragmented. NRK cells were grown on glass coverslips in serum -free medium and treated with or 
without 10pg /ml CHX for 4 hours. Cells were stained with the polycional JPR3 anti -Golgi- membrane 
antibody (red) and the monoclonal anti -MPM2 antibody (green). (A) shows an early mitotic NRK cell 
(prophase) and (B) a prometaphase cell, both staining positively with the anti -mitotic antibody, while 
interphase cells are not stained by MPM -2. (C) apoptotic NRK cells where the Golgi is fragmented in 
those cells with pebbled nuclei and the cells are negative for the anti- mitotic antibody. (D) These cells 
were incubated with z- VAD -fmk alone for 4 hours and the Golgi morphology in interphase cells is the same 
as the control (A) and again the metaphase cell is brightly stained for the anti -mitotic antibody 
demonstrating that z- VAD -fmk has no effect on Golgi morphology or mitosis. Data are representative of 2 
separate experiments. Scalebar represents 1011m. 
3.3 Discussion 
The studies herein show that the Golgi fragments during apoptosis in both HeLa and 
NRK cells treated with SSP or CHX. By electron microscopy, the resulting Golgi 
fragments are morphologically indistinguishable from those found in the cytosplasm 
in mitotic cells (J.Lucocq - personal communication). These results were later 
confirmed in work by Sesso et al. (1999) and Lane et al. (2002). In addition, Golgi 
fragmentation during apoptosis was shown to be a caspase- dependent event. Since 
during mitosis, Golgi fragmentation occurs with a concommittant arrest in the 
secretory pathway, it is possible that protein transport is also arrested during 
apoptosis (Lucocq et al., 1988). 
Apoptosis occurs constitutively when neutrophils are cultured in vitro over 24 h. 
However, apoptosis may be induced in neutrophils over much shorter time points by 
incubating cells with various known apoptosis inducing agents, including the anti - 
FasR monoclonal antibody CH11 and the protein synthesis inhibitor cycloheximide 
(Ward et al., 1999b). To set up systems of neutrophil apoptosis that could be 
monitored by different criteria, CH11 was used initially to drive apoptosis, which was 
monitored by PS externalisation. In the same system, cellular DNA content was 
measured using PI to estimate apoptosis. Both methods estimated the same rate of 
apoptosis, indicating that Annexin -V -FITC binding and cellular DNA content are 
accurate and reliable methods of assessing apoptosis. However, our initial studies 
on Golgi morphology had to be undertaken using indirect immunofluorescence. 
Therefore, in addition to using flow cytometry methods to estimate apoptosis, a 
second marker of apoptosis by indirect immunofluorescence besides nuclear 
morphology, was required. 
The translocation of Bax from the cytosol to the mitochondria is well documented in 
other cell types and is independent of caspase activity (Granville et al., 1999; Murphy 
et al., 1999) but only recently has this also been shown to be independent of 
caspases in neutrophils (Granville et al., 1999; Maianski et al., 2002; Murphy et al., 
1999; Nechushtan et al., 2001). lmmunofluorescence staining of apoptotic 
neutrophils showed large clusters of Bax that co- localised with many of the 
mitochondrial clusters but not all of them. This was consistent with the work of 
Nechushtan et al. (2001), who proposed that Bax initially coats the outer 
mitochondrial membrane before leaving and clustering with Bak molecules in a 
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position adjacent to the mitochondria. In addition, they showed that the Bax/ Bak 
clustering is caspase- independent but BcI -XL can inhibit cluster formation. While Bax 
cluster formation was shown to be caspase- independent, mitochondria) clustering 
was shown to be caspase -dependent (Fig. 3.4C), consistent with previous work in 
other cell types (De Vos et al., 1998; Thomas et al., 2000). Interestingly, in z -VAD- 
fmk treated neutrophils although the mitochondria were not clustered, Bax clusters 
were still seen in close association with nuclei, suggesting that perhaps Bax can also 
bind an as yet unidentified organelle or structure involved in the apoptotic program. 
Thus, Bax translocation is a marker of apoptosis upstream of the execution phase, 
since cells may still be rescued by the inhibition of caspases. Therefore, using Bax 
as a marker of upstream events would be a useful marker to determine whether 
Golgi fragmentation was occurring during the initiation phase or execution phase of 
apoptosis. 
To date, no known studies have shown Golgi staining in neutrophils by indirect 
immunofluorescence. Using a monoclonal antibody raised against p115, I was able 
to detect the Golgi complex in freshly isolated neutrophils (Fig. 3.6). Unfortunately, 
identification of fragments of this relatively small Golgi complex in neutrophils would 
not have been readily achieved. Since Golgi fragmentation is thought to be an 
ubiquitous phenomenon to apoptosis, occurring in all cell types studied so far (Lane 
et al., 2002; Philpott et al., 1996; Sesso et al., 1999), I used cell lines as a model for 
the study of Golgi morphology during apoptosis. 
NRK cells have a large, reticular Golgi complex and all available antibodies 
specifically stain the Golgi in these cells (Fig. 3.5). Golgi fragmentation during 
mitosis can be clearly visualised in these cells (Fig. 3.7) and therefore this cell type 
was used to monitor Golgi morphology during apoptosis. In SSP induced apoptosis 
in NRK cells, it was shown that the Golgi fragmented. In addition, various stages of 
apoptosis were identified in terms of nuclear and Golgi morphology (Fig. 3.9). The 
nuclei condensed before finally fragmenting and the Golgi complex clustered prior to 
fragmentation in both apoptotic NRK and HeLa cells treated with SSP. At least in the 
SSP model of Golgi fragmentation in NRK cells, the Golgi fragmented prior to DNA 
fragmentation (Fig. 3.10), which is dependent on caspase activity (Enari et al., 1998; 
Sakahira et al., 1998). This finding suggested that Golgi fragmentation is a very early 
event in this model. To ensure that nuclear condensation was correlated with the 
onset of apoptosis and not due to SSP alone, we sought a second marker of 
apoptosis that was known as an early marker. PS exposure on the outer plasma 
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membrane is known as an early marker of apoptosis (Fadok et al., 1992). However, 
NRK cells did not bind Annexin -V Alexa -488 reliably despite the presence of clearly 
apoptotic NRK cells by nuclear morphology. Since this seemed likely to be a 
peculiarity of NRK cells, I also examined HeLa cells treated with SSP that bound 
Annexin -V Alexa -488. However, in immunofluorescence analysis, PS exposure 
correlated with DNA fragmentation or pebbled nuclei, a relatively late event in 
apoptotic process and did not bind cells where the nucleus was condensed. 
Therefore, PS exposure was not a useful marker for determining if those cells with 
condensed nuclei were apoptotic. 
Interestingly, the Golgi fragments produced during apoptosis in SSP treated HeLa 
cells are shown to be morphologically identical to those found in the cytoplasm of 
mitotic cells (Fig. 3.13). This finding is consistent with studies by (Sesso et al., 
1999). The similar size of vesicles present in mitotic cells and apoptotic cells raised 
the possibility that the mechanism leading to Golgi fragmentation was related. 
Using a different stimulus to induce apoptosis, NRK cells were treated with CHX over 
4 h to examine whether the Golgi also fragments with a different death stimulus. In 
addition, a newly available antibody, raised against anti -active caspase -3 antibody 
was used to detect the early stages of apoptosis. Caspase -3 activation was reported 
to occur earlier than PS exposure during apoptosis and therefore it was possible that 
this might precede Golgi fragmentation (Belloc et al., 2000). Apoptotic NRK cells 
treated with CHX, where caspase -3 activity was detected also had, in most cases, 
fragmented Golgi (Fig. 3.15C). However, a few cells in the very early stages of 
apoptosis, preceding loss of adherence and shrinkage were observed (for example 
see Fig. 3.15B where the nucleus was condensed but the Golgi was still intact). In 
these cells, the Golgi structure is that of a cell in interphase, juxtanuclear and 
reticular but there is no evidence of clustering; yet caspase -3 is clearly activated. In 
the presence of z- VAD -fmk, Golgi fragmentation was inhibited and the morphology 
indistinct from interphase cells, suggesting that caspase -3 activation preceded Golgi 
and DNA fragmentation. In addition, in the CHX model of apoptosis in NRK cells, the 
`condensed nucleus' morphology was a relatively seldom event, not because it never 
occurred but because in contrast to the SSP model, it seemed to be a very swift 
phase and therefore it was seen rarely. 
There are several possibilities to explain the apparent differences in the kinetics of 
morphological apoptosis between the SSP and CHX model. The most obvious being 
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that in addition to the requirement for caspase activity to fragment DNA, through the 
cleavage of ICAD (Enari et al., 1998; Sakahira et al., 1998) that caspase- dependent 
kinase activity may be required. In the case of apoptosis induced by SSP, a broad - 
range kinase inhibitor, phosphorylation would be inhibited thereby slowing down the 
morphological changes characteristic of apoptosis. Several studies have reported 
that CDK activity is upregulated during apoptosis and in some models inhibition of 
CDKs actually inhibits apoptosis (Gil -Gomez et al., 1998; Harvey et al., 2000; Kim et 
al., 2001). A number of these studies showed that inhibition of CDK activity reduced 
DNA cleavage (Hakem et al., 1999; Schroter et al., 1996; Shi et al., 1994). Since 
SSP is a known inhibitor of CDK activity (Gray et al., 1999) this may be one 
explanation for the relatively long period between chromatin condensation and 
visualisation of DNA fragments. Similarly, the 'clustered Golgi' morphology was 
hardly observed at all in the CHX model of apoptosis, suggesting that the rapid and 
complete fragmentation of the Golgi complex requires kinase activity and is delayed 
during SSP induced apoptosis. Since CDK1 is involved in Golgi fragmentation during 
mitosis, there was a possibility that this pathway of Golgi fragmentation was common 
to both apoptosis and mitosis. The MPM -2 monoclonal antibody recognises a 
phosphorylated amino -acid sequence present on more than 40 proteins during 
mitosis. Therefore, if major mitotic targets were phosphorylated during apoptosis 
then MPM -2 antibody would react positively (Davis et al., 1983). However, 
immunofluorescence staining of apoptotic CHX treated NRK cells showed no positive 
MPM -2 staining. Certainly, this was not entirely unexpected since phosphorylation of 
all mitotic epitopes would be unlikely to accompany apoptosis. Although, CDK1 is 
one of many kinases involved in phosphorylating MPM -2 antigens it is by no means 
alone ( Westendorf et al., 1994). Among the kinases involved are MAP kinase, 
casein kinase Il and polo -like kinases (Escargueil et al., 2000; Logarinho & Sunkel, 
1998; Westendorf et al., 1994). In addition, while CDKs are active during apoptosis 
many of their substrates are thought to be different (O'Connor et al., 2000) and 
importantly their regulation appears to be altered. In non -cycling thymocytes for 
example, Bcl -2 and Bax were shown to regulate Cdk2 activity. Where 
overexpression of BcI -2 was shown to delay the degradation of the Cdk2 inhibitor, 
p27KIP' and Bax overexpression accelerated it (Gil -Gomez et al., 1998). In summary, 
whilst these studies are suggestive of distinct kinetics of Golgi fragmentation during 
apoptosis induced with distinct stimuli, the ultimate outcome in both CHX and SSP 
induced apoptosis in NRK and HeLa cells is caspase- dependent fragmentation of the 
Golgi complex. 
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CHAPTER 4: THE MECHANISM OF GOLGI FRAGMENTATION 
4.1 Introduction 
The results in Chapter 3 showed that the Golgi complex fragmented during apoptosis 
in NRK and HeLa cells treated with different apoptosis- inducing agents and that this 
was inhibited by the broad -range caspase inhibitor z- VAD -fmk. One possibility is that 
Golgi- associated proteins are targeted in a caspase- dependent manner. This could 
involve caspase -dependent phosphorylation or direct cleavage of target proteins. 
GM130, GRASP65, GRASP55, p115 and Rab1 are phosphorylated during mitosis 
(Bailly et al., 1991; Lin et al., 2000; Lowe et al., 1998; Sohda et al., 1998), 
concomitant with the fragmentation of the Golgi complex and inhibition of ER to Golgi 
transport. Since these proteins are targets for phosphorylation during mitosis, it is 
possible that they are also key targets during apoptosis to initiate Golgi 
fragmentation. 
GRASP65 is predicted to form a cytoplasmically orientated homodimer and is 
suggested to associate with Golgi membranes via an N- myristoylated N- terminus 
(Barr et al., 1997). This is in contrast to GM130, which has no known domains or 
modifications that would allow direct interaction with Golgi membranes (Nakamura et 
al., 1995). GM130 is a peripheral membrane protein, predicted to have six coiled -coil 
domains separated by spacer sequences and to bind GRASP65 via its C- terminus 
(Barr et al., 1997). GM130 has 25 putative phosphorylation sites, excluding the 
CDK1 phosphorylation sites, 16 of which are possible casein kinase Il sites 
(Nakamura et al., 1995). GM130 is thought to form a homodimer that binds to the N- 
terminus of homodimeric p115, where p115's C- terminus forms a rod -like structure 
with a globular N- terminus (Barr et al., 1997; Lowe et al., 1998). However, only in the 
case of the interaction between GM130 and p115 has a direct consequence of 
mitotic phosphorylation been identified. Phosphorylation of GM130 on the cis -Golgi 
prevents binding of p115, present on COPI vesicles and therefore tethering of 
vesicles is inhibited prior to the action of SNARES (Linstedt et al., 2000; Lowe et al., 
1998). This discovery provided the first explanation for the high number of COPI 
vesicles present in the mitotic cytosol (Misteli & Warren, 1995). 
Since GM130 is the principal binding partner for p115 and is key to vesicle tethering 
and therefore ER to Golgi transport, we followed the fate of GM130 during apoptosis 
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(Alvarez et al., 2000; Linstedt et al., 2000; Lowe et al., 1998; Moyer et al., 2001; 
Nakamura et al., 1997; Seemann et al., 2000). 
Activation of caspase -8 through signalling via the Fas receptor can trigger two 
distinct apoptosis- inducing pathways depending on the cell type. In type I cells, a 
large amount of caspase -8 is able to activate caspase -3 directly (Scaffidi et al., 
1998). In contrast, in type II cells such as Jurkat cells, caspase -8 cleaves Bid and 
tBid then translocates to the mitochondria to induce formation of the apoptosome 
(Scaffidi et al., 1998). It is thought that the relatively low amounts of caspase -8 
present in type II cells are unable to initiate the caspase cascade directly (Scaffidi et 
al., 1998). For these studies, J.CaM1.6 cells, a derivative of Jurkat cells that 
constitutively express Fas receptor, were treated with a monoclonal antibody raised 
against the human Fas- receptor so that we could induce apoptosis by a receptor - 




4.2.1 Annexin -V -FITC Binding & PI Exclusion by J.CaM1.6 Cells Treated with 
CH11 
To compare the induction of apoptosis by SSP to the induction of apoptosis by the 
CH11 anti -FasR monoclonal antibody, J.CaM1.6 cells were treated with 500ng/ ml of 
CH11. Fig. 4.1A is a representative example of untreated cells, where the majority of 
cells are Annexin -V -ve/ PI -ve. Figure 4.1B shows the SS/ FS properties of 
untreated J.CaM1.6 cells. J.CaM1.6 cells were treated with 500ng/ ml CH11 over 6 
h. At 6 h, approximately 60% of cells were Annexin -V +ve/ PI -ve. The SS/ FS 
profile (Fig. 4.1D) of these cells is broadly similar to that of the Annexin -V -ve/ PI -ve 
population of J.CaM1.6 cells, suggesting that apoptotic cells remain intact and have 
not fragmented into apoptotic bodies. Cells that are Annexin -V +ve/ PI +ve can be 
seen to have different SS/ FS properties, suggesting that these may have 
fragmented into apoptotic bodies. Apoptosis, or Annexin -V -FITC binding was 
inhibited by pre- incubating cells with a neutralising antibody (clone ZB4), raised 
against human FasR (Fig. 4.1E), for 30 min prior to the addition of CH11. This 
experiment demonstrated that apoptosis was specific to the induction of the apoptotic 
Fas signalling pathway. Annexin -V -FITC binding was also inhibited by pre- incubating 
the cells with z- VAD -fmk (Fig. 4.1G), demonstrating that Annexin -V -FITC binding was 
caspase- dependent. The SS/ FS of cells treated with z- VAD -fmk and CH11 (Fig. 
4.1 H) did not differ noticeably from the control SS/ FS. 
4.2.2 Annexin -V -FITC Binding & PI Exclusion by J.CaM1.6 Cells Treated with 
SSP 
J.CaM1.6 cells were incubated at 5 x 106 cells/ ml in the presence of FCS, with or 
without 21aM SSP for different times, as indicated. Fig. 4.2(A) is a typical example of 
an untreated sample of J.CaM1.6 cells, where the vast majority of cells are Annexin- 
V -ve/ PI -ve. Fig. 4.2(B) shows a typical SS/ FS of untreated J.CaM1.6 cells over 4 
h. J.CaM1.6 were treated with SSP over 4 h and samples taken every hour. At 4 h 
(Fig. 4.2B), -80% of J.CaM1.6 cells were Annexin -V +ve/ PI -ve. Fig. 4.2(D), the 
Annexin -V +ve/ PI -ve cells (orange dots) show a different SS/ FS distribution to the 
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Annexin -V +ve/ PI -ve cells. However, there was no significant difference (p =0.05) in 
the amount of necrotic cells present per sample SSP treated cells compared to 
control values. J.CaM1.6 cells that were pre -incubated with z- VAD -fmk for 30 min 
prior to addition of SSP, did not undergo apoptosis, demonstrating that the effects of 
SSP were due to caspase activity (Fig. 4.2(E). Again, there was a slight increase in 
Annexin -V +ve/ Pl +ve and Annexin -V -ve/ Pl +ve cells but this was not statistically 
significant (p= 0.05). Fig. 4.2(F) shows the FF /SS profile of those cells in Fig. 4.2(E), 
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Figure 4.1: Anti -FasR (CH11, 500ng /m1) induced apoptosis in J.CaM1.6 cells. Apoptosis was 
assessed by Annexin -V binding and PI staining. (A) Untreated cells did not externalise Annexin -V and 
excluded Pl. A scatter plot is shown (B) showing the non -apoptotic cell population distribution. After 6 
hours, 64% of cells bound Annexin -V FITC but excluded PI (C). A small percentage of cells had 
undergone necrosis (PI +ve) and this was also seen as a shift in the SS /FS of those cells (D). ZB4 (E) 
and z- VAD -fmk (G) inhibited phosphatidylserine expression in CH11 treated cells, where (F) and (H) 
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Figure 4.2: SSP (2NM) induced apoptosis in J.CaM1.6 cells. Apoptosis was 
assessed by Annexin -V binding and Pl staining. (A) Untreated cells did not externalise 
Annexin -V and excluded Pl. A scatter plot is shown (B) showing the non -apoptotic cell 
population distribution. After 4 hours, 80% of cells bound Annexin -V FITC but excluded 
PI (C). A small percentage of cells had undergone necrosis (Pl +ve) and this was also 
seen as a shift in the SS /FS of those cells (D). z- VAD -fmk (E) inhibited 
phosphatidylserine expression in SSP treated cells, where (F) shows the SS /FS. Data 
are representative of 3 experiments. 
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4.2.3 Kinetics of Apoptotis J.CaM1.6 Cells Treated with CH11 
J.CaM1.6 cells were treated with 500ng/ ml CH11 in the presence of FCS, over 6 h 
and the amount of apoptosis, as assessed by Annexin -V -FITC binding and PI 
exclusion, monitored at 1 hour, 2 h, 4 h and 6 h. At 1 h, the number of apoptotic cells 
was -12 %, significantly (p < 0.05) higher than present in control populations -2 %. 
The proportion of apoptosis increased up to 4 h, where the amount of apoptosis was 
-60 %, after which the rate of apoptosis began to decline. At 6 h, the number of 
apoptotic cells present was -60 %. To ensure the apoptosis inducing stimulus was 
by induction of the Fas pathway, control samples were pre- incubated with 500ng/ ml 
ZB4 for 30 min, prior to addition of CH11. ZB4 abolished the apoptotic effect of 
CH11 of J.CaM1.6 cells and the number of cells, which bound Annexin -V -FITC in 
these samples -5% was not significant (p < 0.05) from control levels. In addition, z- 
VAD-fmk completely inhibited Annexin -V -FITC binding 3% which was not significantly 
(p < 0.05) different from control levels. 
4.2.4 Kinetics of Apoptosis in J.CaM1.6 cells with SSP 
To follow the kinetics of apoptosis induction in J.CaM1.6 cells by 211.M SSP, cells 
were incubated in the presence of 2µM SSP and FCS, over 4 h (Fig. 4.4). Samples 
were taken every hour and apoptosis assessed by Annexin -V -FITC binding and 
exclusion of PI. The results from three separate experiments were then pooled. At 1 
hour, the number of apoptotic cells present, -14 %, was already significantly (p < 
0.05) increased from control cells -2 %. This trend continued up to 4 h, where -80% 
of cells bound Annexin -V -FITC and excluded Pl. The effect was inhibited by z -VAD- 
fmk, where the number of cells -4% binding Annexin -V -FITC was not significantly (p 
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Figure 4.3: Kinetics of anti -FasR (CH11, 500ng /m1) induced apoptosis in 
J.CaM1.6 cells. Apoptosis was assessed by Annexin -V binding and PI 
exclusion. Data represent the mean ± SEM of 3 separate experiments. All 
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Figure 4.4: Kinetics of SSP (2pM) induced apoptosis in J.CaM1.6 cells. 
Apoptosis was assessed by Annexin -V binding and Pl exclusion. Data represent 
the mean ± SEM of 3 separate experiments. All experiments were performed in 
triplicate ( *= p < 0.05 compared with control values). 
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4.2.5 Golgi Fragmentation in Apoptotic J.CaM1.6 Cells Stained with a 
Monoclonal Antibody Raised Against GM130 
To confirm that the Golgi also fragmented in apoptotic J.CaM1.6 cells, cells were 
treated with 500ng/ ml CH11 or 2µM SSP over 4 h to induce apoptosis. Apoptotic 
cells were identified by `pebbled' nuclear morphology and by staining with the 
polyclonal antibody raised against active -caspase -3. No non -specific staining was 
detected in J.CaM1.6 cells stained with (Fig. 4.5A) rabbit IgG, Alexa 568 (red) and 
(Fig. 4.5B) mouse IgG, Alexa 488 (green). Untreated cells showing the normal 
interphase structure of the Golgi complex in J.CaM1.6 cells also had no caspase -3 
activity. Caspase -3 activity was also absent in mitotic cells where the Golgi was 
fragmented (Fig. 4.5C, arrow). In contrast, many of the cells treated with 500ng/ ml 
CH11 (Fig. 4.5D -F) had caspase -3 activity throughout the cytoplasm and in those 
cells the nuclei were pebbled and the Golgi fragmented. In cells that had been pre- 
treated with the FasR neutralising antibody ZB4 or the caspase inhibitor z- VAD -fmk, 
apoptosis and Golgi fragmentation were prevented. This demonstrated that Golgi 
fragmentation and nuclear pebbling were specific to FasR signalling in CH11- treated 
cells and that the morphological changes observed were caspase- dependent. To 
compare the fragmentation of the Golgi complex during SSP induced apoptosis, 
J.CaM1.6 cells were treated with 2 pM SSP for 4 h. The proportion of apoptotic cells 
was higher in SSP treated cells than CH11 treated cells after 4 h with the majority of 
cells being apoptotic. From the kinetic studies, approximately 80% of SSP treated 
J.CaM1.6 cells are apoptotic at 4 h (Fig. 4.4). All cells where nuclear fragmentation 
was detected had caspase -3 activity yet strikingly, a large proportion of these cells 
still had intact Golgi (Fig. 4.5G -I). Since z- VAD -fmk inhibited DNA fragmentation and 
caspase -3 activity was not detected, the morphological changes observed were 
confirmed to be caspase- dependent and not due to broad -range kinase inhibition. 
4.2.6 Golgi Fragmentation in Apoptotic J.CaM1.6 Cells Stained with a 
Monoclonal Antibody Raised Against p115 
To confirm that J.CaM1.6 cells treated with SSP appeared to have a delay in the 
fragmentation of the Golgi complex, the immunofluorescence study was repeated but 
the Golgi complex stained with another Golgi- marker, a monoclonal antibody raised 
against p115. Untreated cells did not stain positively for anti -active -caspase -3 (Fig. 
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4.6A) and Golgi staining with anti-p115 had more punctate cytoplasmic staining 
compared to anti -GM130 staining (Fig. 4.6A -C), likely due to the fact that pl 15 is also 
vesicle -associated as well as to Golgi membranes (Sohda et al., 1998). The same 
morphological pattern was observed in CH11- treated cells stained with anti -p115 as 
with anti- GM130. In all cells where caspase -3 is active, the nuclei are pebbled and 
the Golgi fragmented (Fig. 4.6D -F). Again, caspase -3 activation, nuclear and Golgi 
fragmentation could be inhibited by pre- incubation with ZB4 or z- VAD -fmk 
(Fig.4.6J &K). However, in SSP induced apoptosis, caspase -3 activity and pebbled 
nuclei did not necessarily coincide with fragmented Golgi (Fig. 4.6G -l) confirming the 
previous result when cells were stained with anti- GM130. 
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Figure 4.5: Golgi morphology in J.CaM1.6 cells treated with 500ng /mI CH11 or 2NM 
SSP for 4 hours. Cells were stained with anti -active -caspase -3, Alexa 568 (red) and 
anti- GM130, Alexa 488 (green) and the nuclei with TO -PRO -3 (blue). J.CaM1.6 cells 
stained with (A) rabbit IgG, Alexa 568 and (B) mouse IgG, Alexa 488. (C) Untreated 
cells stained with anti -GM130 and anti -active -caspase -3 (arrow indicates mitotic cell). 
Cells treated with 500ng /ml CH11 over 4 hours (D -F), where (D) shows anti- active- 
caspase -3, (E) shows anti -GM130 and (F) is the composite micrograph of (D &E). Cells 
treated with 2pM SSP over 4 hours (G -I), where (G) shows anti -active -caspase -3, (H) 
shows anti -GM130 and (I) is the composite micrograph of (G &H). Composite micrograph 
of cells treated with CH11 in presence of (J) ZB4, (K) z- VAD -fmk. Cells treated with 
SSP in presence of z- VAD -fmk (L). Data are representative of 3 separate experiments. 
Scalebars represent 10pm. 
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Figure 4.6: Golgi morphology in J.CaM1.6 cells treated with 500ng /ml CH11 or 2pM 
SSP for 4 hours. Cells were stained with anti -active -caspase -3 followed by Alexa 568 
(red) and anti -p115 followed by Alexa 488 (green) and the nuclei with TO -PRO -3 (blue). 
(A -C) Untreated cells stained with anti -p115, where (A) shows anti -active -caspase -3 
staining, (B) anti -p115 staining and (C) is the composite micrograph of (A &B). Cells 
treated with 500ng /m1 CH11 over 4 hours (D -F), where (D) shows anti -active -caspase -3, 
(E) shows anti -p115 and (F) is the composite micrograph of (D &E). Cells treated with 
2pM SSP over 4 hours (G -I), where (G) shows anti -active -caspase -3, (H) shows anti - 
p115 and (I) is the composite micrograph of (G &H). Composite micrographs of cells 
treated with CH11 in presence of (J) ZB4, (K) z- VAD -fmk. Composite micrograph of cells 
treated with SSP in presence of z- VAD -fmk (L). Data are representative of 3 experiments. 
Data are representative of 3 separate experiments. Scalebars represent i Opm. 
4.2.7 GM130 is Cleaved During CH11 Induced Apoptosis 
Immunofluorescence studies suggested that the kinetics of Golgi fragmentation in 
apoptotic cells treated with SSP were different to the kinetics of Golgi fragmentation 
in cells treated with CH11. Of particular interest was the fate of the Golgi matrix 
protein GM130 during apoptosis and the tethering factor p115, both shown to be 
essential for ER to Golgi transport (Allan et al., 2000; Alvarez et al., 1999; Lowe et 
al., 1998; Lowe et al., 2000; Nakamura et al., 1997; Seemann et al., 2000; Sohda et 
al., 1998). J.CaM1.6 cells were incubated with 500ng/ ml of CH11 over 6 h and 
apoptosis and necrosis was assessed by Annexin -V and PI staining. After 1 h, when 
low levels of apoptotic cells were present ( -7 %), as assessed by Annexin -V binding, 
no evidence of GM130, p115 and pro -caspase -3 was seen (Fig. 4.7, lane 2) and 
comparable to untreated cells (Fig. 4.7, lane 1). Similarly, at 2 h, although apoptosis 
had increased to -30 %, GM130, p115, pro -caspase -3 and actin were still present 
(Fig. 4.7, lane 3). By contrast after 4 h, -55% of cells were apoptotic and pro - 
caspase-3 was completely cleaved and there was a concomitant decrease in GM130 
compared to control levels, although p115 and actin levels were similar to control 
(Fig. 4.7, lane 4). At 6 h, no further apoptosis was seen (-55%), when compared 
with 4 h. Interestingly, GM130 was almost completely cleaved, although p115 and 
actin levels (Fig. 4.7, lane 5) remained comparable to control levels. Pro -caspase -3 
cleavage and apoptosis was inhibited by ZB4, a neutralising antibody to CH11, 
demonstrating that apoptosis was specific to anti -FasR (Fig. 4.7, lane 6). Pro - 
caspase-3 cleavage was also completely inhibited by z- VAD -fmk (Fig. 4.7, lane 7) 
and the rate of apoptosis, by Annexin -V binding, similar to control levels. GM130 
cleavage was inhibited by both ZB4 and z- VAD -fmk, demonstrating that this was 
specific to anti -FasR induced apoptosis and caspase -dependent. 
4.2.8 GM130 Cleavage is Inhibited During SSP Induced Apoptosis 
To investigate the apparent morphological differences between the kinetics of Golgi 
fragmentation in CH11 and SSP induced apoptosis, we followed the fate of GM130 
and p115 in SSP induced apoptosis in J.CaM1.6 cells. J.CaM1.6 cells were 
incubated with 2µM staurosporine over 4 h and apoptosis assessed by Annexin -V- 
FITC binding and exclusion of PI. After 1 hour, -13% of cells were apoptotic, 
compared to -2% in untreated cells but GM130, p115 and pro -caspase -3 were not 
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affected (Fig. 4.8, lane 2) and comparable to untreated cells (Fig. 4.8, lane 1). By 2 
h however, the rate of apoptosis had increased to -54% and procaspase -3 was no 
longer detected but GM130, p115 and actin were not diminished (Fig. 4.8, lane 3). 
After 3 and 4 h, despite procaspase -3 processing and - 80% apoptosis, GM130 was 
still not cleaved and comparable to untreated cells (Fig. 4.8, lanes 4 & 5). Pro - 
caspase-3 cleavage was completely inhibited by z- VAD -fmk and the rate of 
apoptosis, by Annexin -V -FITC binding, similar to control levels. GM130 is therefore 
resistant to caspase- dependent cleavage in the presence of SSP, perhaps reflecting 
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Figure 4.7: GM130 is cleaved during CH11 induced apoptosis in J.CaM1.6 cells. 
J.CaM1.6 cells were incubated at 2.5 x 106 cells/ ml in whole RPMI 1640 with or without 
500ng /ml CH11 over 6 hours and samples solubilised in SDS lysis buffer. Nitrocellulose 
was probed with the monoclonal antibodies GM130, p115, pro -caspase -3 and actin. Lane 
1: Untreated cells. Lane 4: procaspase -3 is cleaved and there is some cleavage of 
GM130. Lane 5: GM130 is almost completely cleaved and this effect is inhibited by ZB4 
(Lane 6) and by z- VAD -fmk (Lane 7). % Apoptosis: Annexin -V -FITC binding/ PI exclusion 
was monitored and data represent the mean ± SEM of triplicate samples. Data are 
representative of 3 separate experiments. 
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Figure 4.8: GM130 Cleavage is inhibited during SSP induced apoptosis in J.CaM1.6 
cells. J.CaM1.6 cells were incubated at 2.5 x 106 cells/ ml in whole RPMI 1640 with or 
without 2µM SSP over 4 hours and samples solubilised in SDS lysis buffer. Nitrocellulose 
was probed with the monoclonal antibodies GM130, p115, pro -caspase -3 and actin. Lane 
1: Untreated cells. Lane 3: procaspase -3 is cleaved but both GM130 and p115 are similar 
to untreated cells. Lane 5: GM130 is is not cleaved despite almost 80% apoptosis. Lane 6: 
pro -caspase -3 cleavage was inhibited by z- VAD -fmk. % Apoptosis: Annexin -V -FITC 
binding/ PI exclusion was monitored and data represent the mean ± SEM of triplicate 
samples. Data are representative of 3 separate experiments. 
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4.3 Discussion 
The results described within this chapter show that GM130 but not p115 is cleaved 
during CH11 induced apoptosis in J.CaM1.6 cells. However, neither GM130 nor 
p115 is affected in SSP induced apoptosis over 4 h. 
To assess the rate of apoptosis and to ensure the absence of necrosis in SSP or 
CH11 treated J.CaM1.6 cells we measured Annexin -V -FITC binding/ PI exclusion by 
flow cytometry (Fig. 4.1 & 4.2). The kinetics of apoptosis using both stimuli, were 
measured 3 times and the data pooled to establish a kinetic profile of apoptosis (see 
Fig. 4.3 & 4.4). It is interesting to note that the rate of apoptosis in J.CaM1.6 cells 
following Fas ligation appeared to decrease between 4 and 6 h, whereas in SSP - 
treated cells the rate of apoptosis was time dependent. One possible explanation for 
this is that in CH11 treated populations dividing cells could still be observed, whereas 
in SSP treated cultures mitotic cells were absent. In both SSP and Fas induced 
apoptosis, Annexin -V -FITC binding was inhibited by z- VAD -fmk, demonstrating that 
PS externalisation was caspase- dependent in this system. Additionally, in CH11 
treated J.CaM1.6 cells, ZB4 a neutralising antibody raised against the FasR, was 
able to prevent PS exposure demonstrating that apoptosis was specific to the Fas 
pathway. 
To confirm that the Golgi also fragmented during apoptosis in J.CaM1.6 cells, we 
examined Golgi morphology by indirect immunofluorescence. Surprisingly, Golgi 
morphologies in apoptotic J.CaM1.6 cells treated with CH11 and SSP differed by 
confocal microscopy when stained with a monoclonal antibody raised against rat 
GM130. The majority of cells that stained positively for active -caspase -3 in anti - 
FasR (CH11) treated cells had fragmented Golgi. In contrast, in SSP treated cells 
not all cells with positive anti -active -caspase -3 staining had fragmented Golgi (Fig. 
4.5). This result was confirmed when cells were stained with an antibody raised 
against p115 (Fig. 4.6). However, since full Golgi fragmentation did occur in many 
cells treated with SSP, it is likely that while the kinetics and sequence of cleavage of 
key Golgi proteins differ, ultimately cleavage of Golgi substrates must take place. To 
delineate the underlying mechanism behind this apparent difference in the kinetics of 
Golgi fragmentation, we followed the fate of two of the proteins that are known 
targets during mitotic Golgi fragmentation, p115 and GM130, for which antibodies 
were commercially available. 
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GM130 but not p115 was identified as a target for caspase cleavage during CH11 
induced apoptosis in J.CaM1.6 cells (Fig. 4.7). Pro -caspase -3 was no longer 
detected at 4 h (Fig. 4.7, lane 5), suggesting that most of pro -caspase -3 had been 
proteolytically processed and activated. There was a concomitant reduction in 
GM130 detection with pro -caspase -3 detection at 4 h (Fig. 4.7, lane 5). At 6 h, there 
was a further decrease in GM130 detected despite a slowed rate of apoptosis (Fig. 
4.7, lane 5). This was not due to non -specific proteolysis since p115, nor actin was 
affected. ZB4 inhibited GM130 and pro -caspase -3 cleavage showing that the 
apoptosis observed was specific to CH11 (Fig. 4.7, lane 6). Furthermore, cleavage 
of procaspase -3 and GM130 was completely inhibited by z- VAD -fmk, demonstrating 
that GM130 cleavage was caspase- dependent (Fig. 4.7, lane 7). However, in SSP 
induced apoptosis neither GM130 nor p115 was cleaved in spite of a significantly 
higher percentage of apoptosis ( -25 %) at 4 h than in CH11 treated cells at 6 h. More 
specifically, despite cleavage of pro -caspase -3 at 2 h (Fig. 4.8, lane 3) and -80% 
apoptosis after 4 h, GM130 was not cleaved and the band intensity comparable to 
non -apoptotic cells. This was in direct contrast to CH11 treated cells, where after 6 h 
-55% of cells were apoptotic and yet the band intensity was significantly reduced 
compared to control. 
The monoclonal antibody used to detect GM130 (986 a.a.), was raised against the c- 
terminal region of rat -GM130 (a.a. 869 -982) (Nakamura et al., 1997). Since no 
cleavage products were detected (Fig. 4.7), it is predicted that GM130 is cleaved at 
the c- terminal portion, very close to the antibody binding region. This would explain 
the lack of a cleavage product since the resulting C- terminal fragment would be too 
small to detect on a 8% polyacrylamide gel. If GM130 is cleaved prior to the antibody 
binding region as predicted, GM130 would no longer be able to associate with 
GRASP65, since the GRASP65 binding region is at the very C- terminal portion (Fig. 
4.9) (Barr et al., 1998) and thus no longer be able to bind Golgi membranes during 
apoptosis. Interestingly, in a recent study using a truncated form of GM130, which 
lacks the GRASP65 binding site but contains the p115 binding site, truncated GM130 
did not associate with Golgi membranes. In fact, truncated GM130 became 
associated with the early intermediate compartment (IC) through its interaction with 
p115 (Marra et al., 2001). In addition, cells transfected with GM130 containing the 
GRASP65 binding region but not the p115 binding region, had a significantly reduced 
capacity to deliver protein cargo from the ER to the Golgi complex (Marra et al., 
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2001). This suggests that any disruption of the p115- GM130- GRASP65 interaction 
leads to an inhibition of protein transport. 
There are at least two possibilities to explain the inhibition of GM130 cleavage during 
SSP induced apoptosis. Firstly, SSP could be inhibiting an upstream kinase- 
dependent apoptotic pathway. Secondly, SSP could prevent caspase- dependent 
phosphorylation of GM130, necessary for cleavage during apoptosis. From mitotic 
studies of GM130 and p115 interactions, it was shown that CK1 phosphorylates 
GM130 rendering p115 unable to bind, thus contributing to the inhibition of ER to 
Golgi transport (Linstedt et al., 2000; Nakamura et al., 1997; Seemann et al., 2000). 
CDK activity has also been reported to be activated during apoptosis and in some 
systems appears to be necessary for apoptosis (Choi et al.;, 1999; Gil -Gomez et al., 
1998; Hakem et al., 1999; Harvey et al., 2000; Kim et al., 2001; Ojala et al., 2000; 
Takizawa & Morgan, 2000). p115 can be inhibited from binding Golgi membranes in 
a cell -free system, when mitotic cytosols are treated with staurosporine, or the 
specific CDK inhibitors, olomoucine and roscovitine prior to incubation with Golgi 
membranes (Levine et al., 1996). Therefore it is possible, although the MPM -2 
antibody does not react to apoptotic cells, that CDK activity is nevertheless 
responsible for GM130 phosphorylation in apoptotic cells and that this 
phosphorylation event is required for efficient caspase cleavage. Cells treated with 
SSP however, would be unable to phosphorylate GM130 due to inhibition of CDK1 
and hence the kinetics of Golgi fragmentation would be slowed. 
As mentioned in the introduction, GM130 has 25 putative phosphorylation sites, 
excluding the CDK1 phosphorylation sites. 16 of those sites are possible casein 
kinase Il sites (Nakamura et al., 1995). However, it is unlikely that casein kinase Il is 
involved in the SSP- mediated inhibition of GM130 cleavage since its activity is not 
inhibited by SSP (Meggio et al., 1995). In any case, it will be necessary to determine 
whether direct phosphorylation of GM130 is required for its cleavage by caspases in 
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Figure 4.9: GM130 -GRASP65 interaction and amino acid sequence of GNt130 
(Rattus norvegicus). (NP_072118, National Centre for Biotechnology Information 
(NCBI)). The GM130 monoclonal antibody was raised against amino acids 869 -982 
(gray text), blue text = p115 binding region, underlined blue text = putative CDK1 
phosphorylation sites, pink text = GRASP65 binding region. Caspase- cleavage sites 
on GRASP65 are indicated in schematic of GM130- GRASP65 interaction. 
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Recently, it was shown that GRASP65, a Golgi stacking protein, was cleaved by 
caspase -3, contributing to Golgi fragmentation during apoptosis (Lane et al., 2002). 
Furthermore, it was shown that GRASP65 is cleaved after the GM130 binding region, 
to a 30 -35kDa fragment during apoptosis in SSP treated NRK cells. Whether the 
cleaved form of GRASP65 could still bind GM130 was not assessed. Cleavage of 
GRASP65 was shown to be mediated by caspase -3 in vitro, where incubation of 
Golgi membranes with apoptotic cytosol obtained from caspase -3 deficient MCF -7 
cytosols had no GRASP65 cleavage. NRK cells were treated with 111M SSP for 4 h 
and using a polyclonal antibody against GM130 and monoclonal against GRASP65, 
the authors showed that immunofluorescence staining of GRASP65 was diminished 
as compared to the fluorescence staining of GM130 in the same cell. However, this 
is not surprising since in the studies shown herein, where J.CaM1.6 cells were 
treated with CH11, GM130 was shown to be cleaved but this was inhibited by SSP. 
Although, the evidence the authors presented for GRASP65 cleavage was 
compelling, it is likely that SSP also inhibits GM130 cleavage in their system. 
Furthermore, using HeLa cells transfected with a mutant form of GRASP- 65 -GFP, 
resistant to caspase -3 cleavage, it was shown that Golgi fragmentation in these cells 
was slowed down. 
It was also shown that GRASP65 cleavage occurs prior to Golgi fragmentation in 
SSP treated cells (Lane et al., 2002). These studies on the kinetics of Golgi 
fragmentation were performed using NRK cells treated with SSP. Inherently 
problematic in the chosen system is the `unknown factor', where multiple signalling 
pathways must be inhibited. The question to answer would be: `does GM130 
cleavage precede GRASP -65 cleavage in a physiologically relevant model of 
apoptosis ?' Golgi fragmentation may in actual fact be initiated prior to GRASP -65 
cleavage in a more physiologically relevant model of apoptosis. For example, it is 
possible that in CH11- mediated apoptosis, GM130 is cleaved prior to GRASP -65, 
leading to the inability of COPI vesicles to bind and the accumulation of COPI 
vesicles in the cytosol. More importantly, in this model of Golgi fragmentation during 
apoptosis, GM130 cleavage would likely result in an inhibition of ER to Golgi 
transport. Interestingly, a mutant form of GM130, lacking the GRASP65 binding 
region was found to be unable to associate with the cis -Golgi (Marra et al., 2001). 
Since GRASP65 is cleaved after the GM130 binding region, it is possible that this 
does not affect the GM130- GRASP65 binding interaction and hence incoming COPI 
vesicles would still be able to associate with the cis -Golgi (Fig. 4.9). In in vitro 
studies the interaction between GM130 and GRASP65 was not affected by the 
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deletions of the C- terminus of GRASP65 to positions 237 or 314 (Barr et al., 1998). 
Considering that caspase- mediated cleavage of GRASP65 was shown to be at 
positions 320, 375 and 393 (Fig. 4.9) it is unlikely that this would have a significant 
impact on ER to Golgi transport (Lane et al., 2002). In support of this, the authors 
claimed that GM130 and p115 remained associated with Golgi membranes during 
apoptosis. Furthermore, they concluded that GM130 and p115 were therefore not 
involved in the morphological changes observed in Golgi structure during apoptosis. 
Intuitively, it seems that GRASP65 cleavage would not result in an increase in COPI 
vesicles in the cytosol of apoptotic cells, whereas GM130 cleavage would. 
Therefore, the exact significance of GRASP65 cleavage during apoptosis remains to 
be determined. 
In summary, GM130 was identified as a key target for caspase- mediated cleavage 
during apoptosis induced by CH11 but not SSP in J.CaM1.6 cells. GM130 is also a 
major target during mitosis, where its phosphorylation renders p115 unable to bind. 
Disruption of the GM130 -p115 interaction, has been shown to inhibit ER to Golgi 
transport (Marra et al., 2001). Therefore, we sought to directly study delivery of 
protein cargo from the ER to Golgi to plasma membrane in apoptotic cells (Chapter 
5). 
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CHAPTER 5: ER TO GOLGI TRANSPORT DURING APOPTOSIS 
5.1 Introduction 
During mitosis, the Golgi fragments into thousands of vesicles, coinciding with an 
arrest of ER to Golgi transport. Golgi fragmentation was also shown to occur during 
apoptosis (Chapter 3). One of the key proteins, GM130, involved in vesicle tethering 
during ER to Golgi transport was shown to be cleaved, during Fas- induced apoptosis 
in J.CaM.1.6 cells (Chapter 4). Cleavage of GM130 may result in an inability to bind 
GRASP65, associated with the cis -Golgi. This suggests that vesicle tethering and 
therefore ER to Golgi transport is inhibited during apoptosis. 
The Vesicular Stomatitis Virus (VSV) is a small negative- stranded RNA virus and has 
been used extensively in the past to study the constitutive secretory pathway 
(Robbins et al., 1977; Tabas & Kornfeld, 1978). The VSV genome encodes five 
proteins of which there is only one glycoprotein that forms part of the membrane of 
the mature virion. During infection, the VSV glycoprotein (VSVG) is synthesised 
using host cell machinery and is transported through the constitutive secretory 
pathway (Lenard, 1978). Like the many secretory proteins, VSVG is subject to 
oligosaccharide processing in the ER and Golgi complex (Tabas & Kornfeld, 1978). 
The role of oligosaccharide addition in the ER appears to be mainly related to quality 
control, especially in promoting correct protein folding (Helenius, 1994). Most 
proteins destined for secretion or the plasma membrane, are subject to carbohydrate 
modification. Mature glycoproteins are structurally diverse and vary between cell 
type and species. Addition of glycans begins in the ER, often as the protein is still 
being synthesised by the ribosome (Helenius & Aebi, 2001). Fourteen sugar 
oligosaccharides are added cotranslationally to the growing polypeptide chain, which 
is translocated into the ER lumen through a translocation pore. The core 14 sugar 
oligosaccharide is composed of N- acetylglucosamine, mannose and glucose. 
Transfer of core oligosaccharides is mediated by the ER enzyme 
oligosaccharyltransferase, which recognises the Asn- X -Ser/ Thr sequence, where X 
is any amino acid except proline (Silberstein & Gilmore, 1996). Also, immunoglobulin 
heavy chain binding protein (BiP), a member of the Hsp70 chaperone family and the 
oxidoreductase protein -disulfide isomerase (POI) associate either co- translationally, 
or posttranslationally to accommodate protein folding (Mori, 2000). After the addition 
of the core oligosaccharide, glucose and mannose residues are removed by ER 
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resident glucosidases and mannosidases (Kornfeld & Kornfeld, 1985). 
Oligosaccharide addition and processing in the ER is relatively homogeneous from 
protein to protein, it is in the Golgi where further carbohydrate processing results in 
the diversity of N- linked glycoproteins (Helenius & Aebi, 2001). Glycosylation of 
proteins renders them subject to the calnexin -calreticulin cycle, which is essential to 
ensure proper protein folding and oligomerisation (Parodi, 2000). After removal of 
two of the attached glucoses by glucosidases I and II, monoglycosylated glycans are 
recognised by the molecular chaperones calnexin and/ or calreticulin. Calnexin is a 
type I transmembrane protein located in the ER, while its homologue, calreticulin is a 
soluble protein of the ER lumen (Parodi, 2000). Erp57, a member of the PDI family, 
then binds to the calnexin/ calreticulin/ protein complex promoting the formation of 
correctly paired disulfide bonds (Frickel et al., 2002). Removal of the third glucose 
residue results in the dissociation of this complex and if correctly folded, the protein is 
no longer recognised by glucosyltransferase and lacking any glucose residues, it will 
no longer bind to calnexin or calreticulin (Cannon & Helenius, 1999; Parodi, 1999; 
Parodi, 2000). Correctly folded proteins are then transported from the ER to the 
Golgi complex, where further oligosaccharide trimming takes place and also is the 
site of 0-glycosylation (Roth, 1987). 
Carbohydrate processing in the Golgi complex results in the generation of three 
major N- linked glycoprotein families: 1. high mannose type: contains all mannose 
outside the core oligosaccharide. 2. hybrid type: contains N- acetylglucosaminyl 
(GIcNAc) and galactose (Gal) in addition to mannose residues 3. complex type: 
contains no mannose residues outside the core structure but may contain N- acetyl 
galactosaminyl (GaNAc), fucose and sialic acid outwith the core structure (Helenius 
& Aebi, 2001). The VSVG obtains two complex N- linked oligosaccharides as it 
reaches the Golgi complex (Reading et al., 1978). It is this feature that has made it 
so useful for ER to Golgi transport studies. Using the enzyme endoglycosidase H 
(Endo H), it is possible to distinguish between the ER and the Golgi forms of the 
VSVG. Endo H will cleave the mannose -rich oligosaccharides of the VSVG, but not 
the complex type oligosaccharides that it acquires after processing in the Golgi 
complex. Cleavage of the mannose -rich oligosaccharides, attached to the VSVG, 
results in a clear reduction in molecular weight (Robbins et al., 1977). 
To demonstrate that ER to Golgi transport was inhibited during mitosis, synchronised 
Chinese hamster ovary (CHO) cells, blocked in mitosis were infected with VSV 
(Warren et al., 1983). In transport studies where VSV was used as a tool to study 
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the constitutive secretory pathway, VSV infected -90% of cells as standard. Cells 
were then labelled with [35S- methionine] and the radiolabelled VSVG protein was 
digested with Endo H and immunoprecipitated. Subsequent autoradiographs 
showed that in mitotic cells there was a reduction in the molecular weight of VSVG, 
compared to interphase cells where the VSVG was resistant to Endo H digestion. 
This demonstrated that during mitosis, VSVG is not transported out of the ER where 
the ER form is sensitive to Endo H digestion after extraction from whole cells, 
whereas in interphase cells the VSVG is transported to the cell surface through the 
Golgi apparatus, where it becomes resistant to Endo H processing due to 
carbohydrate modifications. 
To investigate whether ER to Golgi transport is also inhibited during apoptosis as in 
mitosis, by biochemical means, the same method should be employed. However, it 
was shown that VSV infection results in the induction of apoptosis in HeLa cells by 4 
h and by 10 h over 80% of cells were apoptotic (Koyama, 1995). Since most 
methods of inducing apoptosis require incubations of several h with the apoptotic 
stimuli, the use of whole virus infection for apoptotic studies should be avoided. The 
VSVG gene is also available in an expression vector and the use of transfection with 
this expression vector would circumvent any possible problems associated with 
infection of cells with whole virus. However, obtaining equivalent transfection 
efficiencies of 95 %, as is achieved during whole virus infection would be difficult. In 
addition, VSV mutational studies resulted in the generation of a temperature - 
sensitive form of VSVG, designated VSVGts045 that is not transported from the ER 
at 39 °C, but at 32 °C is folded properly, able to exit the ER and be transported to the 
plasma membrane through the Golgi normally (Gallione & Rose, 1985). While, as a 
tool, the temperature sensitive VSVG is superior to non -temperature sensitive VSVG, 
careful monitoring of apoptosis would be necessary since the accumulation of 
unfolded VSVG in the ER could likely induce apoptosis via the UPR. 
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Figure 5.1: Overview of N- linked oligosaccharide processing in the ER through to the Golgi. Pre -formed core 
oligosaccharide is transferred to growing polypeptide chains. The oligosaccharyltransferase enzyme transfers the pre- 
formed oligosaccharide only to the sequence Asn- X -Ser/ Thr, where X is any amino acid except proline. When the 
glycoprotein has folded and reached the Golgi complex, additional trimming takes place but also with the addition of 
new terminal sugars. N- linked glycoproteins all contain a common core of oligosaccharide (boxed areas) attached to the 
polypeptide. This core consists of three mannose residues and two GIcNAc. A variety of other sugars are attached to 
this core and comprise three major N- linked families: 1. High mannose type 2. Hybrid type 3. Complex type. The 
VSVG has the complex N- linked glycoprotein addition, rendering it resistant to Endo H digestion once it has reached 
the Golgi. Glc I & Il = glucosidase I & II, ER Man I = ER mannosidase I, Golgi Man I = Golgi mannosidase I, GnTI = 
GIcNAc tranferase I, Golgi Man lI = Golgi mannosidase II, GnTII = GIcNAc tranferase II. 
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5.2 Results 
5.2.1 Transfection of Mammalian Cell Lines with JC119/ ts045 
Previous attempts to transfect neutrophils in the laboratory were unsuccessful (J. 
Pryde - personal communication). Therefore, cell lines were used instead to model 
VSVGts045 progression through the constitutive secretory pathway during apoptosis. 
Various cell lines were transfected with both JC119/ ts045 to find the cell type that 
would yield the highest transfection efficiency. Spinner HeLa (sHeLa) cells were 
transfected initially as they were the ideal cell type for future immunofluorescence, 
metabolic labelling and flow cytometry studies due to their ability to grow either in 
suspension or as a monolayer. Using the protocol given by the EquiBio 
Electroporator manufacturers, sHeLa cells were electroporated and the amount of 
GFP protein expression measured by flow cytometry over 48 h (Fig. 5.2). After 24 h, 
28% of sHeLa cells transfected with 10 µg and 20 pg PEGFP -N1, expressed GFP. 
31% of sHeLa cells transfected with 40 µg PEGFP -N1 expressed GFP after 24 h. 
After 48 h, 47% of sHeLa cells transfected with 10 p.g PEGFP -N1 expressed GFP. 
53% of cells expressed GFP when transfected with 20 µg PEGFP -N1 and 52% of 
cells expressed GFP when transfected with 40 µg PEGFP -N1. After 72 h, 42% of 
cells transfected with 10 µg of PEGFP -N1 expressed GFP, 46% of cells transfected 
with 20 µg of PEGFP -N1 expressed GFP and 44% of cells transfected with 40 µg of 
PEGFP -N1 expressed GFP. 
Since the highest GFP expression was found to occur at 48 h using 20 µg of PEGFP- 
N1 this DNA concentration was maintained, as was the time post -transfection, to 
allow maximal protein expression. 
Maintaining the same conditions, sHeLa cells were transfected with JC119/ ts045. 
However, no protein expression was detected either by flow cytometry or by indirect 
immunofluorescence. As an alternative to sHeLa cells, HeLa cells were transfected 
using slightly different electroporation conditions. The electroporation medium was 
optimised by using Hank's medium, which contains 500 mM glucose to provide the 
cells with an immediate glycolysis substrate, ATP so that any intracellular loss during 
the electroporation could be temporarily provided for and 50 mM glutathione so that 
the cells were under reducing conditions. HeLa cells were transfected with JC119/ 
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Figure 5.2: Optimisation of DNA concentration and time required for protein 
expression in sHeLa cells. 24 hours after transfection with PEGFP -N1, sHeLa cells 
transfected with 10, 20 and 40µg /ml PEGFP -N1. 24 hours after transfection, GFP 
expression was marginally higher in those cells transfected with 40pg /ml PEGFP -N1 
(30% expression) compared to the lower DNA concentrations, where in both cases 
28% of cells expressed GFP. 48 hours after transfection, GFP expression was 
highest in those cells transfected with 20pg /ml PEGFP -N1 (57% expression) 
compared to the lower DNA concentrations. Tranfection efficiency again was highest 
in those cells transfected with 2011g /ml PEGFP -N1 after 72 hours (48 %), but was 
lower than at 24 hours. n =1 
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recommendations. After 48 h, protein expression was assessed by indirect 
immunofluorescence microscopy. Only 5 % of JC119/ ts045 transfected HeLa cells 
expressed VSVGts045. This was not sufficient expression to yield enough 
VSVGts045 to detect the protein by future metabolic labelling experiments. 
Therefore, another cell line was tested for its ability to express VSVGts045. Hek -293 
cells were electroporated under the same conditions as HeLa cells, however only 
-5% of cells expressed VSVGts045. Although, not the first transfection method of 
choice for these studies, FuG6 (Qiagen) was also tested to determine if transfection 
efficiency could be increased in HeLa cells by this method. Efficiency was increased 
to -8 %, this however, was still not sufficient. Furthermore, the morphology of the 
cells following incubation with FuG6 was abnormal. Nuclei were condensed and 
many cells appeared to be fused by the plasma membrane. 
COS -7 cells were also electroporated under the same conditions and protein 
expression was -10% in this cell line. To capitalise on this increase in protein 
expression, COS -7 cells were electroporated with a double pulse as per the 
manufacturers instructions. This resulted in a large increase in the number of cells 
expressing VSVGts045, with protein expression -35 %. NRK cells were then also 
electroporated under the double pulse conditions, but again, only -5% of cells 
expressed VSVG/ ts045. NRK cells were also transfected by the FuG6 method and 
by the Superfect method and again there was no protein expression using either 
method. J.CaM1.6 cells were transfected under double pulse conditions but this time 
there was no protein expression. 
COS -7 cells were the only cell line that expressed sufficient protein for metabolic 
labelling experiments under any of the electroporation conditions tested. However, 
this cell line was not the ideal choice of cell due to their resistance to most apoptotic 
stimuli. Therefore, to try and obtain sufficient protein expression in the other cell 
lines already tested, the VSVGts045 gene in the JC119 expression vector was sub - 
cloned into a more modern CMV based vector. The JC119 expression vector, in 
which the ts045 gene had been cloned in the early 1980s, is based on the SV40 
promoter. SV40 promoters are generally relatively inefficient compared to CMV 
promoters (Colosimo et al., 2000) and therefore, sub -cloning of the VSVGts045 gene 
into a modern CMV expression vector could enhance protein expression, as well as 
transfection efficiencies not only in COS -7 cells but also in other cell lines. 
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Table 5.1: Transfection of mammalian cell lines by electroporation. 5 x 10b cells were pelleted and resuspended in 
800µI of transfection buffer and transferred to an electroporation cuvette. Cells were pulsed and immediately transferred 
to warmed (37 °C) growth medium and left overnight. Cells were then sub -cultured and incubated for a further 24 hours 
before the total VSVG expression was determined. Cells were fixed and permeabilised and stained with anti -VSVG, 
followed by Alexa -488 (green). 100 cells/ electroporation were counted to estimate transfection efficiency. In COS -7 
cells, % cell loss 24 hours post -transfection was 50 -60 %. 
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5.2.2 Sub -cloning of VSVGts045 
The full restriction map of JC119 was unavailable, although from the published work 
the 1.7Kb gene had been cloned originally into JC119 using Xhol cuts (Sprague et 
al., 1983). Therefore, the JC119 expression vector was digested with Xhol to excise 
the VSVG gene. Fig. 5.2A shows the 1.7Kb band produced upon Xhol digestion. 
The new pcDNA3 vector was prepared in the same way to produce Xhol sticky ends 
but in addition, was treated with shrimp alkaline phosphatase to remove the 5' 
phosphates, preventing self -ligation of the vector Fig. 5.2B. 
After purification of the 1.7Kb band and the linearised pcDNA3, ligation reactions 
were performed using T4 DNA ligase using different vector:gene ratios. Competent 
Escherichia coli (E. cols) DH5a cells were then transformed and plated onto 
ampicillin- containing agar petri dishes. The plates containing the most colonies were 
considered to be the most successful ligation reactions and the colonies were initially 
screened for pcDNA3/ VSVG gene constructs using Xhol digests. 
After Xhol digestion of the potential new clones it was found that the majority of 
clones appeared to contain the 1.7Kb band but the vector size was above 5.4Kb (Fig. 
5.3) indicating that this was not a pcDNA3/ ts045 construct. In Fig. 5.3, one clone 
appeared to have the correct vector size and gene size. The potential construct was 
digested with EcoRV to check that the orientation of the gene was correct. There is 
an EcoRV restriction site in the multi -cloning region of pcDNA3 before the Xhol site 
and also at position 1.6KB of the VSVG gene. If the gene was present in the correct 
orientation the resulting DNA fragments would be approximately 5.5Kb and 1.6Kb 
and -7Kb if in the wrong orientation. Fig. 5.4 shows that the gene was present in the 
correct orientation. To check that the gene was present as a single -copy only, a 
double restriction digest was performed with Xbal and Notl. The Notl restriction site 
is present directly before the Xhol site in the multi -cloning region of the pcDNA3 
expression vector and the Xbal site directly after the Xhol site. Therefore, if the gene 
was present as a single copy only, then the resulting DNA fragment would be 
approximately 1.7Kb. Fig. 5.4 shows that while the gene was present in the correct 
orientation, the Notl /Xbal digests resulted in a 3.4Kb band, demonstrating that 2 
copies of the gene had ligated into pcDNA3. 
Since most of the clones contained the 1.7Kb band but the vector size was too large 
to be pcDNA3, it was concluded that the initial purification step may have contained 
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JC119/ Xhol Di ests 
. 1 7Kb Band 
pcDNA3/ Xhol Digest 
Figure 5.3: pcDNA3 preparation and excision of the ts045 gene from the SV40 based 
expression vector JC119. JC119 was digested with Xhol (A) to excise the VSVG 1.7Kb ts045 
gene. The 1.7Kb band was then separated on a 1% agarose gel and purified. (B) pcDNA3 was 
digested with Xhol to linearise the vector with Xhol sticky ends. The 5.4Kb band was then gel 
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Figure 5.4: Screening for pcDNA3/ ts045. Undigested pcDNA3 (lane 2), Xhol 
digested pcDNA3 (lane 3) and ts045 (lane 4). 10 (lanes 5 -14) potential pcDNA/ ts045 
expression vectors were screened. One clone (lane 5) had the correct fragment sizes 
expected from pcDNA3/ ts045 digested with Xhol 5.4Kb and 1.7Kb. 
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Figure 5.5: Diagnostic restriction digests of putative pcDNA3/ 
ts045. Undigested pcDNA3 (lane 2) was run alongside samples to 
control for any undigested samples. pcDNA3 alone was then 
digested with Notl (lane3), Xbal (lane 4), EcoRV (lane 5) to show that 
these enzymes cut the expression vector only once, resulting in its 
linearisation and a band at 5.4Kb. Purified ts045 was also digested 
with Notl (lane 6) and Xbal (lane7) to show that the 1.7Kb band is not 
cleaved by these enzymes but is cleaved by EcoRV (lane 8) as can 
be seen by the slight decrease in fragment size. As expected, the 
putative pcDNA3/ ts045 clone, upon digestion with EcoRV (lane 9) 
and Xhol (lane 10), yielded 2 fragments (5.4Kb and 1.7Kó). Digestion 
with Notl (lane 11) and Xbal (lane 12) resulted in one fragment as 
expected, however the fragment produced was too large to be 
pcDNA3/ ts045. When digested with both Notl and Xbal (lane 13), it 
was found that the clone contained a double copy of the gene, since 
in addition to the 5.4Kb band expected, there was a fragment of 
3.4Kb, double the size of the expected 1.7Kb band. 
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small amounts of supercoiled undigested vector which would preferentially transform 
competent E. Coli DH5a cells. When clones were initially screened with EcoRV to 
check gene orientation, the clones with the wrong vector size showed a band pattern 
of -3.5Kb, 3Kb and 2.3Kb. When the original vector was digested with EcoRV, the 
exact same band pattern was observed (Fig. 5.5), confirming that undigested 
supercoiled JC119/ ts045 was running in the vicinity of the digested 1.7Kb band and 
that this was being excised from the gel along with the 1.7Kb band and hence 
contaminating the subsequent ligation reactions. To overcome this problem, JC119 
was again digested with Xhol but the digest run on a 0.7% gel instead of a 1% gel 
and run over a day to separate all DNA fragments. From Fig. 5.6, it can be seen that 
a band is present around 4Kb which is likely to be undigested supercoiled JC119. 
The 1.7Kb band was excised and gel purified and used in the subsequent ligation 
reactions. 
The subsequent ligation reactions were performed at vector:insert ratios of 1:1, 1:3, 
1:5, 1:7, 1:10, 1:12. Resulting DH5a colonies ranged from 10 to 15 colonies. DH5a 
cells were also transformed with SAP treated pcDNA3/ Xhol digested vector as a 
control to estimate the number of colonies produced as a result of pcDNA3/ Xhol 
self -ligation of which 5 were counted. Colonies picked from the 1:10 and 1:12 ratios 
contained either self -ligated pcDNA3 or double gene inserts. Colonies picked from 
1:3 to 1:7 ratios contained successful ligations. Colonies were screened for pcDNA3/ 
1.7Kb insert by EcoRV digestion and from Fig. 5.7, lanes 3, 4, 6, 9, 10, 11 and 12 
these colonies contained self -ligated pcDNA3/ Xhol. Two colonies contained the 
1.7Kb insert but in the wrong orientation, demonstrated by the 7.1Kb bands. Lane 1 
however, contained the band pattern expected, a 5.5Kb band and 1.6Kb band, of 
pcDNA3 containing the 1.7Kb gene present as a single copy and in the right 
orientation. 
The candidate pcDNA3/ ts045 was further digested to confirm that the gene was 
present as a single copy only. The vector was digested with EcoRV (Fig. 5.8, lane 5) 
to confirm the previous result that the gene was present in the right orientation. 
Separate digests were performed with Notl and Xbal to show that these restriction 
enzymes cut only in one place in the candidate pcDNA3/ ts045 as expected, resulting 
in 7.1Kb bands (Fig. 5.8, lanes 6, 7). A double digest with Notl and Xbal resulted in 
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Figure 5.7: Gel purification of ts045. JC119/ ts045 was incubated overnight with Xhol and 
the DNA separated on a 0.7% gel. The 1.7Kb bands were cut from the gel, avoiding the top 
portion of the bands so as not to co- purify supercoiled JC119/ ts045. 
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Clones Screened by EcoRV Digests 
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Figure 5.8: Screening for pcDNA3/ ts045 by EcoRV restriction 
digests. 11 potential pcDNA/ ts045 expression vectors (lanes 2 -12) 
were screened by restriction digest using EcoRV. All DNA fragment 
sizes were consistent with either pcDNA3 only (5.4Kb, lanes 3,4, 9 -12), 
pcDNA3 containing a double copy of ts045 (5.4Kb, 3.4Kb, lane 8), 
pcDNA3 with one copy of ts045 (7.1 Kb, lanes 5 & 7) or pcDNA3 
containing ts045 in the correct orientation (5.4Kb, 1.7Kb, lane 1). None 
of the clones contained the old vector JC119/ ts045, suggesting that the 
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Figure 5.9: Diagnostic restriction digests of putative pcDNA3/ ts045 clones. Undigested 
pcDNA3 (lane 2) was run alongside samples to control for partially digested samples. pcDNA3 
alone was then digested with Xhol (lane3). Clone 030800/1 was digested with EcoRV (lane 5) and 
as would be expected if the ts045 gene had ligated with the right copy number and in the right 
orientation, there was a 5.4Kb band and a 1.7Kb band. To ensure that the ts045 gene was present 
as a single copy only, 030800/1 was linearised with Notl (lane 6) and Xbal (lane7) which in both 
digests yielded a single band of the correct size 7.1 Kb. To further verify that pcDNA3 contained the 
ts045 gene in a single copy only, a double restriction digest was performed with Notl and Xbal and 
as expected, there were 2 bands of 5.4Kb and 1.7Kb (lane 8), confirming that 030800/1 was the 
mammalian expression vector pcDNA3 containing the ts045 gene. 
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5.2.3 Sequencing of pcDNA3/ ts045 
To confirm that the 1.7Kb band was the ts045 gene and that it contained the single 
base pair mutation resulting in the temperature sensitive mutant of the VSVG protein 
(Gallione & Rose, 1985) the pcDNA3/ ts045 construct was sent for sequencing at the 
CIR Sequencing Facility. Sequencing was performed using the ABI automated 
fluorescence sequencing kit. 
The ts045 gene sequence was downloaded from the NCB' website and from the 
sequence, 3 forward primers were designed so that the entire gene could be 
sequenced. Using the T7 primer which is located at the start of the multi -cloning 
region of pcDNA3, the first -650 base pairs of the putative VSVGts045 were 
sequenced and the sequence compared with the known VSVGts045 sequence using 
Blast 2.0.14 at the NCB! website. The first -650 base pairs showed 96% homology 
to the known VSVG sequence. Three primers were designed from the known 
VSVGts045 sequence; from 0.5Kb (TTGTTGATGAATACACAGGAGA), 9.0Kb 
(TTGAGAGGATCTTGGATTATTC) and 12.6Kb (ATCTTCATCTTAGCTCAAAGG) so 
that the sequencing ranges overlapped allowing for inaccuracies at the beginning 
and tail -ends of the sequencing reactions could be checked by the next sequencing 
results. 
Sequencing from 0.5Kb to - 1.1 Kb showed 99% homology to the known VSVGts045 
sequence downloaded from NCBI. Present in the sequence was a cytosine base at 
position 0.64Kb, which in the non -temperature sensitive VSVG gene is a thymine 
base, confirming that VSVG gene was the temperature sensitive mutant ts045. This 
single base pair mutation results in the replacement of phenylalanine by serine in the 
VSVG, producing the temperature sensitive VSVG (Gallione & Rose, 1985). The 
sequence obtained using the 0.9Kb primer was 98% homologous to the published 
ts045 sequence and the sequence obtained from the 12.6Kb primer was 97% 
homologous, confirming that the 1.7Kb band that was sub -cloned into pcDNA3 was 
the VSVGts045 gene. (For sequencing results see Appendix, Fig. Al). 
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5.2.4 Transfection of Mammalian Cell Lines with pcDNA3/ ts045 
sHeLa, COS -7, HeLa, Hek -293, NRK and J.CaM1.6 cells were transfected by 
electroporation again with the new pcDNA3/ ts045 CMV based expression vector. 
However, in all of the cell lines tested, except for COS -7 cells, there was no protein 
expression using the new construct or protein expression was reduced compared to 
the old SV40 based construct JC119 containing ts045. Under single pulse 
conditions, <1% of COS -7 cells transfected with pcDNA3/ ts045, expressed 
VSVGts045. This was increased to 10% of COS -7 cells (Table 5.2) when cells were 
electroporated under double pulse conditions, although protein expression compared 
poorly to the -35% achieved in JC119/ ts045 transfected COS -7 cells (Table 5.1). 
5.2.5 Temperature Sensitivity of VSVGts045 Expressed in COS -7 Cells 
To further confirm that the expression vectors JC119/ ts045 and pcDNA3/ ts045 
contained the temperature sensitive VSVG, COS -7 cells were transfected with either 
vector and held at the restrictive temperature (40 °C) for 12 h to accumulate VSVG 
protein within the ER (Gallione & Rose, 1985). The ER was stained with the antibody 
to the ER marker calnexin and at the restrictive temperature the VSVG protein co- 
localised with the reticular membrane structure that encircled the nucleus and 
extended out to the plasma membrane, characteristic of the ER (Fig. 5.10A &E) 
(Louvard et al., 1982). After a 15 min chase in the presence of CHX to prevent 
synthesis of new VSVG protein, a bolus of viral protein moved out of the ER to a 
reticular membrane compartment that was restricted to a juxtanuclear position (Fig. 
5.10B &F). VSVG protein started to reach the cell surface following a 30 min chase 
but the majority of VSVG is positioned juxtanuclearly (Fig. 5.10C &G). However after 
a 120 min chase, VSVG can no longer be seen in intracellular compartments and no 
longer co- localises with the ER (Fig. 5.10D &H). 
The VSVGts045 in both the mammalian expression vectors JC119 and pcDNA3 
performed as expected at the restrictive and permissive temperatures as described in 
previous work (Gallione & Rose, 1985). Therefore, this was further confirmation that 
the gene in pcDNA3 was the same as in JC119 and that the differences in 




Vector Method Buffer Conditions Approximate Efficiency 




400V, 25 pF 




250V, 1500 pF <1% 




750V, 25 µF 
100V, 1500 µF 
_ o 10 /o 




250V, 1500 pF NO EXPRESSION 




250V, 1500 pF NO EXPRESSION 




750V, 25 µF 
100V, 1500 µF 
NO EXPRESSION 
pcDNA3/ ts045 FuG6 NO EXPRESSION 




750V, 25 µF 
100V, 15001.1f 
NO EXPRESSION 
Table 5.2: Transfection of mammalian cell lines by electroporation. 5 x 10b cells were pelleted and 
resuspended in 800µI of transfection buffer and transferred to an electroporation cuvette. Cells were pulsed and 
immediately transferred to warmed (37 °C) growth medium and left overnight. Cells were then sub -cultured and 
incubated for a further 24 hours before the total VSVG expression was determined. Cells were fixed and 
permeabilised and stained with anti -VSVG, followed by Alexa -488 (green). 100 cells/ electroporation were counted 
to estimate transfection efficiency. In COS -7 cells, the typical % cell loss 24 hours post -transfection was between 
80 -90 %. 
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Figure 5.10: Time course of delivery of the VSVGts045 from the ER to the cell surface in COS - 
7 cells transfected with pcDNA3 /ts045 (A -D) and JC119/ts045 (E -H). Transfected cells were 
incubated at 40 °C for 12 hours to allow VSVGts045 to accumulate in the ER and then treated with 
50pg /ml CHX for 30 minutes prior to shifting cells to the permissive temperature. Samples were 
stained with an anti -VSVG monoclonal antibody (green) and a polyclonal anti -calnexin (ER marker) 
antibody. (A & E) At time 0, cells incubated at the restrictive temperature of 40 °C, where the 
VSVGts045 co- localised (yellow) with the ER. At 15 minutes (B & F), the VSVG has started to 
proceed through the secretory pathway in a bolus. After 30 minutes at 32 °C, the VSVG protein no 
longer co- localises with the ER but still appears in an internal structure (C & G), probably the Golgi, 
en -route to the cell surface. At 120 minutes (D &H), delivery to the cell surface is complete and there 
is no more co- localisation with the ER (D) after this time point. Data are representative of at least 3 
separate experiments. Scalebar represents 10pm. 
5.2.6 ER to Golgi Transport is Arrested in SSP Treated COS -7 cells 
Progression of VSVGts045 through the constitutive secretory pathway (Gallione & 
Rose, 1983) was used to assess the secretory function in apoptotic COS -7 cells. 
Transfected cells were held at 40 °C for 12 h to accumulate VSVG protein in the ER 
and in the presence of the P13- kinase inhibitor, LY294002 to sensitise the cells to 
apoptosis (Gallaher et al., 2001; Gluzman, 1981; Valentinis et al., 1994). At 40 °C, 
VSVGts045 was seen to co- localise with the ER- marker calnexin (Fig. 5.11A -C). The 
ER is a reticular membrane compartment that extends all the way to the plasma 
membrane and has a characteristic ring -like structure around the nucleus (Powell & 
Latterich, 2000). After a 15 min chase at the permissive temperature, in the 
presence of CHX to prevent synthesis of new VSVGts045, a bolus of viral protein 
moved out the ER and co- localised with markers for the Golgi complex (Fig. 5.11 D- 
F). LY294002 in itself had no effect on the ability of cells to transport VSVGts045 to 
cell surface and after a 120 min chase at the permissive temperature, delivery of 
VSVGts045 to the cell surface was complete (Fig. 5.11G -I). While LY294002 
sensitised the cells to apoptosis, the P13- kinase inhibitor itself did not induce 
apoptosis, as caspase -3 activity was not detected in transfected cells held at the 
restrictive temperature in the presence of LY294002 (Fig. 5.11J-L). After an 8 h 
incubation with SSP, CHX was added to the samples to prevent any new synthesis of 
VSVGts045 and z- VAD -fmk to halt the progression of apoptosis. Cells were then 
shifted to the permissive temperature for 2 h to allow progression of the VSVGts045 
to the cell surface. Transfected cells with pebbled nuclei, characteristic of apoptosis 
and caspase -3 activity were examined. The majority of those cells did not appear to 
have cell surface staining; instead the VSVGts045 appeared to be held in an internal 
structure (Fig. 5.11M-0). When these cells were double -labelled with the ER marker 
calnexin and antibodies to VSVGts045, the viral protein was shown to co- localise 
with the ER demonstrating that in this system ER to Golgi transport is inhibited during 
apoptosis (Fig. 5.11 P -Q). SSP alone did not cause this arrest in transport since cells 
where SSP was added in combination with z- VAD -fmk to inhibit apoptosis 30 min 
prior to shifting to the permissive temperature, were still able to transport VSVGts045 
to the cell surface (Fig. 5.11S). The arrest of protein transport was shown, like Golgi 
fragmentation, to be caspase -dependent since cells pre- incubated with z- VAD -fmk 




Figure 5.11: ER to Golgi transport is arrested during SSP induced apoptosis in COS -7 cells. 
COS -7 cells were transiently transfected with VSVGts045 and incubated in serum -free medium 
containing 20pM LY294002 overnight at 40 °C and 30 minutes prior to the addition of 2pM SSP for 
8 hours, 50pM CHX was added to each sample. 30 minutes prior to the temperature shift, z -VAD- 
fmk was added to all samples, except those already containing z- VAD -fmk, to inhibit the progress 
of apoptosis. The cells were then shifted to 32 °C for 2 hours to allow transport of VSVGts045 to 
the cell surface. (A -C) Cells were incubated with CHX alone, without incubation at the permissive 
temperature. COS -7 cells were stained with anti -calnexin to mark the ER (A) and anti -VSVG to 
stain the VSVGts045 protein (B), which co- localised with the ER (C). (D -F) After 15 minutes at the 
permissive temperature, the VSVGts045 (E) had left the ER and was transported through the Golgi 
complex (D, Golgi marker is anti -p115) towards the plasma membrane. (G -H) After 2 hours at the 
permissive temperature, the VSVGts045 (H) protein was no longer present in the ER (G) and was 
delivered to the cell surface (I). (J -L) Control cells only and held at 40 °C without incubation at the 
permissive temperature. (J) shows that there was no detectable caspase -3 activity and the VSVG 
ts045 protein shows ER -like staining (H). (L) is the overlay of (J &K). Scalebars represent 10pm. 
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Figure 5.11 continued: (M -O) shows a cell incubated with SSP for 8 hours where (M) shows the 
cell stained positively for caspase -3 activity and the VSVGts045 protein has not reached the cell 
surface, but appears to be held in an internal structure (N). (0) is the composite of (M &N). (P -R) 
An apoptotic transfected cell, where the ER was stained with anti -calnexin (P) and the 
VSVGts045 protein (Q) again was not present on the cell surface but the staining co- localised 
with the ER (R, yellow), indicating a block in the constitutive secretory pathway at the ER during 
apoptosis. SSP nor LY294002 themselves inhibited transport of the VSVGts045 to the plasma 
membrane. SSP was added 30 minutes prior to the temperature drop to cells incubated with 
serum -free medium containing 20pM LY294002 alone. These cells were still able to transport 
VSVGts045 to the cell surface (S). The arrest of ER to Golgi transport in apoptotic cells was 
inhibited by 100pM z- VAD -fmk (T). Data are representative of 3 separate experiments. 
Scalebars represent 10pm. 
5.3 Discussion 
The results shown herein have demonstrated that exit from the ER is inhibited in 
apoptotic COS -7 cells treated with SSP by indirect immunofluorescence. 
Many of the original studies that demonstrated a block in ER to Golgi transport were 
performed using whole VSV. In these studies, 95% of cells were routinely infected, 
providing enough VSVG for metabolic labelling experiments, where VSVG was 
labelled with [35S]- methionine (Featherstone et al., 1985; Green et al., 1981; Lucocq 
et al., 1991; Lucocq & Warren, 1987; Warren et al., 1983). The mannose -rich 
oligosaccharide side chains of the ER form of VSVG are sensitive to digestion with 
Endo H, while VSVG that has reached the Golgi complex acquires complex type 
oligosaccharide side chains which are resistant to Endo H cleavage and therefore the 
two forms of VSVG can be distinguished by molecular weight. The long -term aim is 
that the system that has been developed and adapted to look at constitutive 
secretion during apoptosis, will also provide biochemical evidence of inhibition of ER 
to Golgi transport, in addition to the indirect immunofluorescence evidence presented 
herein. 
In a study by Koyama et al., (1995), infection of whole VSV was shown to induce 
over 80% apoptosis 8 h post- infection in HeLa cells. Since the virus itself induced 
apoptosis, studies using this system would not have been possible as the 
mechanism of apoptosis would be undefined and furthermore induction of apoptosis 
would be uncontrolled. Therefore, instead of using whole virus to infect cells and 
follow the VSVGts045 through the secretory pathway, an expression vector 
containing the VSVGts045 gene alone was used instead, to circumvent induction of 
apoptosis by VSV. To increase the efficiency of transfection obtained with the 
JC119/ ts045 SV40 based vector in a number of cell lines, the ts045 gene was sub - 
cloned into the CMV -based expression vector, pcDNA3. Efficiency of transfection 
was reduced in all cell lines transfected with pcDNA3/ ts045 compared to JC119/ 
ts045 transfected cells. The results were surprising since pcDNA3 is a CMV -based 
expression vector, which is a stronger promoter than SV40 in the JC119 expression 
vector (Colosimo et al., 2000). However, when COS -7 cells were transfected under 
double pulse conditions, there was an increase in cell loss, 24 h post -transfection in 
pcDNA3/ ts045 transfected cells compared to JC119/ ts045 transfected cells. In 
addition, in pcDNA3/ ts045 transfected COS -7 cells, there was an increase in cell 
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loss compared to COS -7 cells transfected with empty pcDNA3 alone, suggesting that 
the ts045 gene conferred a certain degree of lethality on its own. It is possible that in 
this case, the increased efficiency of protein expression in the CMV based vector 
pcDNA3 would in fact result in a decrease in transfection efficiency. Incubation at 
37 °C, while allowing a little VSVG to move to the cell surface, still inhibits correct 
folding of the VSVG/ ts045 and therefore the VSVG/ ts045 accumulates in the ER. 
Accumulation of protein in the ER is known to induce apoptosis, also known as the 
unfolded protein response (Yoneda et al., 2001). COS -7 cells are remarkably 
recalcitrant to apoptotic stimuli, probably why they had the highest transfection 
efficiency of all the cell lines tested. However, it seems that the CMV based vector 
may have increased the expression of VSVGts045 too much, causing the induction 
of apoptosis. In contrast, it is clear that the SV40 based vector JC119, while 
maintaining satisfactory transfection efficiencies, is expressed at a tolerable level for 
these cells. The ability of COS -7 cells to withstand an accumulation of misfolded 
proteins in the ER more than other cell types may involve defective stress signalling 
molecules. While the precise defects in the apoptotic signalling pathways are 
unknown in COS -7 cells, stimulation of the FasR (Memon et al., 1998) or 
overexpression of caspase -2 (Wang et al., 1994) does not induce apoptosis in these 
cells. 
While the relative resistance of COS -7 cells is probably an advantage if high 
transfection efficiencies are required as was the case here, the induction of apoptosis 
is problematic. In addition, apoptosis induction had to be rapid as leaving the 
transfected cells longer than overnight, at the restrictive temperature, may have 
initiated ER stress responses if unfolded VSVG was allowed to accumulate beyond 
this time frame. Insulin -like growth factor -1 (IGF -1), mediates multiple cellular 
responses, including stimulation of both proliferative and anti -apoptotic pathways via 
P13- kinase activation and is constitutively activated in COS -7 cells (Gallaher et al., 
2001; Gluzman, 1981; Valentinis et al., 1994). To reduce the anti -apoptotic effect of 
IGF -1, transfected COS -7 cells were incubated with the specific PI3- kinase inhibitor 
LY294002 overnight. This in itself did not induce apoptosis, but sensitised the cells 
to SSP induced apoptosis, allowing a more rapid induction of apoptosis. While SSP 
was not the ideal stimulus of choice to induce apoptosis, out of the reagents tried 
(CHX, mitomycin c and etoposide), it was the only method that was sufficiently 
effective. Moreover, it was shown that neither LY294002 nor SSP inhibit the 
secretory pathway in themselves. This was demonstrated by incubating COS -7 cells 
in LY294002 overnight as usual and 30 min prior to shifting to the permissive 
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temperature, adding SSP together with z- VAD -fmk. While the morphology of those 
cells was clearly different from untreated cells, VSVGts045 was still transported to 
the cell surface (Fig. 5.11S). 
Since SSP was shown to slow the kinetics of Golgi fragmentation compared to other 
apoptotic stimuli (Chapters 3,4), only cells with pebbled nuclei were examined for 
their ability to transport VSVG/ ts045 to the cell surface. Before the shift to the 
permissive temperature, cells were incubated with z- VAD -fmk, halting all caspase- 
activity and preventing apoptosis occurring or proceeding during incubation at the 
permissive temperature. This was important since without pre- incubation with z- 
VAD -fmk prior to the temperature shift, some cells may have initiated the apoptotic 
program during incubation at the permissive temperature. This would result in many 
cells having delivered VSVGts045 to the cell surface before acquiring the apoptotic 
morphology. During apoptosis the ER appears to retain its structure (Fig. 5.11P), in 
agreement with other reports where the ER was shown to be dilated but intact in 
apoptotic cells (Chu -Wang I.W., 1978; Sesso et al., 1999). In the vast majority of 
apoptotic COS -7 cells, VSVGts045 was retained in the ER during apoptosis (Fig. 
5.11R). Confirming that ER to Golgi transport is inhibited during apoptosis. In 
addition, inhibition of ER to Golgi transport was shown to be dependent on caspase 
activity, since pre- incubation of transfected COS -7 cells with z- VAD -fmk allows 
transport of the VSVGts045 to the cell surface in SSP treated cells (Fig. 5.11T). 
BAP31 is a ubiquitously expressed 28kDa integral membrane protein of the ER that 
is constantly recycled between the ER and Golgi complex (Annaert et al., 1997; 
Mosser et al., 1994). It is involved in the export from the ER of cellubrevin, a protein 
largely localised to the endocytic pathway and functions in the exocytic pathway but 
its expression is cell type specfiic (Annaert et al., 1997; Chilcote et al., 1995), . 
However, BAP31 has received the most attention for its role in apoptosis. The 
cytosolic tail contains a death effector domain flanked by caspase cleavage sites, 
preferentially cleaved by caspase -8 and weakly cleaved by caspase -3 (Ng et al., 
1997; Ng & Shore, 1998). Caspase -8 mediated cleavage results in a 20kDa 
membrane -integrated BAP31 product which when transfected is a potent inducer of 
apoptosis. It was shown that in cells transfected with the 20kDa cleavage product of 
BAP31 to induce apoptosis and infected with Semliki Forest Virus (SFV) (where the 
coat glycoprotein may also be followed through the secretory pathway in a similar 
manner to VSVG), that transport from the ER to the Golgi was inhibited (Maatta et 
al., 2000) in agreement with the data presented herein. Since cellubrevin is also 
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involved in the exocytic pathway in some cells, the authors suggested that inhibition 
of ER to Golgi transport could be attributed to BAP31 cleavage alone. However, their 
system was fundamentally flawed since truncated BAP31, while no longer able to 
export cellubrevin, is still able to export the transferrin receptor (Annaert et al., 1997). 
This suggests that BAP31 is involved in the export of specific proteins but its 
cleavage alone does not result in a global inhibition of ER to Golgi transport. BAP31 
has also been shown to interact with procaspase -8, Bcl -2 and Bcl -XL (Ng et al., 
1997; Ng & Shore, 1998), which is more suggestive of a role as a global sensor to 
death signals rather than being directly linked to the inhibition of the secretory 
pathway. Their results are in agreement with the data shown herein, however it is 
likely that the inhibition of ER to Golgi transport reported by the authors was due to 
cleavage of specific tethering/ docking factors and not a direct result of BAP31 
cleavage. 
The results shown herein are the first formal demonstration that protein exit from the 
ER is inhibited during apoptosis. Inhibition of the secretory pathway is likely to play a 
significant role in `isolating' the apoptotic cell from its extracellular milieu. Since Golgi 
fragmentation occurred in a variety of cell lines and with different apoptotic stimuli, it 
is predicted that ER to Golgi transport is also a ubiquitous occurrence during 
apoptosis. Therefore, the apoptotic neutrophils' inability to respond to inflammatory 
mediators (Whyte et al., 1993) is likely to occur due in part to a shut down of the 
constitutive secretory pathway. Receptor molecules, already present on the cell 
surface before the induction of apoptosis, will have a finite half -life resulting in the net 
loss of receptors and therefore the cells ability to respond to extracellular signals as 
apoptosis progresses. 
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CHAPTER 6: SUMMARY & FUTURE DIRECTION 
Modulation of neutrophil secretion may provide a key therapeutic target in preventing 
tissue damage often associated with inflammatory disease. Phagocytosis of 
apoptotic neutrophils before they undergo secondary necrosis is thought to be a 
major mechanism preventing the inappropriate release of neutrophil granules. 
However, there is a time window where apoptotic neutrophils could still degranulate 
at the inflammatory site before phagocytosis takes place. However, Whyte et al. 
(1993) demonstrated that apoptotic neutrophils do not degranulate in response to 
inflammatory stimuli. Therefore, not only does apoptosis mark the neutrophil for 
removal, it also prevents the cell from exacerbating the inflammatory response by 
releasing its granule contents. This inability of the neutrophil to respond to 
inflammatory stimuli may in part be due to an inhibition of the secretory pathway, 
which would result in the failure of cell surface receptors to reach the plasma 
membrane, effectively cutting off the cells' ability to respond to stimuli. 
6.1 Golgi Morphology During Apoptosis 
The work presented in this thesis has for the first time sought to investigate the 
mechanism by which neutrophils become functionally static when apoptotic. The 
Golgi apparatus was identified by indirect immunofluorescence for the first time in 
neutrophils, however the resolution of this structure was not sufficient for 
morphological studies. Using cell lines that have a large, well- defined Golgi 
apparatus the fate of this organelle was investigated during apoptosis. Golgi 
fragmentation was used as a preliminary indicator of an arrest in the constitutive 
secretory pathway and initially Golgi fragmentation was shown to occur in apoptotic 
SSP- treated NRK cells. Golgi fragmentation during apoptosis was then also shown 
to occur in other cell lines using a variety of apoptotic stimuli, suggesting that this is a 
ubiquitous morphological event, in agreement with other studies (Lane et al., 2002; 
Philpott et al., 1996; Sesso et al., 1999). Additionally, Golgi fragmentation was 
shown to be a caspase- dependent event and therefore part of the execution phase of 
apoptosis. Furthermore, the Golgi- derived vesicles in apoptotic cells were found to 
be morphologically identical to those found in the cytoplasm of mitotic cells (John 
Lucocq - personal communication), indicating that the target Golgi- associated 
proteins during mitosis that lead to Golgi fragmentation may be the same during 
128 
apoptosis. It is quite likely that at the EM level Golgi structure in neutrophils could be 
defined during apoptosis. Therefore, to confirm that Golgi fragmentation also occurs 
in neutrophils during apoptosis, the antibody against p115 that specifically stained 
the Golgi apparatus in neutrophils by indirect immunofluorescence, could be used to 
perform immunogold labelling for EM. 
6.2 Cleavage of GM130 During Apoptosis 
One of the key target Golgi- associated proteins, GM130 that is phosphorylated 
during mitosis and believed to play a significant role in Golgi fragmentation and 
inhibition of ER to Golgi transport during mitosis (Alvarez et al., 2000; Barr et al., 
1998; Linstedt et al., 2000; Moyer et al., 2001) was also shown to be targeted during 
apoptosis. GM130 was demonstrated to be cleaved in a caspase- dependent manner 
when apoptosis was induced via the Fas pathway by ligation of the FasR with the 
monoclonal antibody CH11. However, GM130 cleavage was inhibited when 
apoptosis was induced by SSP, despite caspase activation. These differences 
between Golgi fragmentation in CH11- treated cells and SSP- treated cells were 
strikingly reflected in the rate of Golgi fragmentation between the 2 treatments when 
these cells were viewed by indirect immunofluorescence. SSP is a broad -range 
kinase inhibitor and therefore it is possible that phosphorylation of GM130 is required 
to sensitise it to caspase cleavage. To verify if this is the case, labelling with 32P- 
phosphate should identify phosphorylation of GM130 prior to caspase cleavage in the 
first instance. The fact that Golgi fragmentation was delayed in cells where GM130 
was not cleaved, implicates GM130 as a central molecule involved in the 
maintenance of Golgi structure, which is related to its role in tethering incoming 
secretory vesicles. This is the first demonstration that GM130 is cleaved during 
apoptosis and is in direct opposition to the work of Lane et al., (2002) who stated that 
GM130 was not cleaved during apoptosis. However, since one of their main 
methods of inducing apoptosis was by SSP, it is likely that GM130 cleavage was also 
inhibited in their system. 
The monoclonal antibody used to detect GM130 by Western blotting is the only 
antibody commercially available. However, the immunogen against which it was 
raised presides on the C- terminal end of GM130, presumably just before the putative 
GM130 caspase cleavage site. No cleavage products and therefore the size of 
fragment or fragments produced were obtained to allow a more accurate estimation 
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of where the caspase cleavage site may lie. However, Walker et al., (2002) were 
able to detect a proteolytic fragment of GM130 of about -111 kDa using a polyclonal 
antibody in apoptotic NRK cells and in a cell -free system using apoptotic neutrophil 
cytosol (Pryde et al., 2000) and rat liver Golgi membranes. This confirmed the 
prediction that the GM130 cleavage site lies close to the C- terminal end. Walker et 
al., (2002) further examined the GM130 amino acid sequence and identified a 
potential caspase cleavage site at the DMGD75 position. Cleavage at this site would 
be consistent with not only the loss of the C- terminal domain amino acids 869 -982 
but also with the molecular mass of the remaining N- terminal fragment. 
Future studies using an expression vector containing the GM130 sequence, would 
allow GM130 to be translated in vitro and incubated with recombinant effector 
caspases, to identify the caspase or caspases that cleave GM130. To formally 
identify the precise caspase recognition site, cells could be transfected with an 
expression vector containing the GM130 sequence mutated in the predicted 
cleavage site. Resistance of mutant GM130 to caspase- mediated cleavage would 
then formally identify the caspase cleavage site. In addition, it would be interesting to 
transfect cells with an expression vector encoding a truncated form of GM130 
identical to GM130 after caspase cleavage. From this, cells could be co- transfected 
with expression vectors containing VSVGts045 and truncated GM130 to assess the 
impact that cleaved GM130 alone has on ER to Golgi transport. 
6.3 ER to Golgi Transport During Apoptosis 
ER to Golgi transport was demonstrated to be inhibited in apoptotic COS -7 cells 
transfected with VSVGts045 by indirect immunofluorescence. This is the first formal 
demonstration of an inhibition of the constitutive secretory pathway during apoptosis. 
Walker et al., 2002 were able to continue this work using the system described 
herein, to demonstrate a block in the ER to Golgi transport during apoptosis by 
biochemical means. Endo -H only cleaves the mannose -rich oligosaccharides of the 
VSVGts045 acquired in ER. Transport of VSVGts045 to the Golgi complex results in 
the further processing of its oligosaccharide side chains to the complex form that is 
resistant to Endo -H digestion, providing a convenient biochemical method for 
monitoring VSVGts045 progress through the constitutive secretory pathway. Walker 
et al., 2002 showed that in apoptotic COS -7 cells treated with SSP VSVGts045 
remained sensitive to oligosaccaride removal by Endo -H indicating that in apoptotic 
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cells the VSVGts045 was unable to reach the Golgi apparatus. Furthermore, pre - 
incubation with z- VAD -fmk allowed transport of VSVGts045 to the Golgi apparatus 
since VSVGts045 was resistant to Endo -H digestion in these cells. 
COS -7 cells are unusually resistant to apoptosis, which may explain why this cell 
type yielded the highest transfection efficiencies. It was shown that inducing 
apoptosis with SSP results in differential kinetics of Golgi fragmentation and in 
addition that GM130 cleavage is inhibited in SSP treated J.CaM1.6 cells, a derivative 
of Jurkat cells. However, SSP in combination with LY294002 was the only stimuli 
tested that induced a sufficient amount of apoptosis within a relatively short time 
frame. It may be possible however to initiate apoptosis in COS -7 cells by a more 
physiological method by co- transfecting cells with a vector containing a chimeric 
FasR that is fused with the cytoplasmic procaspase -8 molecule as described by 
Memon et al., (1998). COS -7 cells undergo apoptosis when treated with the DNA 
damaging agent mitomycin c, although the kinetics of apoptosis are too slow for the 
requirements of the system used (Mahajan et al., 1999). However, transfecting 
COS -7 cells with for example the pro -apoptotic Bcl -2 family member Bax may 
sensitise the cells to mitomycin c induced apoptosis. The advantage of these 
alternative methods of killing would be the avoidance of SSP- mediated inhibition of 
GM130 cleavage. While inhibition of ER to Golgi transport was demonstrated to 
occur in the SSP system, a more physiological method of killing would allow a 
greater understanding of the kinetics of this inhibition. To transfer this system to 
neutrophils to demonstrate a block in ER to Golgi transport would appear to be 
problematic since previous attempts to transfect neutrophils were unsuccessful (J. 
Pryde - personal communication). In addition, it is likely that the presence of viral 
DNA/ protein would result in a rapid induction of apoptosis. Also, the size of the 
Golgi apparatus in neutrophils is indicative of a low level of protein trafficking through 
the constitutive secretory pathway, which would make detection of any protein 
trafficking through this route difficult. It may therefore be better to model inhibition of 
ER to Golgi transport during apoptosis in cell lines but identify the caspase- 
dependent cleavage of key trafficking molecules leading to this inhibition, verify their 
existence in neutrophils and show that they are also cleaved in apoptotic neutrophils. 
This together with morphological studies showing Golgi fragmentation by EM in 
neutrophils would be highly indicative that constitutive exocytosis is also inhibited in 
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Figure Al: Sequencing of VSVGts045 sub -cloned into pcDNA3. The upper nucleotide 
sequence is the VSVGts045 sequence and the lower was obtained from sequencing of the 
VSVGts045 sub -cloned into pcDNA3 (Sequence data was from CIR Sequencing Facility). 
The first 480 bases were sequenced from the T7 primer within the pcDNA3 construct located 
just before the multi -cloning site. The sequences highlighted in yellow are the primer 
sequences used to sequence -500 bases. A thymidine residue is substituted by cytosine 
resulting in VSVGts045 temperature sensitivity at position 640 and is highlighted in pink. This 
can be seen to be present in the VSVGts045 sequence obtained from the pcDNA3 construct, 
confirming that this is the VSVGts045 gene. 
134 
REFERENCES 
Adams, J.M., Cory, S. 1998. The Bcl -2 protein family: arbiters of cell survival. 
Science 281, 1322 -1326. 
Akgul, C., Moulding, D.A., Edwards, S.W. 2001. Molecular control of neutrophil 
apoptosis. FEBS Lett. 487, 318 -322. 
Allan, B.B., Moyer, B.D., Balch, W.E. 2000. Rab1 recruitment of p115 into a cis - 
SNARE complex: programming budding COPII vesicles for fusion. Science 289, 
444 -448. 
Alnemri, E.S., Livingston, D.J., Nicholson, D.W., Salvesen, G., Thornberry, N.A., 
Wong, W.W., Yuan, J. 1996. Human ICE /CED -3 protease nomenclature. Cell 87 , 
171 -171. 
Alvarez, C., Fujita, H., Hubbard, A., Sztul, E. 1999. ER to Golgi transport: 
Requirement for p115 at a pre -Golgi VTC stage. J. Cell Biol. 147, 1205 -1222. 
Alvarez, C.I., Garcia -Mata, R., Hauri, H.P., Sztul, E.S. 2000. The p115- interactive 
proteins, GM130 and giantin participate in ER- Golgi traffic. J. Biol. Chem. 276 (4), 
2693 -2700. 
Annaert, W.G., Becker, B., Kistner, U., Reth, M., Jahn, R. 1997. Export of 
cellubrevin from the endoplasmic reticulum is controlled by BAP31. J. Cell Biol. 139, 
1397 -1410. 
Aridor, M., Bannykh, S.I., Rowe, T., Balch, W.E. 1995. Sequential coupling between 
COPII and COPI vesicle coats in endoplasmic reticulum to Golgi transport. J. Cell 
Biol. 131, 875 -893. 
Ash, J.F., Louvard, D., Singer, S.J. 1977. Antibody- induced linkages of plasma 
membrane proteins to intracellular actomyosin- containing filaments in cultured 
fibroblasts. Proc. Natl. Acad. Sci. U.S.A 74, 5584- 5588. 
Ashkenazi, A., Dixit, V.M. 1998. Death receptors: signaling and modulation. 
Science 281, 1305 -1308. 
Ashkenazi, A., Dixit, V.M. 1999. Apoptosis control by death and decoy receptors. 
Curr. Opin. Cell Biol. 11, 255 -260. 
Bailly, E., McCaffrey, M., Touchot, N., Zahraoui, A., Goud, B., Bornens, M. 1991. 
Phosphorylation of two small GTP- binding proteins of the Rab family by p34cdc2 
Nature 350, 715 -718. 
135 
Bainton, D.F. 1973. Sequential degranulation of the two types of polymorphonuclear 
leukocyte granules during phagocytosis of microorganisms. J. Cell Biol. 58, 249- 
264. 
Bainton, D.F., Ullyot, J.L., Farquhar, M.G. 1971. The development of neutrophilic 
polymorphonuclear leukocytes in human bone marrow. J. Exp. Med. 134, 907 -934. 
Balch, W.E., Glick, B.S., Rothman, J.E. 1984. Sequential intermediates in the 
pathway of intercompartmental transport in a cell -free system. Cell 39, 525 -536. 
Barlowe, C., Orci, L., Yeung, T., Hosobuchi, M., Hamamoto, S., Salama, N., Rexach, 
M.F., Ravazzola, M., Amherdt, M., Schekman, R. 1994. COPII: a membrane coat 
formed by Sec proteins that drive vesicle budding from the endoplasmic reticulum. 
Cell 77, 895 -907. 
Barlowe, C., Schekman, R. 1993. SEC12 encodes a guanine- nucleotide- exchange 
factor essential for transport vesicle budding from the ER. Nature 365, 347 -349. 
Barr, F.A., Nakamura, N., Warren, G. 1998. Mapping the interaction between 
GRASP65 and GM130, components of a protein complex involved in the stacking of 
Golgi cisternae. EMBO J. 17, 3258 -3268. 
Barr, F.A., Puype, M., Vandekerckhove, J., Warren, G. 1997. GRASP65, a protein 
involved in the stacking of Golgi cisternae. Cell 91, 253 -262. 
Baumert, M., Maycox, P.R., Navone, F., De Camilli, P., Jahn, R. 1989. 
Synaptobrevin: an integral membrane protein of 18,000 daltons present in small 
synaptic vesicles of rat brain. EMBO J. 8, 379 -384. 
Beckers, C.J., Plutner, H., Davidson, H.W., Balch, W.E. 1990. Sequential 
intermediates in the transport of protein between the endoplasmic reticulum and the 
Golgi. J. Biol. Chem. 265, 18298 -18310. 
Bedner, E., Li, X., Gorczyca, W., Melamed, M.R., Darzynkiewicz, Z. 1999. Analysis 
of apoptosis by laser scanning cytometry. Cytometry 35, 181-195. 
Belloc, F., Belaud -Rotureau, M.A., Lavignolle, V., Bascans, E., Braz- Pereira, E., 
Durrieu, F., Lacombe, F. 2000. Flow cytometry detection of caspase 3 activation in 
preapoptotic leukemic cells. Cytometry 40, 151 -160. 
Berger, M., O'Shea, J., Cross, A.S., Folks, T.M., Chused, T.M., Brown, E.J., Frank, 
M.M. 1984. Human neutrophils increase expression of C3bi as well as C3b 
receptors upon activation. J. Clin. Invest 74, 1566 -1571. 
Berger, M., Wetzler, E.M., Welter, E., Turner, J.R., Tartakoff, A.M. 1991. 
Intracellular sites for storage and recycling of C3b receptors in human neutrophils. 
Proc. Natl. Acad. Sci. U.S.A 88, 3019 -3023. 
136 
Block, M.R., Glick, B.S., Wilcox, C.A., Wieland, F.T., Rothman, J.E. 1988. 
Purification of an N -ethyl maleimide- sensitive protein catalyzing vesicular transport. 
Proc. Natl. Acad. Sci. U.S.A 85, 7852 -7856. 
Borregaard, N., Cowland, J.B. 1997. Granules of the human neutrophilic 
polymorphonuclear leukocyte. Blood 89, 3503 -3521. 
Borregaard, N., Sehested, M., Nielsen, B.S., Sengelov, H., Kjeldsen, L. 1995. 
Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a 
marker of terminal neutrophil differentiation. Blood 85, 812 -817. 
Brumell, J.H., Volchuk, A., Sengelov, H., Borregaard, N., Cieutat, A.M., Bainton, D.F., 
Grinstein, S., Klip, A. 1995. Subcellular distribution of docking /fusion proteins in 
neutrophils, secretory cells with multiple exocytic compartments. J. lmmunol. 155, 
5750 -5759. 
Burke B, Griffiths G, Reggio H, Louvard D, Warren G. 1982. A monoclonal antibody 
against a 135 -K Golgi membrane protein. EMBO J. 1, 1621 -1628. 
Cannistra, S.A., Griffin, J.D. 1988. Regulation of the production and function of 
granulocytes and monocytes. Semin. Hematol. 25, 173 -188. 
Cannon, K.S., Helenius, A. 1999. Trimming and readdition of glucose to N- linked 
oligosaccharides determines calnexin association of a substrate glycoprotein in living 
cells. J. Biol. Chem. 274, 7537 -7544. 
Cao, X., Ballew, N., Barlowe, C. 1998. Initial docking of ER- derived vesicles 
requires Uso1 p and Ypt1 p but is independent of SNARE proteins. EMBO J. 17, 
2156 -2165. 
Chai, J., Du, C., Wu, J.W., Kyin, S., Wang, X., Shi, Y. 2000. Structural and 
biochemical basis of apoptotic activation by Smac /DIABLO. Nature 406, 855 -862. 
Chao, J.R., Wang, J.M., Lee, S.F., Peng, H.W., Lin, Y.H., Chou, C.H., Li, J.C., 
Huang, H.M., Chou, C.K., Kuo, M.L., Yen, J.J., Yang -Yen, H.F. 1998. mcI -1 is an 
immediate -early gene activated by the granulocyte- macrophage colony- stimulating 
factor (GM -CSF) signaling pathway and is one component of the GM -CSF viability 
response. Mol. Cell Biol. 18, 4883 -4898. 
Chen, Y.A., Scales, S.J., Patel, S.M., Doung, Y.C., Scheller, R.H. 1999. SNARE 
complex formation is triggered by Cat+ and drives membrane fusion. Cell 97, 165- 
174. 
Chen, Y.A., Scheller, R.H. 2001. SNARE -mediated membrane fusion. Nat. Rev. 
Mol. Cell Biol. 2, 98 -106. 
Chilcote, T.J., Galli, T., Mundigl, O., Edelmann, L., McPherson, P.S., Takei, K., De 
Camilli, P. 1995. Cellubrevin and synaptobrevins: similar subcellular localization and 
biochemical properties in PC12 cells . J. Cell Biol. 129, 219 -231. 
137 
Choi, K.S., Eom, Y.W., Kang, Y., Ha, M.J., Rhee, H., Yoon, J.W., Kim, S.J. 1999. 
Cdc2 and Cdk2 kinase activated by transforming growth factor -betal trigger 
apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma 
cells. J. Biol. Chem. 274, 31775 -31783. 
Chou, J.J., Matsuo, H., Duan, H., Wagner, G. 1998. Solution structure of the RAIDD 
CARD and model for CARD /CARD interaction in caspase -2 and caspase -9 
recruitment. Cell 94, 171 -180. 
Chu -Wang I.W. 1978. Cell Death of Motoneurons in the Chick Embryo Spinal Cord. 
J. of Comp. Neur. 177, 33 -57. 
Chuang, P.I., Yee, E., Karsan, A., Winn, R.K., Harlan, J.M. 1998. Al is a 
constitutive and inducible BcI -2 homologue in mature human neutrophils. Biochem. 
Biophys. Res. Commun. 249, 361 -365. 
Clarke, P.R., Karsenti, E. 1991. Regulation of p34cdc2 protein kinase: new insights 
into protein phosphorylation and the cell cycle. J. Cell Sci. 100, 409 -414. 
Clary, D.O., Griff, I.C., Rothman, J.E. 1990. SNAPs, a family of NSF attachment 
proteins involved in intracellular membrane fusion in animals and yeast. Cell 61, 
709 -721. 
Cluett, E.B., Brown, W.J. 1992. Adhesion of Golgi cisternae by proteinaceous 
interactions: intercisternal bridges as putative adhesive structures. J. Cell Sci. 103, 
773 -784. 
Colosimo, A., Goncz, K.K., Holmes, A.R., Kunzelmann, K., Novelli, G., Malone, R.W., 
Bennett, M.J., Gruenert, D.C. 2000. Transfer and expression of foreign genes in 
mammalian cells . Biotechniques 29, 314 -2, 324. 
Cox, J.S., Walter, P. 1996. A novel mechanism for regulating activity of a 
transcription factor that controls the unfolded protein response. Cell 87, 391 -404. 
Crepaldi, L., Gasperini, S., Lapinet, J.A., Calzetti, F., Pinardi, C., Liu, Y., Zurawski, 
S., de Waal, M.R., Moore, K.W., Cassatella, M.A. 2001. Up- regulation of IL -10R1 
expression is required to render human neutrophils fully responsive to IL -10. J. 
Immunol. 167, 2312 -2322. 
Crockett- Torabi, E., Fantone, J.C. 1995. The selectins: insights into selectin- 
induced intracellular signaling in leukocytes. Immunol. Res. 14, 237 -251. 
Crockett- Torabi, E., Sulenbarger, B., Smith, C.W., Fantone, J.C. 1995. Activation of 
human neutrophils through L- selectin and Mac -1 molecules. J. Immunol. 154, 2291- 
2302. 
Daigle, I., Simon, H.U. 2001. Critical role for caspases 3 and 8 in neutrophil but not 
eosinophil apoptosis. Int. Arch. Allergy Immunol. 126, 147 -156. 
138 
Davis, F.M., Tsao, T.Y., Fowler, S.K., Rao, P.N. 1983. Monoclonal antibodies to 
mitotic cells. Proc. Natl. Acad. Sci. U.S.A 80, 2926 -2930. 
De Vos, K., Goossens, V., Boone, E., Vercammen, D., Vancompernolle, K., 
Vandenabeele, P., Haegeman, G., Fiers, W., Grooten, J. 1998. The 55 -kDa tumor 
necrosis factor receptor induces clustering of mitochondria through its membrane - 
proximal region. J. Biol. Chem. 273, 9673 -9680. 
Desagher, S., Martinou, J. -C. 2000. Mitochondria as the central control point of 
apoptosis. Trends Cell Biol. 10, 369 -377. 
Desagher, S., Osen -Sand, A., Montessuit, S., Magnenat, E., Vilbois, F., Hochmann, 
A., Journot, L., Antonsson, B., Martinou, J.C. 2001. Phosphorylation of bid by 
casein kinases I and II regulates its cleavage by caspase 8. Mol. Cell 8, 601 -611. 
Deveraux, Q.L., Roy, N., Stennicke, H.R., Van Arsdale, T., Zhou, Q., Srinivasula, 
S.M., Alnemri, E.S., Salvesen, G.S., Reed, J.C. 1998. IAPs block apoptotic events 
induced by caspase -8 and cytochrome c by direct inhibition of distinct caspases. 
EMBO J. 17, 2215 -2223. 
Deveraux, Q.L., Takahashi, R., Salvesen, G.S., Reed, J.C. 1997. X- linked IAP is a 
direct inhibitor of cell -death proteases. Nature 388, 300 -304. 
Dirac -Svejstrup, A.B., Shorter, J. , Waters, M.G., Warren, G. 2000. Phosphorylation 
of the vesicle- tethering protein p115 by a casein kinase II -like enzyme is required for 
Golgi reassembly from isolated mitotic fragments. J. Cell Biol. 150, 475 -488. 
Downward, J. 1999. How BAD phosphorylation is good for survival [news]. Nat. 
Cell Biol. 1, E33 -E35. 
Draviam, V.M., Orrechia, S., Lowe, M., Pardi, R., Pines, J. 2001. The localization of 
human cyclins B1 and B2 determines CDK1 substrate specificity and neither enzyme 
requires MEK to disassemble the Golgi apparatus. J. Cell Biol. 152, 945 -958. 
Droin, N., Bichat, F., Rebe, C., Wotawa, A., Sordet, O., Hammann, A., Bertrand, R., 
Solary, E. 2001. Involvement of caspase -2 long isoform in Fas -mediated cell death 
of human leukemic cells. Blood 97, 1835 -1844. 
Du, C., Fang, M., Li, Y., Li, L., Wang, X. 2000. Smac, a mitochondrial protein that 
promotes cytochrome c- dependent caspase activation by eliminating IAP inhibition. 
Cell 102, 33 -42. 
Duan, H., Dixit, V.M. 1997. RAIDD is a new 'death' adaptor molecule. Nature 385, 
86 -89. 
Earnshaw, W.C., Martins, L.M., Kaufmann, S.H. 1999. Mammalian caspases: 
Structure, activation, substrates, and functions during apoptosis. Ann. Rev. 
Biochem. 68, 383 -424. 
139 
Ekert, P.G., Silke, J., Vaux, D.L. 1999. Caspase inhibitors. Cell Death Differ. 6, 
1081 -1086. 
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., Nagata, S. 1998. 
A caspase- activated DNase that degrades DNA during apoptosis, and its inhibitor 
ICAD. Nature 391, 43 -50. 
Escargueil, A.E., Plisov, S.Y., Filhol, O., Cochet, C., Larsen, A.K. 2000. Mitotic 
phosphorylation of DNA topoisomerase II alpha by protein kinase CK2 creates the 
MPM -2 phosphoepitope on Ser -1469. J. Biol. Chem. 275, 34710 -34718. 
Eystathioy, T., Jakymiw, A., Fujita, D.J., Fritzler, M.J., Chan, E.K. 2000. Human 
autoantibodies to a novel Golgi protein golgin -67: high similarity with golgin -95 /gm 
130 autoantigen. J. Autoimmun. 14 , 179 -187. 
Fadok, V.A., Voelker, D.R., Campbell, P.A., Cohen, J.J., Bratton, D.L., Henson, P.M. 
1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes 
triggers specific recognition and removal by macrophages. J. Immunol. 148, 2207- 
2216. 
Featherstone, C., Griffiths, G., Warren, G. 1985. Newly synthesized G protein of 
vesicular stomatitis virus is not transported to the Golgi complex in mitotic cells. J. 
Cell Biol. 101, 2036 -2046. 
Ferri, K.F., Kroemer, G. 2001. Organelle- specific initiation of cell death pathways. 
Nat. Cell Biol. 3, E255 -E263. 
Frickel, E.M., Riek, R., Jelesarov, I., Helenius, A., Wuthrich, K., Ellgaard, L. 2002. 
TROSY -NMR reveals interaction between ERp57 and the tip of the calreticulin P- 
domain. Proc. Natl. Acad. Sci. U.S.A 99, 1954 -1959. 
Gallaher, B.W., Hille, R., Raile, K., Kiess, W. 2001. Apoptosis: live or die --hard work 
either way! Horm. Metab. Res. 33, 511 -519. 
Gallione, C.J., Rose, J.K. 1985. A single amino acid substitution in a hydrophobic 
domain causes temperature- sensitive cell- surface transport of a mutant viral 
glycoprotein. J. Virol. 54. 374 -382. 
Gil- Gomez, G., Berns, A., Brady, H.J. 1998. A link between cell cycle and cell 
death: Bax and Bcl -2 modulate Cdk2 activation during thymocyte apoptosis. EMBO 
J. 17, 7209 -7218. 
Girard, D., Paquet, M.E., Paquin, R., Beaulieu, A.D. 1996. Differential effects of 
interleukin -15 (IL -15) and IL -2 on human neutrophils: modulation of phagocytosis, 
cytoskeleton rearrangement, gene expression, and apoptosis by IL -15. Blood 88, 
3176 -3184. 
Girard, D., Paquin, R., Beaulieu, A.D. 1997. Responsiveness of human neutrophils 
to interleukin -4: induction of cytoskeletal rearrangements, de novo protein synthesis 
and delay of apoptosis. Biochem. J. 325, 147 -153. 
140 
Gluzman, Y. 1981. SV40- transformed simian cells support the replication of early 
SV40 mutants. Cell 23, 175 -182. 
Goping, I.S., Gross, A., Lavoie, J.N., Nguyen, M., Jemmerson, R., Roth, K., 
Korsmeyer, S.J., Shore, G.C. 1998. Regulated targeting of BAX to mitochondria. J. 
Cell Biol. 143, 207 -215. 
Gotte, M., von Mollard, G.F. 1998. A new beat for the SNARE drum. Trends Cell 
Biol. 8, 215 -218. 
Granville, D.J., Shaw, J.R., Leong, S., Carthy, C.M., Margaron, P., Hunt, D.W., 
McManus, B.M. 1999. Release of cytochrome c, Bax migration, Bid cleavage, and 
activation of caspases 2, 3, 6, 7, 8, and 9 during endothelial cell apoptosis. Am. J. 
Pathol. 155, 1021 -1025. 
Gray, N., Detivaud, L., Doerig, C., Meijer, L. 1999. ATP -site directed inhibitors of 
cyclin- dependent kinases. Curr. Med. Chem. 6, 859 -875. 
Green, J., Griffiths, G., Louvard, D., Quinn, P., Warren, G. 1981. Passage of viral 
membrane proteins through the Golgi complex. J. Mol. Biol. 152, 663 -698. 
Grenier, A., Dehoux, M., Boutten, A., Arce -Vicioso, M., Durand, G., Gougerot- 
Pocidalo, M.A., Chollet -Martin, S. 1999. Oncostatin M production and regulation by 
human polymorphonuclear neutrophils. Blood 93, 1413 -1421. 
Hakem, A., Sasaki, T., Kozieradzki, I., Penninger, J.M. 1999. The cyclin- dependent 
kinase Cdk2 regulates thymocyte apoptosis. J. Exp. Med. 189, 957 -968. 
Harding, H.P., Zhang, Y., Ron, D. 1999. Protein translation and folding are coupled 
by an endoplasmic -reticulum- resident kinase. Nature 397, 271 -274. 
Hart, S.P., Ross, J.A., Ross, K., Haslett, C., Dransfield, I. 2000. Molecular 
characterization of the surface of apoptotic neutrophils: implications for functional 
downregulation and recognition by phagocytes. Cell Death Differ. 7, 493 -503. 
Harvey, K.J., Lukovic, D., Ucker, D.S. 2000. Caspase- dependent Cdk activity is a 
requisite effector of apoptotic death events. J. Cell Biol. 148, 59 -72. 
Haslett, C. 1992. Resolution of acute inflammation and the role of apoptosis in the 
tissue fate of granulocytes. Clin. Sci. (Lond) 83, 639 -648. 
Haslett, C., Guthrie, L.A., Kopaniak, M.M., Johnston, R.B., Jr., Henson, P.M. 1985. 
Modulation of multiple neutrophil functions by preparative methods or trace 
concentrations of bacterial lipopolysaccharide. Am. J. Pathol. 119, 101 -110. 
Haslett, C., Savill, J.S., Meagher, L. 1989. The neutrophil. Curr. Opin. Immunol. 2, 
10-18. 
141 
Haslett, C., Savill, J.S., Whyte, M.K., Stern, M., Dransfield, I., Meagher, L.C. 1994. 
Granulocyte apoptosis and the control of inflammation. Philos. Trans. R. Soc. Lond 
B Biol. Sci. 345, 327 -333. 
Hauri, H.P., Schweizer, A. 1992. The endoplasmic reticulum -Golgi intermediate 
compartment. Curr. Opin. Cell Biol. 4, 600 -608. 
Hay, J.C., Chao, D.S., Kuo, C.S., Scheller, R.H. 1997. Protein interactions 
regulating vesicle transport between the endoplasmic reticulum and Golgi apparatus 
in mammalian cells. Cell 89, 149 -158. 
Hay, J.C., Hirling, H., Scheller, R.H. 1996. Mammalian vesicle trafficking proteins of 
the endoplasmic reticulum and Golgi apparatus. J. Biol. Chem. 271, 5671 -5679. 
Hay, J.C., Klumperman, J., Oorschot, V., Steegmaier, M., Kuo, C.S., Scheller, R.H. 
1998. Localization, dynamics, and protein interactions reveal distinct roles for ER 
and Golgi SNAREs. J. Cell Biol. 141, 1489 -1502. 
Hay, J.C., Scheller, R.H. 1997. SNAREs and NSF in targeted membrane fusion. 
Curr. Opin. Cell Biol. 9, 505 -512. 
Haze, K., Yoshida, H., Yanagi, H., Yura, T., Mori, K. 1999. Mammalian transcription 
factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis 
in response to endoplasmic reticulum stress. Mol. Biol. Cell 10, 3787 -3799. 
Helenius, A. 1994. How N- linked oligosaccharides affect glycoprotein folding in the 
endoplasmic reticulum. Mol. Biol. Cell 5, 253 -265. 
Helenius, A., Aebi, M. 2001. Intracellular functions of N- linked glycans. Science 
291, 2364 -2369. 
Hiller, G., Weber, K. 1982. Golgi detection in mitotic and interphase cells by 
antibodies to secreted galactosyltransferase. Exp. Cell Res. 142, 85 -94. 
Hu, Y., Benedict, M.A., Ding, L., Nunez, G. 1999. Role of cytochrome c and 
dATP /ATP hydrolysis in Apaf -1- mediated caspase- 9 activation and apoptosis. 
EMBO J. 18, 3586 -3595. 
Hunt, J.M., Bommert, K., Charlton, M.P., Kistner, A., Habermann, E., Augustine, G.J., 
Betz, H. 1994. A post- docking role for synaptobrevin in synaptic vesicle fusion. 
Neuron 12, 1269 -1279. 
Iwai, K., Miyawaki, T., Takizawa, T., Konno, A., Ohta, K., Yachie, A., Seki, H., 
Taniguchi, N. 1994. Differential expression of bc1-2 and susceptibility to anti -Fas- 
mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. 
Blood 84, 1201 -1208. 
142 
Jin, Y.H., Yoo, K.J., Lee, Y.H., Lee, S.K. 2000. Caspase 3- mediated Cleavage of 
p21WAF1 /CIP1 Associated with the Cyclin A- Cyclin- dependent Kinase 2 Complex Is 
a Prerequisite for Apoptosis in SK -HEP -1 Cells. J. Biol. Chem. 275, 30256- 30263. 
Jost, C.R., Gaillard, M.L., Fransen, J.A., Daha, M.R., Ginsel, L.A. 1991. Intracellular 
localization of glycosyl -phosphatidylinositol -anchored CD67 and FcRIII (CD16) in 
affected neutrophil granulocytes of patients with paroxysmal nocturnal 
hemoglobinuria. Blood 78, 3030 -3036. 
Jost, C.R., Huizinga, T.W., de Goede, R., Fransen, J.A., Tetteroo, P.A., Daha, M.R., 
Ginsel, L.A. 1990. Intracellular localization and de novo synthesis of FcRIII in 
human neutrophil granulocytes. Blood 75, 144 -151. 
Kaiser, C., Ferro -Novick, S. 1998. Transport from the endoplasmic reticulum to the 
Golgi . Curr. Opin. Cell Biol. 10, 477 -482. 
Karsan, A., Yee, E., Kaushansky, K., Harlan, J.M. 1996. Cloning of human Bcl -2 
homologue: inflammatory cytokines induce human Al in cultured endothelial cells. 
Blood 87, 3089 -3096. 
Kelekar, A., Thompson, C.B. 1998. Bcl -2- family proteins: the role of the BH3 
domain in apoptosis. Trends Cell Biol. 8, 324 -330. 
Kerr, J.F., Wyllie, A.H., Currie, A.R. 1972. Apoptosis: a basic biological 
phenomenon with wide -ranging implications in tissue kinetics. Br. J. Cancer 26, 
239 -257. 
Kiener, P.A., Davis, P.M., Starling, G.C., Mehlin, C., Klebanoff, S.J., Ledbetter, J.A., 
Liles, W.C. 1997. Differential induction of apoptosis by Fas -Fas ligand interactions 
in human monocytes and macrophages. J. Exp. Med. 185, 1511 -1516. 
Kim, S.G., Kim, S.N., Jong, H.S., Kim, N.K., Hong, S.H., Kim, S.J., Bang, Y.J. 2001. 
Caspase- mediated Cdk2 activation is a critical step to execute transforming growth 
factor -betal- induced apoptosis in human gastric cancer cells. Oncogene 20, 1254- 
1265. 
Kischkel, F.C., Lawrence, D.A., Tinel, A., LeBlanc, H., Virmani, A., Schow, P., 
Gazdar, A., Blenis, J., Arnott, D., Ashkenazi, A. 2001. Death receptor recruitment of 
endogenous caspase -10 and apoptosis initiation in the absence of caspase -8. J. 
Biol. Chem. 276, 46639- 46646. 
Kjeldsen, L., Bjerrum, O.W., Askaa, J., Borregaard, N. 1992. Subcellular localization 
and release of human neutrophil gelatinase, confirming the existence of separate 
gelatinase- containing granules. Biochem. J. 287, 603 -610. 
Kluck, R.M., Bossy -Wetzel, E., Green, D.R., Newmeyer, D.D. 1997. The release of 
cytochrome c from mitochondria: a primary site for Bcl -2 regulation of apoptosis. 
Science 275, 1132 -1136. 
143 
Kluck, R.M., Esposti, M.D., Perkins, G., Renken, C., Kuwana, T., Bossy -Wetzel, E., 
Goldberg, M., Allen, T., Barber, M.J., Green, D.R., Newmeyer, D.D. 1999. The pro - 
apoptotic proteins, Bid and Bax, cause a limited permeabilization of the mitochondrial 
outer membrane that is enhanced by cytosol. J. Cell Biol. 147, 809 -822. 
Kornfeld, R., Kornfeld, S. 1985. Assembly of asparagine- linked oligosaccharides. 
Annu. Rev. Biochem. 54, 631 -664. 
Koyama, A.H. 1995. Induction of apoptotic DNA fragmentation by the infection of 
vesicular stomatitis virus. Virus Res. 37, 285 -290. 
Kuehn, M.J., Herrmann, J.M., Schekman, R. 1998. COPII -cargo interactions direct 
protein sorting into ER- derived transport vesicles. Nature 391, 187 -190. 
Kuijpers, T.W., Tool, A.T., van der Schoot, C.E., Ginsel, L.A., Onderwater, J.J., Roos, 
D., Verhoeven, A.J. 1991. Membrane surface antigen expression on neutrophils: a 
reappraisal of the use of surface markers for neutrophil activation. Blood 78, 1105- 
1111. 
Kumar, S. 1999. Mechanisms mediating caspase activation in cell death. Cell 
Death. Differ. 6, 1060 -1066. 
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the 
head of bacteriophage T4. Nature 227, 680 -685. 
Lane, J.D., Lucocq, J., Pryde, J., Barr, F.A., Woodman, P.G., Allan, V.J., Lowe, M. 
2002. Caspase- mediated cleavage of the stacking protein GRASP65 is required for 
Golgi fragmentation during apoptosis. J. Cell Biol. 156(3), 495 -509. 
Leist, M., Jaattela, M. 2001. Four deaths and a funeral: from caspases to alternative 
mechanisms. Nat. Rev. Mol. Cell Biol. 2, 589 -598. 
Lenard, J. 1978. Virus envelopes and plasma membranes. Annu. Rev. Biophys. 
Bioeng. 7, 139 -165. 
Lesa, G.M., Seemann, J., Shorter, J., Vandekerckhove, J., Warren, G. 2000. The 
amino -terminal domain of the Golgi protein giantin interacts directly with the vesicle - 
tethering protein p115. J. Biol. Chem. 275, 2831 -2836. 
Levine, T.P., Rabouille, C., Kieckbusch, R.H., Warren, G. 1996. Binding of the 
vesicle docking protein p115 to Golgi membranes is inhibited under mitotic 
conditions. J. Biol. Chem. 271, 17304 -17311. 
Lew, P.D., Monod, A., Waldvogel, F.A., Dewald, B., Baggiolini, M., Pozzan, T. 1986. 
Quantitative analysis of the cytosolic free calcium dependency of exocytosis from 
three subcellular compartments in intact human neutrophils. J. Cell Biol. 102, 2197- 
2204. 
144 
Li, F., Ambrosini, G., Chu, E.Y., Plescia, J., Tognin, S., Marchisio, P.C., Altieri, D.C. 
1998. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 
580 -584. 
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S., 
Wang, X. 1997. Cytochrome c and dATP- dependent formation of Apaf -1 /caspase -9 
complex initiates an apoptotic protease cascade. Cell 91, 479 -489. 
Li, X., Weinman, S.A. 2002. CHLORIDE CHANNELS AND HEPATOCELLULAR 
FUNCTION: Prospects for Molecular Identification. Annu. Rev. Physiol. 64, 609- 
633. 
Liles, W.C., Kiener, P.A., Ledbetter, J.A., Aruffo, A., Klebanoff, S.J. 1996. 
Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: 
implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184, 429- 
440. 
Lin, C.Y., Madsen, M.L., Yarm, F.R., Jang, Y.J., Liu, X., Erikson, R.L. 2000. 
Peripheral Golgi protein GRASP65 is a target of mitotic polo -like kinase (Plk) and 
Cdc2. Proc. Natl. Acad. Sci. U.S.A 97, 12589 -12594. 
Lin, R.C., Scheller, R.H. 1997. Structural organization of the synaptic exocytosis 
core complex. Neuron 19, 1087 -1094. 
Linstedt, A.D., Jesch, S.A., Mehta, A., Lee, T.H., Garcia -Mata, R., Nelson, D.S., 
Sztul, E. 2000. Binding relationships of membrane tethering components. The 
giantin N terminus and the GM130 N terminus compete for binding to the p115 C 
terminus. J. Biol. Chem. 275, 10196- 10201. 
Logarinho, E., Sunkel, C.E. 1998. The Drosophila POLO kinase localises to multiple 
compartments of the mitotic apparatus and is required for the phosphorylation of 
MPM2 reactive epitopes. J. Cell Sci. 111, 2897 -2909. 
Louvard, D., Reggio, H., Warren, G. 1982. Antibodies to the Golgi complex and the 
rough endoplasmic reticuium. J. Cell Biol. 92, 92 -107. 
Lowe, M., Gonatas, N.K., Warren, G. 2000. The mitotic phosphorylation cycle of the 
cis -Golgi matrix protein GM130. J. Cell Biol. 149, 341 -356. 
Lowe, M., Rabouille, C., Nakamura, N., Watson, R., Jackman, M., Jamsa, E., 
Rahman, D., Pappin, D.J., Warren, G. 1998. Cdc2 kinase directly phosphorylates 
the cis -Golgi matrix protein GM130 and is required for Golgi fragmentation in mitosis. 
Cell 94, 783 -793. 
Lucocq, J., Warren, G., Pryde, J. 1991. Okadaic acid induces Golgi apparatus 
fragmentation and arrest of intracellular transport. J. Cell Sci. 100, 753 -759. 
Lucocq, J.M., Pryde, J.G., Berger, E.G., Warren, G. 1988. A mitotic form of the 
Golgi apparatus identified using immuno- electronmicroscopy. Prog. Clin. Biol. Res. 
270, 431 -440. 
145 
Lucocq, J.M., Warren, G. 1987. Fragmentation and partitioning of the Golgi 
apparatus during mitosis in HeLa cells. EMBO J. 6, 3239 -3246. 
Määttä, J., Hallikas, O., Welti, S., Hilden, P., Schroder, J., Kuismanen, E. 2000. 
Limited caspase cleavage of human BAP31. FEBS Lett. 484, 202 -206. 
Mackay, D., Kieckbusch, R., Adamczewski, J., Warren, G. 1993. Cyclin A- mediated 
inhibition of intra -Golgi transport requires p34odo2 FEBS Left. 336, 549 -554. 
Mahajan, N.P., Harrison -Shostak, D.C., Michaux, J., Herman, B. 1999. Novel 
mutant green fluorescent protein protease substrates reveal the activation of specific 
caspases during apoptosis. Chem. Biol. 6, 401 -409. 
Maianski, N.A., Mul, F.P., van Buul, J.D., Roos, D., Kuijpers, T.W. 2002. 
Granulocyte colony -stimulating factor inhibits the mitochondria -dependent activation 
of caspase -3 in neutrophils. Blood 99, 672 -679. 
Mancini, M., Machamer, C.E., Roy, S., Nicholson, D.W., Thornberry, N.A., Casciola- 
Rosen, L.A., Rosen, A. 2000. Caspase -2 is localized at the Golgi complex and 
cleaves golgin -160 during apoptosis. J. Cell Biol. 149, 603 -612. 
Marra, P., Maffucci, T., Daniele, T., Tullio, G.D., Ikehara, Y., Chan, E.K., Luini, A., 
Beznoussenko, G., Mironov, A., De Matteis, M.A. 2001. The GM130 and GRASP65 
Golgi proteins cycle through and define a subdomain of the intermediate 
compartment. Nat. Cell Biol. 3, 1101 -1113. 
Martin -Martin, B., Nabokina, S.M., Blasi, J., Lazo, P.A., Mollinedo, F. 2000. 
Involvement of SNAP -23 and syntaxin 6 in human neutrophil exocytosis. Blood 96, 
2574 -2583. 
McCullough, K.D., Martindale, J.L., Klotz, L.O., Aw, T.Y., Holbrook, N.J. 2001. 
Gadd153 sensitizes cells to endoplasmic reticulum stress by down- regulating Bcl2 
and perturbing the cellular redox state. Mol. Cell Biol. 21, 1249 -1259. 
Meagher, L.C., Savill, J.S., Baker, A., Fuller, R.W., Haslett, C. 1992. Phagocytosis 
of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J. 
Leukoc. Biol. 52, 269 -273. 
Meggio, F., Donella, D.A., Ruzzene, M., Brunati, A.M., Cesaro, L., Guerra, B., Meyer, 
T., Mett, H., Fabbro, D., Furet, P., . 1995. Different susceptibility of protein kinases 
to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of 
protein kinase CK2. Eur. J. Biochem. 234, 317 -322. 
Memon, S.A., Hou, J., Moreno, M.B., Zacharchuk, C.M. 1998. Apoptosis induced 
by a chimeric Fas /FLICE receptor: lack of requirement for Fas- or FADD- binding 
proteins. J. lmmunol. 160, 2046 -2049. 
Miller, T.M., Moulder, K.L., Knudson, C.M., Creedon, D.J., Deshmukh, M., 
Korsmeyer, S.J., Johnson, E.M., Jr. 1997. Bax deletion further orders the cell death 
146 
pathway in cerebellar granule cells and suggests a caspase- independent pathway to 
cell death. J. Cell Biol. 139, 205- 217. 
Misteli, T., Warren, G. 1995. Mitotic disassembly of the Golgi apparatus in vivo. J. 
Cell Sci. 108, 2715 -2727. 
Mori, K. 2000. Tripartite management of unfolded proteins in the endoplasmic 
reticulum. Cell 101, 451 - 454. 
Mosser, J., Sarde, C.O., Vicaire, S., Yates, J.R., Mandel, J.L. 1994. A new human 
gene (DXS1357E) with ubiquitous expression, located in Xq28 adjacent to the 
adrenoleukodystrophy gene. Genomics 22, 469 -471. 
Moulding, D.A., Akgul, C., Derouet, M., White, M.R., Edwards, S.W. 2001. BCL -2 
family expression in human neutrophils during delayed and accelerated apoptosis. J. 
Leukoc. Biol. 70, 783 -792. 
Moulding, D.A., Quayle, J.A., Hart, C.A., Edwards, S.W. 1998. McI -1 expression in 
human neutrophils: regulation by cytokines and correlation with cell survival. Blood 
92, 2495 -2502. 
Moyer, B.D., Allan, B.B., Balch, W.E. 2001. Rab1 interaction with a GM130 effector 
complex regulates COPII vesicle cis -Golgi tethering. Traffic 2, 268 -276. 
Murphy, K.M., Streips, U.N., Lock, R.B. 1999. Bax membrane insertion during 
Fas(CD95)- induced apoptosis precedes cytochrome c release and is inhibited by Bcl- 
2. Oncogene 18, 5991 -5999. 
Muzio, M., Stockwell, B.R., Stennicke, H.R., Salvesen, G.S., Dixit, V.M. 1998. An 
induced proximity model for caspase -8 activation. J. Biol. Chem. 273, 2926 -2930. 
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B.A., Yuan, J. 2000. 
Caspase -12 mediates endoplasmic -reticulum- specific apoptosis and cytotoxicity by 
amyloid -beta. Nature 403, 98- 103. 
Nakamura, K., Zuppini, A., Arnaudeau, S., Lynch, J., Ahsan, I., Krause, R., Papp, S., 
De Smedt, H., Parys, J.B., Muller -Esterl, W., Lew, D.P., Krause, K.H., Demaurex, N., 
Opas, M., Michalak, M. 2001. Functional specialization of calreticulin domains. J. 
Cell Biol. 154, 961 -972. 
Nakamura, N., Lowe, M., Levine, T.P., Rabouille, C., Warren, G. 1997. The vesicle 
docking protein p115 binds GM130, a cis -Golgi matrix protein, in a mitotically 
regulated manner. Cell 89, 445 -455. 
Nakamura, N., Rabouille, C., Watson, R., Nilsson, T., Hui, N., Slusarewicz, P., Kreis, 
T.E., Warren, G. 1995. Characterization of a cis -Golgi matrix protein, GM130. J. 
Cell Biol. 131, 1715 -1726. 
147 
Narita, M., Shimizu, S., Ito, T., Chittenden, T., Lutz, R.J., Matsuda, H., Tsujimoto, Y. 
1998. Bax interacts with the permeability transition pore to induce permeability 
transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. 
U.S.A 95, 14681- 14686. 
Nechushtan, A., Smith, C.L., Lamensdorf, I., Yoon, S.H., Youle, R.J. 2001. Bax and 
Bak coalesce into novel mitochondria -associated clusters during apoptosis. J. Cell 
Biol. 153, 1265 -1276. 
Newmeyer, D.D., Farschon, D.M., Reed, J.C. 1994. Cell -free apoptosis in Xenopus 
egg extracts: inhibition by BcI -2 and requirement for an organelle fraction enriched in 
mitochondria. Cell 79, 353 -364. 
Ng, F.W., Nguyen, M., Kwan, T., Branton, P.E., Nicholson, D.W., Cromlish, J.A., 
Shore, G.C. 1997. p28 Bap31, a Bcl -2 /BcI -XL- and procaspase -8- associated protein 
in the endoplasmic reticulum. J. Cell Biol. 139, 327 -338. 
Ng, F.W., Shore, G.C. 1998. Bcl-XL cooperatively associates with the Bap31 
complex in the endoplasmic reticulum, dependent on procaspase -8 and Ced -4 
adaptor. J. Biol Chem. 273, 3140 -3143. 
Nicholson, D.W. 1999. Caspase structure, proteolytic substrates, and function 
during apoptotic cell death. Cell Death Differ. 6, 1028 -1042. 
Novick, P., Zerial, M. 1997. The diversity of Rab proteins in vesicle transport. Curr. 
Opin. Cell Biol. 9, 496 -504. 
O'Connor, L., Huang, D.C., O'Reilly, L.A., Strasser, A. 2000. Apoptosis and cell 
division. Curr. Opin. Cell Biol. 12, 257 -263. 
Obaya, A.J., Sedivy, J.M. 2002. Regulation of cyclin -Cdk activity in mammalian 
cells. Cell Mol. Life Sci. 59, 126 -142. 
Ojala, P.M., Yamamoto, K., Castanos -Velez, E., Biberfeld, P., Korsmeyer, S.J., 
Makela, T.P. 2000. The apoptotic v- cyclin -CDK6 complex phosphorylates and 
inactivates Bcl- 2. Nat. Cell Biol 2, 819 -825. 
Ottonello, L., Tortolina, G., Amelotti, M., Dallegri, F. 1999. Soluble Fas ligand is 
chemotactic for human neutrophilic polymorphonuclear leukocytes. J. lmmunol. 
162, 3601 -3606. 
Pan, G., Humke, E.W., Dixit, V.M. 1998a. Activation of caspases triggered by 
cytochrome c in vitro. FEBS Lett. 426, 151 -154. 
Pan, G., O'Rourke, K., Dixit, V.M. 1998b. Caspase -9, Bcl-XL, and Apaf -1 form a 
ternary complex. J. Biol. Chem. 273, 5841 -5845. 
148 
Parodi, A.J. 1999. Reglucosylation of glycoproteins and quality control of 
glycoprotein folding in the endoplasmic reticulum of yeast cells. Biochim. Biophys. 
Acta 1426, 287 -295. 
Parodi, A.J. 2000. Role of N- oligosaccharide endoplasmic reticulum processing 
reactions in glycoprotein folding and degradation. Biochem. J. 348, 1 -13. 
Patel, K.D., Modur, V., Zimmerman, G.A., Prescott, S.M., McIntyre, T.M. 1994. The 
necrotic venom of the brown recluse spider induces dysregulated endothelial cell - 
dependent neutrophil activation. Differential induction of GM -CSF, IL -8, and E- 
selectin expression. J. Clin. Invest. 94, 631 -642. 
Pevsner, J., Hsu, S.C., Braun, J.E., Calakos, N., Ting, A.E., Bennett, M.K., Scheller, 
R.H. 1994. Specificity and regulation of a synaptic vesicle docking complex. 
Neuron 13, 353 -361 . 
Pfeffer, S.R. 1999. Transport- vesicle targeting: tethers before SNAREs. Nat. Cell 
Biol. 1, E17 -E22. 
Philpott, K.L., McCarthy, M.J., Becker, D., Gatchalian, C., Rubin, L.L. 1996. 
Morphological and biochemical changes in neurons: apoptosis versus mitosis. Eur. 
J. Neurosci. 8, 1906 -1915. 
Powell, K.S., Latterlich, M. 2000. The making and breaking of the endoplasmic 
reticulum. Traffic 1, 689 -694. 
Pryde, J.G. 1994. A group of integral membrane proteins of the rat liver Golgi 
contains a conserved protein of 100kDa. J. Cell Sci. 107, 3425 -3436. 
Pryde, J.G., Farmaki, T., Lucocq, J.M. 1998. Okadaic acid induces selective arrest 
of protein transport in the rough endoplasmic reticulum and prevents export into 
COPII- coated structures. Mol. Cell. Biol. 18, 1125 -1135. 
Pryde, J.G., Walker, A., Rossi, A.G., Hannah, S., Haslett, C. 2000. Temperature - 
dependent arrest of neutrophil apoptosis: failure of bax insertion into mitochondria at 
15 °C prevents the release of cytochrome c. J. Biol. Chem. 276 (43), 33574 -33584. 
Rabouille, C., Levine, T.P., Peters, J.M., Warren, G. 1995. An NSF -like ATPase, 
p97, and NSF mediate cisternal regrowth from mitotic Golgi fragments. Cell 82, 905- 
914. 
Raff, M.C. 1992. Social controls on cell survival and cell death. Nature 356, 397- 
400. 
Reading, C.L., Penhoet, E.E., Ballou, C.E. 1978. Carbohydrate structure of 
vesicular stomatitis virus glycoprotein. J. Biol. Chem. 253, 5600 -5612. 
Rice, W.G., Ganz, T., Kinkade, J.M., Jr., Selsted, M.E., Lehrer, R.I., Parmley, R.T. 
1987. Defensin -rich dense granules of human neutrophils. Blood 70, 757 -765. 
149 
Robbins, P.W., Hubbard, S.C., Turco, S.J., Wirth, D.F. 1977. Proposal for a 
common oligosaccharide intermediate in the synthesis of membrane glycoproteins. 
Cell 12, 893 -900. 
Rossi, A.G., Haslett, C. 1998. Inflammation, Cell Injury, and Apoptosis. Chapter 2. 
In: Pro -inflammatory and Anti -inflammatory Peptides, ed. Said, S.I. Volume 112. In 
the series: Lung Biology in Health and Disease, (Series ed. Lenfant, C.) Marcel 
Dekker, Inc., New York, pp. 9 -24. 
Roth, J. 1987. Subcellular organization of glycosylation in mammalian cells. 
Biochim. Biophys. Acta 906, 405 -436. 
Rothman, J.E. 1994. Mechanisms of intracellular protein transport. Nature 372, 55- 
63. 
Roy, N., Deveraux, Q.L., Takahashi, R., Salvesen, G.S., Reed, J.C. 1997. The c- 
IAP-1 and c -IAP -2 proteins are direct inhibitors of specific caspases. EMBO J. 16, 
6914 -6925. 
Sakahira, H., Enari, M., Nagata, S. 1998. Cleavage of CAD inhibitor in CAD 
activation and DNA degradation during apoptosis. Nature 391, 96 -99. 
Saleh, A., Srinivasula, S.M., Acharya, S., Fishel, R., Alnemri, E.S. 1999. 
Cytochrome c and dATP- mediated oligomerization of Apaf -1 is a prerequisite for 
procaspase -9 activation. J. Biol. Chem. 274, 17941- 17945. 
Santos -Beneit, A.M., Mollinedo, F. 2000. Expression of genes involved in initiation, 
regulation, and execution of apoptosis in human neutrophils and during neutrophil 
differentiation of HL -60 cells. J. Leukoc. Biol. 67, 712 -724 . 
Saraste, J., Kuismanen, E. 1984. Pre- and post -Golgi vacuoles operate in the 
transport of Semliki Forest virus membrane glycoproteins to the cell surface. Cell 
38, 535 -549. 
Savill, J. 1997. Apoptosis in resolution of inflammation. J. Leukoc. Biol. 61, 375- 
380. 
Savill, J., Fadok, V., Henson, P., Haslett, C. 1993. Phagocyte recognition of cells 
undergoing apoptosis. Immunol. Today 14, 131 -136. 
Savill, J., Haslett, C. 1995. Granulocyte clearance by apoptosis in the resolution of 
inflammation. Semin. Cell Biol. 6, 385 -393. 
Savill, J.S., Wyllie, A.H., Henson, J.E., Walport, M.J., Henson, P.M., Haslett, C. 
1989. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed 
cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest 
83, 865 -875. 
150 
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K.J., Debatin, 
K.M., Krammer, P.H., Peter, M.E. 1998. Two CD95 (APO -1 /Fas) signaling 
pathways. EMBO J. 17, 1675 -1687. 
Scales, S.J., Chen, Y.A., Yoo, B.Y., Patel, S.M., Doung, Y.C., Scheller, R.H. 2000. 
SNAREs contribute to the specificity of membrane fusion. Neuron 26, 457 -464. 
Schroter, M., Peitsch, M.C., Tschopp, J. 1996. Increased p34cdc2 -dependent 
kinase activity during apoptosis: a possible activation mechanism of DNase I leading 
to DNA breakdown. Eur. J. Cell Biol. 69, 143 -150. 
Schurmann, A., Mooney, A.F., Sanders, L.C., Sells, M.A., Wang, H.G., Reed, J.C., 
Bokoch, G.M. 2000. p21- activated kinase 1 phosphorylates the death agonist bad 
and protects cells from apoptosis. Mol. Cell Biol. 20, 453 -461. 
Schweizer, A., Fransen, J.A., Matter, K., Kreis, T.E., Ginsel, L., Hauri, H.P. 1990. 
Identification of an intermediate compartment involved in protein transport from 
endoplasmic reticulum to Golgi apparatus. Eur. J. Cell Biol. 53, 185 -196. 
Seemann, J., Jokitalo, E.J., Warren, G. 2000. The role of the tethering proteins 
p115 and GM130 in transport through the Golgi apparatus in vivo. Mol. Biol. Cell 11, 
635 -645. 
Sengelov, H., Follin, P., Kjeldsen, L., Lollike, K., Dahigren, C., Borregaard, N. 1995. 
Mobilization of granules and secretory vesicles during in vivo exudation of human 
neutrophils. J. lmmunol. 154, 4157 -4165. 
Sengelov, H., Kjeldsen, L., Borregaard, N. 1993a. Control of exocytosis in early 
neutrophil activation. J. lmmunol. 150, 1535 -1543. 
Sengelov, H., Kjeldsen, L., Diamond, M.S., Springer, T.A., Borregaard, N. 1993b. 
Subcellular localization and dynamics of Mac -1 (alpha m beta 2) in human 
neutrophils. J. Clin. Invest. 92, 1467 -1476. 
Sengelov, H., Kjeldsen, L., Kroeze, W., Berger, M., Borregaard, N. 1994. Secretory 
vesicles are the intracellular reservoir of complement receptor 1 in human 
neutrophils. J. lmmunol. 153, 804 -810. 
Sesso, A., Fujiwara, D.T., Jaeger, M., Jaeger, R., Li, T.C., Monteiro, M.M., Correa, 
H., Ferreira, M.A., Schumacher, R.I., Belisario, J., Kachar, B., Chen, E.J. 1999. 
Structural elements common to mitosis and apoptosis. Tissue Cell 31, 357 -371. 
Sheehan, J.P., Palmer, P.E., Helm, G.A., Tuttle, J.B. 1997. MPP+ induced apoptotic 
cell death in SH -SY5Y neuroblastoma cells: an electron microscope study. J. 
Neurosci. Res. 48, 226 -237. 
Shi, L., Nishioka, W.K., Th'ng, J., Bradbury, E.M., Litchfield, D.W., Greenberg, A.H. 
1994. Premature p34cdc2 activation required for apoptosis. Science 263, 1143- 
1145. 
151 
Shorter, J., Warren, G. 1999. A role for the vesicle tethering protein, p115, in the 
post- mitotic stacking of reassembling Golgi cisternae in a cell -free system. J. Cell 
Biol. 146, 57 -70. 
Shorter, J., Watson, R., Giannakou, M.E., Clarke, M., Warren, G., Barr, F.A. 1999. 
GRASP55, a second mammalian GRASP protein involved in the stacking of Golgi 
cisternae in a cell -free system. EMBO J. 18, 4949 -4960. 
Silberstein, S., Gilmore, R. 1996. Biochemistry, molecular biology, and genetics of 
the oligosaccharyltransferase. FASEB J. 10, 849 -858. 
Slee, E.A., Adrain, C., Martin, S.J. 1999a. Serial killers: ordering caspase activation 
events in apoptosis. Cell Death. Differ. 6, 1067 -1074. 
Slee, E.A., Adrain, C., Martin, S.J. 2001. Executioner caspase -3, -6, and -7 perform 
distinct, non -redundant roles during the demolition phase of apoptosis. J. Biol. 
Chem. 276, 7320 -7326. 
Slee, E.A., Harte, M.T., Kluck, R.M., Wolf, B.B., Casiano, C.A., Newmeyer, D.D., 
Wang, H.G., Reed, J.C., Nicholson, D.W., Alnemri, E.S., Green, D.R., Martin, S.J. 
1999b. Ordering the cytochrome c- initiated caspase cascade: hierarchical activation 
of caspases -2, -3, -6, -7, -8, and -10 in a caspase -9- dependent manner. J. Cell Biol. 
144, 281 -292. 
Smith, C.A., Farrah, T., Goodwin, R.G. 1994. The TNF receptor superfamily of 
cellular and viral proteins: activation, costimulation, and death . Cell 76, 959 -962. 
Sohda, M., Misumi, Y., Yano, A., Takami, N., Ikehara, Y. 1998. Phosphorylation of 
the vesicle docking protein p115 regulates its association with the Golgi membrane. 
J. Biol. Chem. 273, 5385 -5388. 
Sollner, T., Bennett, M.K., Whiteheart, S.W., Scheller, R.H., Rothman, J.E. 1993. A 
protein assembly -disassembly pathway in vitro that may correspond to sequential 
steps of synaptic vesicle docking, activation, and fusion. Cell 75, 409 -418. 
Sonnichsen, B., Lowe, M., Levine, T., Jamsa, E., Dirac -Svejstrup, B., Warren, G. 
1998. A role for giantin in docking COPI vesicles to Golgi membranes. J. Cell Biol. 
140, 1013 -1021. 
Sossin, W.S., Fisher, J.M., Scheller, R.H. 1990. Sorting within the regulated 
secretory pathway occurs in the trans- Golgi network. J. Cell Biol. 110, 1 -12. 
Sprague, J., Condra, J.H., Arnheiter, H., Lazzarini, R.A. 1983. Expression of a 
recombinant DNA gene coding for the vesicular stomatitis virus nucleocapsid protein. 
J. Virol. 45, 773 -781. 
Srinivasula, S.M., Ahmad, M., Fernandes -Alnemri, T., Alnemri, E.S. 1998. 
Autoactivation of procaspase -9 by Apaf -1- mediated oligomerization. Mol. Cell 1, 
949 -957. 
152 
Srinivasula, S.M., Hegde, R., Saleh, A., Datta, P., Shiozaki, E., Chai, J., Lee, R.A., 
Robbins, P.D., Fernandes -Alnemri, T., Shi, Y., Alnemri, E.S. 2001. A conserved 
XIAP- interaction motif in caspase -9 and Smac /DIABLO regulates caspase activity 
and apoptosis. Nature 410, 112 -116. 
Stennicke, H.R., Jurgensmeier, J.M., Shin, H., Deveraux, Q., Wolf, B.B., Yang, X., 
Zhou, Q., Ellerby, H.M., Ellerby, L.M., Bredesen, D., Green, D.R., Reed, J.C., 
Froelich, C.J., Salvesen, G.S. 1998. Pro -caspase -3 is a major physiologic target of 
caspase -8. J. Biol. Chem. 273, 27084 -27090. 
Strasser, A., O'Connor, L., Dixit, V.M. 2000. Apoptosis signaling. Annu. Rev. 
Biochem. 69, 217 -245. 
Stuart, R.A., Mackay, D., Adamczewski, J., Warren, G. 1993. Inhibition of intra- 
Golgi transport in vitro by mitotic kinase. J. Biol. Chem. 268, 4050 -4054. 
Subramaniam, V.N., Peter, F., Philp, R., Wong, S.H., Hong, W. 1996. GS28, a 28- 
kilodalton Golgi SNARE that participates in ER -Golgi transport. Science 272, 1161- 
1163. 
Susin, S.A., Zamzami, N., Castedo, M., Hirsch, T., Marchetti, P., Macho, A., Daugas, 
E., Geuskens, M., Kroemer, G. 1996. Bcl -2 inhibits the mitochondrial release of an 
apoptogenic protease. J. Exp. Med. 184, 1331 -1341. 
Sutterlin, C., Lin, C.Y., Feng, Y., Ferris, D.K., Erikson, R.L., Malhotra, V. 2001. Polo - 
like kinase is required for the fragmentation of pericentriolar Golgi stacks during 
mitosis. Proc. Natl. Acad. Sci. U.S.A. 98, 9128 -9132. 
Tabas, I., Kornfeld, S. 1978. The synthesis of complex -type oligosaccharides. Ill. 
Identification of an alpha -D- mannosidase activity involved in a late stage of 
processing of complex -type oligosaccharides. J. Biol. Chem. 253, 7779 -7786. 
Takizawa, C.G., Morgan, D.O. 2000. Control of mitosis by changes in the 
subcellular location of cyclin -B1- Cdk1 and Cdc25C. Curr. Opin. Cell Biol. 12, 658- 
665. 
Tartaglia, L.A., Ayres, T.M., Wong, G.H., Goeddel, D.V. 1993. A novel domain 
within the 55 kd TNF receptor signals cell death. Cell 74, 845 -853. 
Thomas, W.D., Zhang, X.D., Franco, A.V., Nguyen, T., Hersey, P. 2000. TNF- 
related apoptosis- inducing ligand- induced apoptosis of melanoma is associated with 
changes in mitochondrial membrane potential and perinuclear clustering of 
mitochondria. J. Immunol. 165, 5612 -5620. 
Thornberry, N.A. 1999. Caspases: A decade of death research. Cell Death Diff. 6, 
1023 -1027. 
Towbin, H., Staehelin, T., Gordon, J. 1979. Electrophoretic transfer of proteins from 
polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. 
Natl. Acad. Sci. U.S.A. 76, 4350 -4354. 
153 
Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H.P., Ron, D. 
2000. Coupling of stress in the ER to activation of JNK protein kinases by 
transmembrane protein kinase IRE1. Science 287, 664 -666. 
Valentinis, B., Porcu, P.L., Quinn, K., Baserga, R. 1994. The role of the insulin -like 
growth factor I receptor in the transformation by simian virus 40 T antigen. 
Oncogene 9, 825 -831. 
Van de, C.M., Van Loo, G., Pype, S., Van Criekinge, W., Van, d.b., I, Molemans, F., 
Fiers, W., Declercq, W., Vandenabeele, P. 1998. Identification of a new caspase 
homologue: caspase -14. Cell Death Differ. 5, 838 -846. 
Varfolomeev, E.E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J.S., 
Mett, I.L., Rebrikov, D., Brodianski, V.M., Kemper, O.C., Kollet, O., Lapidot, T., 
Soffer, D., Sobe, T., Avraham, K.B., Goncharov, T., Holtmann, H., Lonai, P., Wallach, 
D. 1998. Targeted disruption of the mouse Caspase 8 gene ablates cell death 
induction by the TNF receptors, Fas /Apo1, and DR3 and is lethal prenatally. 
Immunity. 9, 267 -276. 
von Mollard, G.F., Nothwehr, S.F., Stevens, T.H. 1997. The yeast v -SNARE Vti1 p 
mediates two vesicle transport pathways through interactions with the t- SNAREs 
Sed5p and Pep12p. J. Cell Biol. 137, 1511 -1524. 
Wagner, J.G., Roth, R.A. 2000. Neutrophil migration mechanisms, with an 
emphasis on the pulmonary vasculature. Pharmacol. Rev. 52, 349 -374. 
Walker, A., Sheldrake, T., Haslett, C., Pryde, J.G. 2002. Exocytic transport between 
the endoplasmic reticulum and the Golgi complex is arrested during apoptosis. In 
preparation. 
Wang, L., Miura, M., Bergeron, L., Zhu, H., Yuan, J. 1994. lch-1, an Ice /ced -3- 
related gene, encodes both positive and negative regulators of programmed cell 
death. Cell 78, 739 -750. 
Ward, C., Chilvers, E.R., Lawson, M.F., Pryde, J.G., Fujihara, S., Farrow, S.N., 
Haslett, C., Rossi, A.G. 1999a. NF- kappaB activation is a critical regulator of human 
granulocyte apoptosis in vitro. J. Biol. Chem. 274, 4309 -4318. 
Ward, C., Dransfield, I., Chilvers, E.R., Haslett, I., Rossi, A.G. 1999b. 
Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. 
Trends Pharmacol. Sci. 20, 503 -509. 
Warren, G., Levine, T., Misteli, T. 1995. Mitotic disassembly of the mammalian 
Golgi apparatus. trends in CELL BIOLOGY 5, 413 -416. 
Warren, G. 1989. Cell biology: mitosis and membranes [news]. Nature 342, 857- 
858. 
154 
Warren, G., Featherstone, C., Griffiths, G., Burke, B. 1983. Newly synthesized G 
protein of vesicular stomatitis virus is not transported to the cell surface during 
mitosis. J. Cell Biol. 97, 1623 -1628. 
Waters, M.G., Clary, D.O., Rothman, J.E. 1992. A novel 115 -kD peripheral 
membrane protein is required for intercisternal transport in the Golgi stack. J. Cell 
Biol 118, 1015 -1026. 
Watt, J.A., Pike, C.J., Walencewicz- Wasserman, A.J., Cotman, C.W. 1994. 
Ultrastructural analysis of beta -amyloid- induced apoptosis in cultured hippocampal 
neurons. Brain Res. 661, 147- 156. 
Wei, M.C., Zong, W.X., Cheng, E.H., Lindsten, T., Panoutsakopoulou, V., Ross, A.J., 
Roth, K.A., MacGregor, G.R., Thompson, C.B., Korsmeyer, S.J. 2001. Proapoptotic 
BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 
292, 727 -730. 
Weide, T., Bayer, M., Koster, M., Siebrasse, J.P., Peters, R., Barnekow, A. 2001. 
The Golgi matrix protein GM130: a specific interacting partner of the small GTPase 
rabl b. EMBO Rep. 2, 336 -341. 
Westendorf, J.M., Rao, P.N., Gerace, L. 1994. Cloning of cDNAs for M -phase 
phosphoproteins recognized by the MPM2 monoclonal antibody and determination of 
the phosphorylated epitope. Proc. Natl. Acad. Sci. U. S. A 91, 714 -718. 
Whyte, M.K., Meagher, L.C., MacDermot, J., Haslett, C. 1993. Impairment of 
function in aging neutrophils is associated with apoptosis. J. lmmunol. 150, 5124- 
5134. 
Whyte, M.K., Savill, J., Meagher, L.C., Lee, A., Haslett, C. 1997. Coupling of 
neutrophil apoptosis to recognition by macrophages: coordinated acceleration by 
protein synthesis inhibitors. J. Leukoc. Biol. 62, 195 -202. 
Williams, M.A., Solomkin, J.S. 1999. Integrin- mediated signaling in human 
neutrophil functioning. J. Leukoc. Biol. 65, 725 -736. 
Wilson, B.S., Nuoffer, C., Meinkoth, J.L., McCaffery, M., Feramisco, J.R., Balch, 
W.E., Farquhar, M.G. 1994. A Rab1 mutant affecting guanine nucleotide exchange 
promotes disassembly of the Golgi apparatus. J. Cell Biol 125, 557 -571. 
Wolter, K.G., Hsu, Y.T., Smith, C.L., Nechushtan, A., Xi, X.G., Youle, R.J. 1997. 
Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 
139, 1281 -1292. 
Wyllie, A.H., Kerr, J.F., Currie, A.R. 1980. Cell death: the significance of apoptosis. 
Int. Rev. Cytol. 68, 251 -306. 
Yamashita, K., Takahashi, A., Kobayashi, S., Hirata, H., Mesner, P.W., Jr., 
Kaufmann, S.H., Yonehara, S., Yamamoto, K., Uchiyama, T., Sasada, M. 1999. 
155 
Caspases mediate tumor necrosis factor -alpha- induced neutrophil apoptosis and 
downregulation of reactive oxygen production. Blood 93, 674 -685. 
Ye, J., Rawson, R.B., Komuro, R., Chen, X., Dave, U.P., Prywes, R., Brown, M.S., 
Goldstein, J.L. 2000. ER stress induces cleavage of membrane -bound ATF6 by the 
same proteases that process SREBPs. Mol. Cell 6, 1355 -1364. 
Yoneda, T., Imaizumi, K., Oono, K., Yui, D., Gomi, F., Katayama, T., Tohyama, M. 
2001. Activation of caspase -12, an endoplastic reticulum (ER) resident caspase, 
through tumor necrosis factor receptor- associated factor 2- dependent mechanism in 
response to the ER stress. J. Biol. Chem. 276, 13935 -13940. 
Yoshida, H., Okada, T., Haze, K., Yanagi, H., Yura, T., Negishi, M., Mori, K. 2000. 
ATF6 activated by proteolysis binds in the presence of NF -Y (CBF) directly to the cis - 
acting element responsible for the mammalian unfolded protein response. Mol. Cell 
Biol. 20, 6755 -6767. 
Yuan, J., Shaham, S., Ledoux, S., Ellis, H.M., Horvitz, H.R. 1993. The C.elegans 
cell death genes ced -3 encodes a protein similar to mammalian interleukin-113 
converting enzyme. Cell 75, 641 -652. 
Zajicek, G., Shohat, M., Polliack, A. 1984. On the maturation rate of the neutrophil. 
Anat. Rec. 209, 85 -94. 
Zamzami, N., Kroemer, G. 2001. The mitochondrion in apoptosis: how Pandora's 
box opens. Nat. Rev. Mol. Cell Biol. 2, 67 -71. 
Zerial, M., McBride, H. 2001. Rab proteins as membrane organizers. Nat. Rev. Mol. 
Cell Biol. 2, 107 -117. 
Zhou, B.B., Li, H., Yuan, J., Kirschner, M.W. 1998. Caspase- dependent activation of 
cyclin- dependent kinases during Fas- induced apoptosis in Jurkat cells. Proc. Natl. 
Acad. Sci. U. S. A 95, 6785 -6790. 
Zhou, Z., Richard, C., Menard, H.A. 2000. De novo synthesis of proteinase 3 by 
cytokine primed circulating human polymorphonuclear neutrophils and mononuclear 
cells. J. Rheumatol. 27, 2406 -2411. 
Zimmermann, K.C., Green, D.R. 2001. How cells die: apoptosis pathways. J. 
Allergy Clin. Immunol. 108, S99 -103. 
Zuppini, A., Groenendyk, J., Cormack, L.A., Shore, G., Opas, M., Bleackley, R.C., 
Michalak, M. 2002. Calnexin deficiency and endoplasmic reticulum stress -induced 
apoptosis. Biochemistry 41, 2850- 2858. 
156 
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 275, No. 43, Issue of October 27, pp. 33574 -33584, 2000 
© 2000 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. 
Temperature -dependent Arrest of Neutrophil Apoptosis 
FAILURE OF Bax INSERTION INTO MITOCHONDRIA AT 15 °C PREVENTS THE RELEASE OF CYTOCHROME c* 
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Apoptosis is essential for the resolution of neutro- 
philic inflammation. To define the mechanisms trigger- 
ing the execution phase of apoptosis we developed and 
utilized a model in which culture of human neutrophils 
at 15 °C for 20 h arrested apoptosis and subsequent 
warming to 37 °C triggered a synchronous burst of apo- 
ptosis. Treatment of 15 °C cultured neutrophils with the 
pan -caspase inhibitor zVAD -fink just before warming to 
37 °C inhibited the morphological changes associated 
with apoptosis, but did not prevent the insertion of the 
proapoptotic protein Bax into mitochondria nor the in- 
hibition of secretion and the externalization of phos- 
phatidylserine, indices of neutrophil apoptosis. In both 
intact neutrophils and a cell-free extract, cytochrome c 
released from mitochondria induced proteolytic cleav- 
age of procaspase -3. At 15 °C the binding of Bax to mito- 
chondria was uncoupled from Bax insertion into the 
mitochondrial membrane required for the release of cy- 
tochrome c. Apoptosis was also inhibited by low pH dur- 
ing warming to 37 °C, suggesting that changes to the 
conformation of Bax, necessary for membrane insertion, 
were being inhibited. Bax insertion was only sensitive to 
zVAD -fmk when added at the start of the 15 °C culture 
period, suggesting that a cytoplasmic substrate of the 
effector caspases may mediate in the mechanism of Bax 
insertion into mitochondria. 
Successful resolution of the inflammatory response requires 
that granulocytes, neutrophils and eosinophils, trigger an in- 
tracellular program for "silent" self -destruction called apopto- 
sis (1, 2). If cell -death occurs by necrosis the cytotoxic cargo of 
granulocyte molecules is released, inducing tissue damage and 
chronic inflammation and stimulating the release of proinflam- 
matory macrophage products to promote inflammation by 
other routes. The apoptotic program induces the morphological 
hallmarks of apoptosis, nuclear condensation and cell shrink- 
age, and shuts down the secretory potential of granulocytes (3). 
Changes to the molecular profile of the surface of apoptotic 
neutrophils target them for phagocytosis by macrophages (4, 
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5), without release of proinflammatory mediators from macro- 
phages (6). Proinflammatory mediators and cytokines, such as 
granulocyte- macrophage colony -stimulating factor, lipopo- 
lysaccharide, C5a, or an hypoxic environment at the site of 
inflammation can prolong the functional life span of granulo- 
cytes by delaying apoptosis (7, 8) through increased expression 
of the anti -apoptotic proteins Bcl -XL (9) and Mc1-1 (10). The 
molecular mechanism triggering the execution phase of apo- 
ptosis in granulocytes is unknown but activation of tumor 
necrosis factor a and Fas (CD95) cell surface receptors increase 
expression of the proapoptotic proteins Bax and procaspase -3 
(9 -14). Both the p38 mitogen- activated protein kinase and 
p42/p44 mitogen- activated protein kinase, and the transcrip- 
tion factor nuclear factor -KB, regulate the granulocyte apo- 
ptotic program (15, 16), the signals transduced by these path- 
ways converging to induce activation of procaspase -3 (17 -20). 
In mammalian cells the execution phase of apoptosis in- 
by caspase -8 
(21), or indirect activation of procaspase -3 through the release 
of apoptosis- inducing factors, such as cytochrome c, from mito- 
chondria (22 -30). The proapoptotic Bd-2 family member Bax is 
a soluble, monomeric, cytoplasmic protein (31) that inserts an 
hydrophobic C- terminal membrane -spanning domain into mi- 
tochondria (32, 33), inducing release of cytochrome c (31 -35), 
triggering the activation of caspase -3 (36 -38) and the execu- 
tion phase of apoptosis. Bax dimerization (39), the addition of 
recombinant Bax to isolated mitochondria (36) or overexpres- 
sion of Bax (40) has also been shown to induce the release of 
cytochrome c. The mechanism by which cytochrome c is trans - 
located from mitochondria into the cytoplasm is controversial 
(41). However, once in the cytoplasm cytochrome c complexes 
with apoptosis -protease- activating factor -1 (Apaf -1) and pro - 
caspase-9 (26) to form a protein complex the "apoptosome" (42). 
In the presence of dATP this complex induces the proteolytic 
cleavage and activation of procaspase -3 that triggers a down- 
stream cascade of caspase activity (43). It has been reported 
that after differentiation and maturation neutrophils have a 
reduced number of phenotypically atypical mitochondria, ob- 
taining ATP predominantly by glycolysis (10). Thus, whether 
mitochondria play a role in triggering neutrophil apoptosis 
remains to be established. 
Here we show that peripheral blood neutrophils cultured in 
vitro at 15 °C for 20 h failed to induce the execution phase of 
apoptosis until warmed to 37 °C, when they showed a synchro- 
nous burst of apoptosis. In temperature -arrested neutrophils 
endogenous Bax showed peripheral binding to mitochondria 
but failed to induce activation of caspase -3 and apoptosis. On 
warming to 37 °C Bax inserted into the neutrophil membranes 
with concomitant proteolytic cleavage of procaspase -3 and in- 
duction of apoptosis. In both intact neutrophils and cell -free 
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neutrophil extracts we show that the proteolytic cleavage of 
procaspase -3 is induced by translocation of cytochrome c into 
the cytoplasm. Analysis of plasma membrane events showed 
that externalization of phosphatidylserine and the inhibition of 
secretion were uncoupled from the activation of caspase -3, 
when the pan -caspase inhibitor benzyloxycarbonyl -Val -Ala- 
Asp-fluoromethyl ketone (zVAD -fmk)1 was added to 15 °C cul- 
tured neutrophils before warming them to 37 °C. Under these 
conditions the caspase inhibitor did not prevent Bax insertion 
into mitochondria when the cells were warmed from 15 to 
37 °C. However, surprisingly, Bax insertion was inhibited if 
zVAD -fmk was added to neutrophils at the start of their incu- 
bation at 15 °C. This experimental model of apoptosis has 
provided insights into the molecular mechanisms that trigger 
the execution phase of neutrophil apoptosis. 
EXPERIMENTAL PROCEDURES 
Granulocyte Isolation and Culture -Neutrophils were purified on 
gradients of Percoll® from Amersham Pharmacia Biotech (Bucks, 
United Kingdom) (44). They were cultured in Tuf- Tainer® Teflon® pots 
from Pierce & Warriner Ltd. (Chester, UK) at 5 x 106 cells/ml in growth 
medium containing: Iscove's modified Dulbecco's medium supple- 
mented with 2 mM glutamine, 100 units /ml penicillin, 100 pg /ml strep- 
tomycin, and 10% (v /v) autologous serum. Culture at 15 °C was in 
growth medium containing: 25 mM Hepes -NaOH, pH 7, 0.2% (w /v) 
endotoxin -free bovine serum albumin (BSA), and 20 pg/ml cyclohexi- 
mide. BSA and all other chemicals were from Sigma. Neutrophil prep- 
arations were 98% pure with <2% eosinophil contamination (16). Gran- 
ulocytes from atopic donors were used to purify eosinophils by a 
negative selection procedure (16). Incubations with zVAD -fmk from 
BACHEM Ltd. (Essex, UK), staurosporine from CN Biosciences (Not- 
tingham, UK), and bongkrekic acid from BIOMOL Research Laborato- 
ries Inc. (Plymouth Meeting, PA) were in Iscove's medium with 0.2% 
(w /v) BSA and 20 µg/ml cycloheximide. 
Assessment of Granulocyte Apoptosis -Nuclear morphology was as- 
sessed on cytocentrifuged slides stained with Diff-Quikk Gemidor Ltd. 
(Abingdon, Oxon, UK) (16). Annexin V -FITC, from BenderMed Systems 
(Vienna, Austria), was used at 1:200 dilution (5 x 105 cells /ml) to assay 
phosphatidylserine externalization and propidium iodide (10 pg /ml in 
Ca2+ /Mg2+ -free phosphate- buffered saline) was used to monitor mem- 
brane integrity by flow cytometry on an EPICS Profile II from Coulter 
Electronics (Luton, UK) (16). DNA fragmentation was detected by the 
TUNEL in situ cell death detection kit from Roche Molecular Bio- 
chemicals (East Sussex, UK) and by sizing of DNA fragments on aga- 
rose gels, capturing images using a GS 1600m gel documentation sys- 
tem Ultra- Violet Products Ltd. (Cambridge, UK) (16, 45). The data is 
representative of at least three experiments unless indicated. 
Measurement of Intracellular pH- Neutrophils (5 x 10' cells) in 100 
.d of Hank's buffered saline, supplemented with 20 mM Hepes -NaOH, 
pH 7.4, 5 mM glucose, 0.2% (w /v) BSA, and 10 as SNARF -1/AM from 
Molecular Probes (Eugene, OR) were incubated for 10 min at 37 °C. 
Intracellular SNARF -1 was excited at 488 nm and emission was meas- 
ured at 575 and 670 nm using linear amplifiers and data plotted as 
forward scatter versus fluorescence ratio (FL2/FL3). The intracellular 
pH (pHi) was determined by comparing mean 575/670 mn fluorescence 
ratio values of histograms, to a calibration curve of histograms from 
fresh neutrophils. The pH was clamped between 5.6 and 7.8, with 
overlapping 0.2 pH unit intervals, in 20 mM Mes, Pipes, and Hepes 
buffers and 2 µg/ml nigericin, in a high- potassium medium containing: 
110 mM KC1, 20 mM NaCI, 5 mM glucose, 1 mM MgC12, 1.5 mM CaCl2, 
0.2% (w /v) BSA. 
Preparation of Cytosol from 15 °C Neutrophils- Neutrophils (5 x 
108; <5% apoptotic after 20 h at 15 °C) were sedimented at 1,500 X g° 
at 4 °C. They were washed twice in 50 ml of homogenization buffer: 15 
mM Pipes -NaOH, pH 7.4, 80 mM KC1, 20 mM NaC1, 0.25 M sucrose, 1 mM 
dithiothreitol, and a 1:1000 dilution of protease inhibitor mixture: 87 
1 The abbreviations used are: zVAD-fmk, benzyloxycarbonyl- Val -Ala- 
Asp-fluoromethylketone; Apaf -1, apoptosis protease activating factor; 
PARP, poly(ADP- ribose) polymerase; FITC, fluorescein isothiocyanate; 
PAGE, polyacrylamide gel electrophoresis; Pipes, 1,4- piperazinedi- 
ethane sulfonic acid; Mes, 2- (N- morpholino)ethanesulfonic acid; 
TUNEL, terminal deoxynucleotydyl transferase (tdt)- mediated dUTP- 
FITC nick end labeling; BSA, bovine serum albumin; mtHSP, mitochon- 
dria) heat shock protein 70; SNARF -1, seminaphthorhodafluor -1. 
mg of phenylmethylsulfonyl fluoride, 160 mg benzamidine, and 10 mg of 
leupeptin and aprotinin, and 5 mg each of bestatin, antipain, chymo- 
statin, and pepstatin A solubilized in 1 ml of Me2SO. Neutrophils were 
resuspended in 1 ml of homogenization buffer then broken with 20-30 
strokes of a tight- fitting pestle in a glass Dounce homogenizer from 
Wheaton (Millville, NJ), until 809ó of the nuclei stained with trypan 
blue. Intact cells and nuclei were removed by centrifugation at 350 x 
g°, for 5 min at 4 °C. Post -nuclear supernatants were centrifuged at 
17,000 x g °V in a TLA 100.3 rotor from Beckman (High Wycombe, 
Bucks, UK) for 10 min to remove secretory granules and mitochondria 
and the supernatant centrifuged at 541,000 x g,,,00 for 15 min in a TLA 
100.3 rotor to yield a membrane -free cytosol. Cytosol (200 µl) was frozen 
and stored in liquid nitrogen. Protein concentrations were assayed by 
the bicinchonic acid protocol from Pierce & Warriner Ltd. The immu- 
noprecipitation procedure, with a monoclonal antibody to a native cy- 
tochrome c epitope (6H2.B4, PharMingen), was as described previously 
(46). 
Cell -free Proteolytic Cleavage ofProcaspase -3 -Cell -free mixtures for 
the proteolytic cleavage of procaspase -3 contained: 10 µl of 15 °C cytosol 
(50 mg of protein/ml) and 10 µl of an assay dilution buffer containing: 
10 mM Hepes -NaOH, pH 7.4, 40 mM /3- glycerophosphate, 50 mM Noel, 
2 mM MgC12, 5 mM EGTA, 1 mM dithiothreitol, supplemented with 
dATP (20 µM) and inhibitors where appropriate. Incubations were 
stopped by transferring samples to ice and adding 20 µl of 50 mM 
Tris -HC1, pH 8, 0.4 M NaC1, 1% (w/v) deoxycholate, 1% (w /v) Nonidet 
P -40, 5 mM EDTA, containing protease inhibitor mixture (lysis buffer) 
for 0.5 h. 
Isolation of Mitochondria -Rat liver was washed in 10 mM Pipes - 
NaOH, pH 7.2, 0.25 M sucrose, 2 mM EDTA and protease inhibitor 
mixture then forced through a stainless steel sieve (150 µm aperture; 
Endecotes Ltd., London) to break cells (46). The mitochondria were 
isolated from a post -nuclear supernatant as described previously and 
washed in the assay dilution buffer described above (47). 
SDS -PAGE and Immunoblotting -Assay samples (40 pl), treated 
with ice -cold lysis buffer for 0.5 h (40 pl) were solubilized with 80 µl of 
2 x SDS -PAGE sample buffer (46) at 95 °C for 10 min, then treated 
with 1 mM dithiothreitol, cooled, and treated with 10 mM iodoacetamide. 
The proteins were separated on 12% (w/v) polyacrylamide gels and 
electrophoretically transferred to nitrocellulose (46). The blots were 
probed with monoclonal antibodies to procaspase -3 (clone 19) and pro - 
caspase-7 (clone 51) from Transduction Laboratories (Lexington, KY) 
and monoclonal antibodies to procaspase -8 (clone B9 -2), procaspase -9 
(clone B40), cytochrome c (clone 7H8.2C12), and polyclonal human Bax 
(13666E) all from PharMingen (San Diego, CA), at dilutions of 1:500- 
1:1000. A hybridoma supernatant to poly(ADP- ribose)polymerase 
(PARP), used at 1:500 dilution, was a gift from Said Aoufuchi (Labora- 
tory of Molecular Biology, Cambridge, UK). The horseradish peroxi- 
dase- conjugated anti -mouse and anti -rabbit IgGs from Kirkegaard & 
Perry Labs (Gaithersburg, MA) were used at 1:4000 dilution for 0.5 h 
and detected by enhanced chemiluminescence (46). The level of protein 
loading and nonspecific proteolysis were monitored by Ponceau S stain- 
ing (46). Tubulin and actin were assayed with anti -bovine a- tubulin 
monoclonal antibody (236- 10501) from Molecular Probes and a mono- 
clonal antibody to actin; a gift from Simon Brown (Center for Inflam- 
mation Research, University of Edinburgh). 
Confocal Microscopy -Neutrophils (106 cells in 100 .d of medium) 
were cytocentrifuged (300 rpm for 3 min) onto 1.5 x 22 x 22 -mm glass 
coverslips and fixed in methanol -free 3% (w /v) p- formaldehyde/phos - 
phate- buffered saline and processed for immunofluorescence micros- 
copy as described previously (46). The fixed cells were permeabilized 
with 0.1% (w /v) Triton X -100 and nonspecific binding sites blocked for 
1 h with 0.2% (w /v) fish skin gelatin and 20% (v /v) sheep serum in 
phosphate -buffered saline. A monoclonal antibody to mitochondrial 
heat shock protein 70 (mtHSP70) from Affinity Bioreagents Inc. (Gold- 
en, CO) and a rabbit polyclonal antibody to ubiquinol -cytochrome c 
oxidoreductase (complex III) produced by Herman Schagger (University 
of Frankfurt -am- Main), were used at 1:200 dilution to stain mitochon- 
dria. The polyclonal antibody to human Bax was used at 1:200 dilution. 
The secondary antibodies used at 1:400 dilution were Alexa® 488 
(green) goat anti -mouse IgG (highly cross- adsorbed) and Alexa® 568 
(red) goat anti- rabbit (highly cross -adsorbed) and the nucleic acid stain 
TOPO -30 (8 pm), from Molecular Probes. Cells were observed using a 
x63 water immersion objective lens with a numerical aperture of 1.2 on 
a Leica TCS NT confocal laser scanning microscope system (Heidelberg, 
GMBH). Single optical sections of the images captured with Leica TCS 
software were digitally processed using Adobe Photoshop 5.02 and 
Paint Shop Pro 4. 
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RESULTS 
Neutrophil Apoptosis Is Arrested at 15 °C- Neutrophils from 
peripheral blood can be maintained in culture at 37 °C for 
several hours in autologous serum before asynchronously un- 
dergoing apoptosis (Fig. 1A, closed squares). Apoptosis was 
quantified using annexin V -FITC binding to externalized phos- 
phatidylserine and morphological counting of pyknotic nuclei 
(16). A synchronous commitment to apoptosis has previously 
been induced in cells by using cell -free systems (28, 47 -49). 
Dividing cells, for example, blocked at cell cycle checkpoints 
provide an homogeneous cytosol (49). Although neutrophils are 
terminally differentiated (post -replicative) cells, we synchro- 
nized their commitment to the execution phase of apoptosis by 
exposure to low temperature. 
Low temperature blocks intracellular pathways that rely on 
membrane fission and fusion, as exemplified by vesicular 
transport (50, 51). In neutrophils (Fig. 1A, open circles) or 
eosinophils (data not shown) cultured at 15 °C, apoptosis was 
arrested suggesting that a membrane -associated event re- 
quired for apoptosis was inhibited. In contrast, culture of 
HL -60 promyelocytic leukemia cells at 15 °C induced apoptosis 
(data not shown) as described previously for these and many 
other dividing mammalian cells (52), suggesting that there 
may be cell -type or differentiation state -dependent pathways 
for apoptosis. The rate of neutrophil apoptosis at 37 °C was 
accelerated by treatment with cycloheximide (Fig. 1A, closed 
circles). In addition to preventing the translation of new pro- 
teins in the cytoplasm, cycloheximide can induce apoptosis 
through FADD- dependent mechanisms downstream of cell -sur- 
face Fas death receptors (53). However, when we cultured 
neutrophils at 15 °C with cycloheximide there was no increase 
in the rate of apoptosis (Fig. lA, open circles). Treatment of 
15 °C cultured neutrophils with tumor necrosis factor a (16) did 
not induce apoptosis (data not shown), suggesting that the 
block to the induction of the execution phase of apoptosis was 
downstream of these plasma membrane -associated events. 
Temperature Shift to 37 °C Triggers Synchronous Apopto- 
sis -The low temperature arrest of neutrophil apoptosis was 
reversed by re- warming neutrophils, cultured for 20 h at 15 °C, 
to 37 °C. There was reorganization of the cytoskeleton associ- 
ated with cell polarization (shape- change), monitored by flow 
cytometry, that showed cytoskeletal integrity had been main- 
tained at 15 °C (data not shown). This polarization of the neu- 
trophils was followed by a burst of synchronous apoptosis (Fig. 
1B, closed circles). The initial rate of apoptosis was 10 -fold 
greater than the rate of constitutive apoptosis in neutrophils 
maintained at 37 °C (Fig. lA, closed squares), and by 2 h after 
warming 80 -90% of the cells were apoptotic (Fig. 1B, closed 
circles). Neutrophils maintained for a further 2 h at 15 °C 
showed no shape change and no increase in their rate of apop- 
tosis (Fig. 1B, open circles). By culturing neutrophils in me- 
dium containing BSA and cycloheximide we removed experi- 
mental variables induced by serum factors and translation of 
mRNA into new protein. 
The accelerated rate of neutrophil apoptosis at 37 °C, follow- 
ing preincubation at 15 °C, depended on the period of time 
neutrophils had been cultured at 15 °C. It was not a cold -shock 
response, as previously shown for lymphocytes (54). We dem- 
onstrated this by maintaining cells at 15 °C for increasing 
periods of time before warming them to 37 °C and estimating 
the initial rate of apoptosis over a 1.5 -h period as shown in Fig. 
1B (closed circles). For the first 6 h in culture there was no 
increase in the initial rate of apoptosis (Fig. 1C). However, as 
the cells were cultured for longer periods at 15 °C there was an 
increase in the initial rate of apoptosis on warming (Fig. 1C). 
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FIG. 1. Human neutrophil apoptosis was arrested at 15 °C and 
warming to 37 °C induced a rapid and synchronous apoptosis. 
Neutrophils were cultured in medium supplemented with: A, 0.2% BSA 
and 20 µg/ml cycloheximide at 15 °C (0) and 37 °C (0), an incubation 
with 10% (v /v) autologous serum, without cycloheximide at 37 °C is also 
shown (). Apoptosis was assessed by annexin V -FITC binding ana- 
lyzed by flow cytometry. B, neutrophils cultured and analyzed as de- 
scribed in A were held at 15 °C for 20 h (0), and subsequently warmed 
to 37 °C, O. C, neutrophils were cultured at 15 °C as described in and 
at 1 -h intervals harvested and warmed to 37 °C for 1.5 h as described in 
B to assess the initial rate of apoptosis (single experiment). D, DNA, 
extracted from 5 X 10e neutrophils cultured at 15 °C for 20 h and 
warmed to 37 °C as described in B, was separated in agarose gels and 
stained with ethidium bromide. A 1- kilobase ladder of DNA standards 
(Std) is shown. Annexin V -FITC binding was used to assess apoptosis 
and the percentage ( %) apoptosis for each sample is shown. 
15 °C Inhibits Bax- insertion and Arrests Neutrophil Apoptosis 
FIG. 2. zVAD -fmk inhibited morpho- 
logical apoptosis but not the external- 
ization of phosphatidylserine that is 
inhibited by staurosporine but not 
okadaic acid. Effects of the global caspase 
inhibitor zVAD -fmk on the triggering of 
neutrophil apoptosis. A, neutrophils were 
cultured, as described in the legend to Fig. 
IA, at 15 °C for 20 h (O, D) and warmed to 
37 °C (, ) and apoptosis estimated by 
morphological counting. The neutrophils 
were treated with 100 µM zVAD-fink for 15 
min (E, ) prior to warming to 37 °C and 
control neutrophils were mock treated with 
Me2SO (O, ). B, DNA fragmentation in 
the 15 and 37 °C neutrophils shown in A 
was analyzed by TUNED and flow cytom- 
etry. C, the externalization of phosphati- 
dylserine at the surface of the neutrophil 
plasma membrane at 15 °C (O, ) and 
37 °C (, ) was estimated by annexin V- 
FITC binding for the samples shown in A 
above. D, staurosporine inhibited phos- 
phatidylserine externalization. Apoptosis, 
assessed by morphological counting for 
neutrophils warmed from 15 °C (0) to 
37 °C () was not inhibited by 2 µM stau- 
rosporine treatment of 15 °C cultured neu- 
trophils () for 1 h prior to warming to 
37 °C (). E, however, the externalization 
of phosphatidylserine, assessed by annexin 
V- FITC- binding, at 15 °C (0), and after 
warming to 37 °C (0) was inhibited by 
treatment with staurosporine (D, ). F, 
neutrophils were cultured at 15 °C for 
20 h (0) and before warming to 37 °C (0) 
they were treated at 15 °C (D) for 1 h with 
the 1 .LM okadaic acid then warmed to 
37 °C () and showed no inhibition of the 
triggering of apoptosis assessed by an- 
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dependent accumulation of a proapoptotic factor at the site of 
the temperature arrest that led to a synchronization of apo- 
ptosis when the cells were subsequently warmed to 37 °C. DNA 
laddering (Fig. 1D), a downstream hallmark of activation of the 
execution phase of apoptosis, showed kinetics similar to the 
morphological and annexin V -FITC estimates of apoptosis 
when 15 °C cultured neutrophils were warmed to 37 °C. 
15 °C Arrest Is Proximal to Procaspase -3 Activation -To es- 
tablish whether inhibition of neutrophil apoptosis at 15 °C 
(Fig. 2A, open circles) was upstream of caspase -3 activation and 
apoptosis at 37 °C (Fig. 2A, closed circles), 15 °C cultured neu- 
trophils were treated with 100 µM zVAD -fmk (18) (Fig. 2A, open 
squares) for 15 min before warming to 37 °C. zVAD -fmk inhib- 
ited chromatin condensation and the formation of pyknotic 
nuclei when neutrophils were warmed from 15 to 37 °C (Fig. 
2A, closed squares). DNA fragmentation at 37 °C (Fig. 2B, 
closed circles), indicative of caspase -3 activation, was also in- 
hibited (Fig. 2B, closed squares) by zVAD -fmk. Phosphatidyl- 
serine was still translocated to the cell surface in the presence 
of zVAD -fmk (Fig. 2C, closed squares), although the kinetics of 
translocation were significantly different from the untreated 
neutrophils (Fig. 2C, closed circles). Phosphatidylserine exter- 
nalization has been linked to caspase -3 activity (19, 55 -57) so 
their uncoupling was surprising. However, two other plasma 
membrane hallmarks of apoptosis phagocytosis (57) and regu- 
lated secretion were also uncoupled from caspase -3 by zVAD- 
fink. The protein kinase inhibitor staurosporine together with 
cycloheximide induces apoptosis in many cells (58). However, 
staurosporine did not stimulate apoptosis at 15 °C (Fig. W, 
open squares) nor did it accelerate the induction of morpholog- 
2 J. Pryde unpublished results. 
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ical apoptosis when neutrophils were warmed to 37 °C (Fig. 2D, 
closed squares). Phosphatidylserine, detected on the cell sur- 
face by annexin -V -FITC after warming to 37 °C (Fig. 2E, closed 
circles), was not detected in the presence of staurosporine (Fig. 
2E, closed squares), suggesting that translocation of this phos- 
pholipid to the cell surface may rely on a critical phosphoryla- 
tion event. The inhibition of mitochondrial respiration also 
blocks phosphatidylserine externalization in apoptotic U937 
and THP.1 cells, suggesting that this may be an energy -de- 
pendent event (57). Okadaic acid, an inhibitor of phosphatases 
1 and 2A (46) had no effect on the induction of apoptosis in 
15 °C cultured neutrophils warmed to 37 °C (Fig. 2F, closed 
squares). This suggested that caspase activation might not be 
modulated by phosphorylation events in this experimental 
model. A number of other agents that induce neutrophil apo- 
ptosis, such as the nuclear factor -KB inhibitor gliotoxin (16) 
and the phosphatidylinositol kinase inhibitor wortmannin, had 
no effect on the rate of apoptosis in 15 °C cultured neutrophils 
(data not shown). Our results suggest that the temperature - 
dependent arrest of apoptosis in neutrophils was not due to 
signal transduction nor gene transcription events. 
A Low Intracellular pH Inhibits the Triggering of Apopto- 
sis -Acid conditions at sites of inflammation inhibit neutrophil 
apoptosis (59), but conversely, low pH has also been implicated 
in triggering apoptosis in many cells (60, 61). The pHi of freshly 
isolated neutrophils was 7.1, equivalent to the "set point" for 
resting cells in culture when measured by accumulation of 
carboxy -seminaphthorhodafluor -1 (SNARF -1), a fluorescent 
probe whose emission changes with pH (61 -63). The pH1 of 
neutrophils incubated at 15 °C for 20 h was 6.8 -7.0 (Fig. 3A, 
open circles). However, following the induction of apoptosis 
(assayed by annexin -V- binding and morphology, Fig. 3, B and 
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FIG. 3. Acid pH arrested the trigger- 
ing of apoptosis following a shift in 
temperature from 15 to 37 °C. A, neu- 
trophils were cultured at 15 °C for 20 h 
then either maintained at an external pH 
of 7.2 at 15 °C (0) or 37 °C () for 1.5 h, 
clamped at pH 6.2 in a high- potassium 
buffer containing nigericin to maintain a 
pH; of 6.2 when cultured at 15 °C () or 
warmed to 37 °C () for 1.5 h or exposed 
to an external pH of 6.2, in the absence of 
any added nigericin and potassium, at 
15 °C (A) or 37 °C (A). B, apoptosis for the 
samples shown in A was assessed by an- 
nexin V -FITC- binding at 15 °C (O, , A) 
and 37 °C (, U, A) for neutrophils ex- 
posed to an external pH of 7.2 (O, ) or 6.2 
(0, A) or clamped at pH 6.2 with nigericin 
in a high potassium buffer (, ). C, mor- 
phological estimates for neutrophil apop- 
tosis of samples in B above at 1.5 h after 
warming from 15 to 37 °C and for neutro- 
phils exposed to external pH of 6.2 (pH 
6.2) or clamped with nigericin and potas- 
sium (pH 6.2 N). D, apoptosis estimated 
by annexin -V -FITC binding for neutro- 
phils cultured at 15 °C for 20 h and either 
held at 15 °C (0) or warmed to 37 °C () 
and their pH; clamped at either 7.2 (, U) 
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C), by increasing the temperature to 37 °C the pH, dropped to 
6.4 (Fig. 3A, closed circles) as apoptosis progressed (Fig. 3B, 
closed circles), consistent with previous measurements of acidic 
pH, during apoptosis (60, 61). However, clamping neutrophils 
at pH 6.2, with nigericin and high K+ (Fig. 3A, squares) did not 
trigger apoptosis at 15 °C (Fig. 3, B, open squares, and C) or at 
37 °C (Fig. 3, B, closed squares, and C). This suggested that 
acid pH alone was not a sufficient trigger for apoptosis as 
previously suggested (60, 61). Neutrophils cultured in growth - 
medium buffered at pH 6.2, in the absence of nigericin (Fig. 3A, 
triangles), did not induce apoptosis at 15 °C (Fig. 3,B, open 
triangles, and C) nor on warming to 37 °C (Fig. 3, B, closed 
triangles, and C). This in vitro response to low pH appears to 
mimic the arrest of neutrophil apoptosis at inflammatory foci 
where the pH has dropped below 7 (59). When the pHi of 15 °C 
cultured neutrophils was clamped at 7.2, the rate of apoptosis 
was significantly greater when the cells were warmed to 37 °C 
(Fig. 3D, squares) than in cells clamped at pH 6.2 (Fig. 3D, 
closed triangles). However, apoptosis was still not as efficient 
as in the untreated cells (Fig. 3D, closed circles). This result is, 
however, consistent with reports that suggest an alkaline 
pH transient is necessary to trigger the execution phase of 
apoptosis (64). 
Neutrophil Apoptosis Is Correlated with Procaspase -3 Cleav- 
age- Procaspase -3 cleavage is required for neutrophil apopto- 
sis (65), but was not detected by immunoblotting in freshly 
isolated human neutrophils (Fig. 4A, lane 2). However, treat- 
ment of neutrophils with diisopropyl fluorophosphate, a serine 
protease inhibitor, before solubilization at 0 °C in a nondena- 
turing lysis buffer and SDS sample buffer for PAGE, prevented 
nonspecific proteolysis of procaspase -3 (Fig. 4A, lane 3). Neu - 
trophils were treated with diisopropyl fluorophosphate before 
isolating cytosols, but while this was not absolutely necessary 
for 15 °C cultured neutrophils (Fig. 4A, lanes 4 and 5), diiso- 
propyl fluorophosphate treatment did allow detection of endog- 
enous procaspase -7 and procaspase -8 by immunoblotting. We 
have been unable to detect procaspase -9 (data not shown). 
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37 °C for 2 h, proteolytically cleaved procaspase -3 in a time -de- 
pendent manner (Fig. 4B, upper panel, lanes 1 -11) that corre- 
lated with estimates of apoptosis by counting of pyknotic nuclei 
and annexin V -FITC binding (Fig. 2, A and C). Neutrophils 
held for a further 2 h at 15 °C showed no proteolytic processing 
of procaspase -3 (Fig. 4B, lower panel, lanes 1 -11). 
Proapoptotic Events Can be Detected in Neutrophil Cy- 
tosols-To identify the molecular events leading to the proteo- 
lytic cleavage and activation of neutrophil procaspase -3, cy- 
tosols were prepared from cultures of neutrophils maintained 
at 15 °C for 20 h. The neutrophils were homogenized in buff- 
ered sucrose and fractionated using a two -step ultracentrifu- 
gation procedure (see "Experimental Procedures ") to minimize 
damage to organelles, particularly secretory granules. Elas- 
tase, a secretory granule marker, sedimented with membrane 
fractions (data not shown), while procaspase -3 remained in the 
cytosol (Fig. 5A, lane 1). Neutrophils cultured at 15 °C and 
warmed to 37 °C for 1.5 h before preparing the cytosols did not 
contain procaspase -3 (Fig. M, lane 2). The proteolytic cleavage 
of procaspase -3, observed in unbroken 15 °C cultured neutro- 
phils warmed to 37 °C (Fig. 4B, lanes 5 -11), had presumably 
been triggered by apoptosis -inducing factors released from the 
membranes into the cytoplasm before the cells had been ho- 
mogenized. Significantly, when cytosols from 15 °C cultured 
neutrophils were warmed to 37 °C in the presence of dATP, a 
cofactor involved in the activation of the apoptosome (42), pro - 
caspase-3 was not proteolytically cleaved (Fig. 5A, lane 5) and 
was present in an amount comparable to the zVAD -fmk- treated 
controls (Fig. 5A, lane 6). These data suggested that apoptosis- 
inducing factors were missing from the cytosol and had been 
removed with the membrane fraction. The fraction of cytosol 
from the small number of contaminating apoptotic cells did not 
catalyze a significant rate of proteolytic cleavage of procaspase -3. 
Mitochondria have been shown to play a key role in the 
control and amplification of apoptotic signals (23, 42). Cytosols 
from Xenopus laevis eggs only trigger apoptosis when mem- 
brane fractions enriched in mitochondria are added (25, 27, 48). 
When rat liver mitochondria were added to cytosols isolated 
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FIG. 4. Temperature- dependent pro - 
teolytic cleavage of endogenous pro - 
caspase-3 in intact neutrophils. A, 
freshly isolated human neutrophils 
(PMN) (lanes 2 and 3) and neutrophils 
cultured at 15 °C for 20 h (lanes 4 and 5) 
were either treated with 2.3 mie diisopro- 
pyl fluorophosphate for 15 min on ice 
(lanes 3 and 5) or left untreated (lanes 2 
and 4). Each lane contains 80 p.g of pro- 
tein solubilized in lysis buffer on ice then 
in SDS sample buffer before separation 
on a 12% (w /v) polyacrylamide gel and 
electrophoretic transfer to nitrocellulose 
sheets and probing with a monoclonal an- 
tibody to procaspase -3. Lane 1 shows cy- 
tosol from 15 °C cultured neutrophils. B, 
neutrophils cultured at 15 °C, as de- 
scribed in the legend to Fig. 1, and cell 
pellets (5 x 106 cells) were solubilized and 
analyzed as described in A. The 15 °C cul- 
tured neutrophils were either warmed to 
37 °C (upper panel, lanes 1 -11) or held at 
15 °C (lower panel, lanes 1 -11) for the 
times indicated and proteolytic cleavage of 
procaspase -3 assessed by immunoblotting. 
Re- probing the blots with antibodies to tu- 
bulin or actin (not shown) assessed protein 
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from 15 °C cultured neutrophils, supplemented with dATP 
then incubated at 15 °C for 2 h, immunoblotting revealed no 
significant proteolytic processing of procaspase -3 (Fig. 5B, 
lanes 1 -5). The degree of proteolytic processing was compared 
with 15 °C cytosols pretreated with zVAD-fmk (Fig. 5B, lane 6) 
and with 15 °C cytosols without added mitochondria (Fig. 5B, 
lane 8). In cytosols containing dATP and mitochondria perme- 
abilized with Triton X -100, to release apoptosis -inducing fac- 
tors, an efficient proteolytic cleavage of procaspase -3 was ob- 
served by 2 h at either 15 or 37 °C (Fig. 5B, lanes 7 and 14). 
Cytosol from 15 °C neutrophils warmed to 37 °C with rat liver 
mitochondria, and dATP induced proteolytic cleavage of pro - 
caspase-3 in a time- dependent manner (Fig. 5B, lanes 9 -12). 
The protease activity was inhibited by zVAD -fmk (Fig. 5B, lane 
13) and was dependent upon the addition of mitochondria at 
37 °C (Fig. 5B, lane 15). 
The involvement of membrane -associated events in the trig- 
gering of neutrophil apoptosis was also suggested by analysis of 
the rate of apoptosis as a function of temperature (Fig. 5C). 
There was a sharp decline in the rate of apoptosis below 20 °C 
and an Arrhenius plot of this data (not shown) (66) showed that 
the temperature dependence was biphasic. As the temperature 
drops to 15 °C reduction in the fluidity of the membrane lipid 
may affect the behavior of membrane -associated proteins (50, 
51, 66). Mitochondrial anion channels have also been shown to 
respond to lowered temperature by changing their probability 
of being open, a parameter that is also affected by changes in 
pH (67). Thus, in our cell -free assay low temperature main- 
tained the segregation of apoptosis -inducing factors within mi- 
tochondria, preventing apoptosome activation. 
Cytochrome c Induces Procaspase -3 Cleavage -When horse 
heart cytochrome c and dATP were added to cytosol from 15 °C 
cultured neutrophils and incubated at 15 or 37 °C for 1 h, 
proteolytic cleavage of procaspase -3 was induced (Fig. 5D, 
lanes 2 and 4). The kinetics of procaspase -3 proteolytic cleavage 
were dependent on the concentration of cytochrome c, being 
complete between 10 and 100 ng of cytochrome c /80 µg of 
cytosol protein after 1 h at 37 °C. Treatment of the neutrophil 
cytosol with 100 µM zVAD -fmk prior to the addition of cyto- 
chrome c prevented proteolytic cleavage of procaspase -3 at 15 
and 37 °C (Fig. 5D, lanes 3 and 5). Since an efficient proteolytic 
cleavage of procaspase -3 occurred at 15 °C the arrest of apo- 
ptosis was unlikely to be a consequence of the failure of the 
apoptosome proteins to undergo conformational changes at low 
temperature (68). 
Poly(ADP- ribose)polymerase Is Cleaved by 15 °C Cytosols- 
Neutrophil cytosols containing cytochrome c and dATP pro- 
duced active caspase -3 that processed HL -60 PARP (116 kDa), 
not present in mature neutrophils (17), to an 85 -kDa polypep- 
tide fragment after a 1.5 -h incubation at 15 °C (Fig. 6, lower 
panel, lane 3). This proteolytic cleavage was inhibited by zVAD- 
fmk (Fig. 6, lower panel, lane 4). There was no apparent pro- 
teolysis of procaspase -3 under these conditions (Fig. 6, upper 
panel, lane 3). There was variability between cytosol prepara- 
tions, and under similar conditions procaspase -3 was fully 
processed (see Fig. 5D, lane 2). At 37 °C there was complete 
proteolytic cleavage of procaspase -3 (Fig. 6, upper panel, lane 5) 
with concomitant proteolytic cleavage of PARP (Fig. 6, lower 
panel, lane 5); again this was inhibited by zVAD -fmk (Fig. 6, 
lower panel, lane 6). No proteolytic processing of neutrophil 
procaspase -3 or HL -60 -PARP by endogenous proteases was 
detected in the absence of cytochrome c (Fig. 6, upper panel, 
lane 1, and lower panel, lane 7, respectively). 
Release of Cytochrome c from Neutrophil Mitochondria Oc- 
curs at 37 but not 15 °C- Cytochrome c induced the proteolytic 
cleavage of endogenous neutrophil procaspase -3 but there was 
the possibility that this was only a property of the cell -free 
assay, particularly since we were unable to detect procaspase -9 
a component of the apoptosome (42). To monitor translocation 
of cytochrome c from mitochondria into the cytoplasm of intact 
neutrophils, warmed from 15 to 37 °C, we separated post - 
nuclear supernatants into membrane and cytosol fractions. 
Cytochrome c was immunoprecipitated from the fractions with 
a monoclonal antibody to a native cytochrome c epitope and 
identified by immunoblotting with an anti -cytochrome c anti- 
body that recognized SDS- denatured cytochrome c. Neutrophil 
cytochrome c (Fig. 7, lane 3) co- migrated with cytochrome c 
from both horse heart and HeLa cells (Fig. 7, lanes 1 and 2). In 
neutrophils held at 15 °C, cytochrome c remained with the 
membrane fraction (Fig. 7, lanes 4 and 5), but on warming to 
37 °C cytochrome c was translocated to the cytosol (Fig. 7, lanes 
7 and 8). Thus neutrophils released endogenous cytochrome c 
from mitochondria into the cytoplasm, an event that correlated 
with the onset of apoptosis. 
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Fic. 5. Cell -free proteolytic cleavage of procaspase -3. A, the proteolytic cleavage of endogenous neutrophil procaspase -3 was analyzed in 
cytosol supplemented with 20 µM dATP (lanes 1, 3 -6), and in 15 °C cultured neutrophil cytosol warmed to 37 °C (lane 2) by immunoblotting. 
Samples of the 15 °C cytosol (lane 1) and cytosol from 15 °C cultured cells warmed to 37 °C (lane 2) were held at 0 °C. The 15 °C cytosol was also 
held at 15 °C (lane 3) or warmed to 37 °C (lane 5) in the presence (lanes 4 and 6) or absence (lanes 3 and 5) of 100 µM zVAD -fmk. B, cell -free assays 
containing cytosol from 15 °C cultured neutrophils were supplemented with 5 of rat liver mitochondria fraction (47) and incubated at 15 °C for 
the times indicated (lanes 1 -5, respectively). Control incubations at 15 °C contained: 100 µM zVAD -fmk (lane 6), mitochondria plus 0.1% (w /v) 
Triton X -100 (lane 7), or no mitochondria (lane 8). Lanes 9 -12 show incubations at 37 °C for the times indicated, a zVAD -fmk 2 h control (lane 13), 
a mitochondria plus 0.1% (w /v) Triton X -100 control (lane 14), and a control lane with no added mitochondria (lane 15). C, the rate of neutrophil 
apoptosis is temperature dependent. Neutrophils were incubated for 22 h at 15 °C and then warmed to the given temperatures (between 15 and 
40 °C). The rate of apoptosis was estimated by annexin V -FITC binding as described in the legend for Fig. 1B. D, induction of the proteolytic 
cleavage of procaspase -3 by horse heart cytochrome c. Incubations and analysis were as described above in A and were for 1 h at the temperatures 
shown. Lane 1, 37 °C cytosol control. In lanes 2 -6 the assays were supplemented with 200 ng of cytochrome c. Incubations were at 15 °C (lanes 2 
and 3), 37 °C (lanes 4 and 5), and 0 °C (lane 6). Controls containing 100 µM zVAD -fmk are shown in lanes 1, 3, and 5. 
The Translocation of Bax to Membrane Fractions -How the 
mitochondrial membrane is permeabilized to release cyto- 
chrome c during apoptosis is not known (68, 69). However, 
while the opening or formation of the putative membrane chan- 
nels may be temperature- sensitive, movement of cytochrome c 
through the channels may not be sensitive to reduced temper- 
ature (30). Bax is highly expressed in neutrophils (9 -14) and 
can form membrane pores (39) so we examined the subcellular 
distribution of Bax during neutrophil apoptosis. Immunoblot- 
ting showed that Bax was present in the postnuclear superna- 
tants of 15 °C cultured neutrophils (Fig. 8, upper panel, lane 1). 
Sedimentation of the membranes by ultracentrifugation (Fig. 
8, upper panel, lane 2) showed that Bax partitioned into the 
cytosol (Fig. 8, upper panel, lane 3) with procaspase -3 (Fig. 8, 
lower panel, lane 3). This is consistent with their localization in 
freshly isolated neutrophils (data not shown), murine thymo- 
cytes, splenocytes, and HL -60 cells (33, 35). In 15 °C cultured 
neutrophils warmed to 37 °C for 3 h, procaspase -3 was proteo- 
lytically cleaved (Fig. 8, lower panel, lanes 4 -6) and Bax had 
translocated to the washed membrane fraction (Fig. 8, upper 
panel, lane 5) from the cytosol (Fig. 8, upper panel, lane 6). This 
location suggested that Bax had inserted its hydrophobic mem- 
brane- spanning domain into mitochondria (40). In some exper- 
iments membrane -associated Bax was processed to an 18 -kDa 
fragment (data not shown), a cleavage product identified in a 
number of other apoptotic cells (70, 71). 
Bax insertion into mitochondria and the release of cyto- 
chrome c in many experimental models is insensitive to zVAD- 
fmk (28). In subcellular fractions from neutrophils cultured for 
18 h at 15 °C and treated with 100 µM zVAD -fmk for 2 h, before 
warming to 37 °C, Bax had translocated to the membrane 
fraction (Fig. 8, upper panel, lane 11). Under these conditions 
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FIG. 6. Proteolytic processing of 
HL -60 PARP in heterologous cell-free 
assays. HL-60 nuclei were incubated 
with 15 °C neutrophil cytosol and dATP 
and proteolytic cleavage of procaspase -3 
triggered by the addition of cytochrome c 
(200 ng). Samples were taken at 0 h (lane 
2) and at 1.5 h after incubation at 15 °C 
(lanes 3 and 4), without zVAD -fink treat- 
ment (lanes 1-3, 5 and 7), with 100 gm 
zVAD-fink treatment (lanes 4 and 6), and 
after incubation at 37 °C (lanes 1 and 
5 -7). Samples were solubilized as de- 
scribed in the legend to Fig. 5B and the 
immunoblots probed with monoclonal an- 
tibodies to procaspase -3 (upper panel) and 
PARP (lower panel). 
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Temperature °C 37 0 15 15 37 37 37 
Time (minutes) 90 0 90 90 90 90 90 
15 °C PMN cytosol + + + + + + - 
HL60 nuclei - + + + + + + 
Cytochrome c - + + + + + - 
zVAD -fmk - - - + - + - 
Procaspase -3 
34 -kDa 11liiirrwr0.4 r meirep +1ll __ 
PARP 116 -kDa 
85 -kDa wommor 
1 2 1 3 4 5 6 7 
Temperature °C 0 0 15 15 15 37 37 37 
Fraction C HP M S PM S 
Cytochrome c 
15 kDa 
1 I 2 I 3 4 I 5 I 6 I 7 I 8 
FIG. 7. The release of endogenous neutrophil cytochrome c from membrane fractions into the cytosol. Neutrophils were cultured at 
15 °C as described in the legend to Fig. 1A. Samples were solubilized in a nondenaturing lysis buffer for immunoprecipitation (46) with monoclonal 
antibodies to a native epitope on cytochrome c. After SDS -PAGE and electroblotting to nitrocellulose, cytochrome c was identified with a 
monoclonal antibody to the SDS -denatured form of cytochrome c. Lane 1 contains 50 ng of horse heart cytochrome c (C). Lane 2 shows an 
immunoprecipitation of cytochrome c from 0.5 x 106 HeLa cells (H). Lanes 3 -8 show cytochrome c immunoprecipitated from: in lane 3, a 
post -nuclear supernatants (P) of 15 °C cultured neutrophils (7.5 x 10' cells); lane 4, 15 °C cultured neutrophil membrane fraction (M); lane 5, 15 °C 
cultured neutrophil supernatant (S) fraction; lane 6, post -nuclear supernatants (S) of 15 °C cultured neutrophils warmed to 37 °C for 2 h (apoptosis 
by annexin V -FITC 85 %); lane 7, 37 °C membrane fraction (M); lane 8, 37 °C supernatant (S) fraction. 
Temperature °C 15 37 37 37 
100µM zVAD-fmk _ _ + TO +T18 
% Apoptosis 4 94 12 11 
Cell fraction PNS I M I C PNS I M I C PNS I M I C PNS I M I C 
Bax 21-kDa , 4.11110"441111 
Procaspase-3 
34-kDa 
1 I 2 I 3 I 4 I 5 I 6 I 7 I 8 I 9 I 10 I 11 I 12 
FIG. 8. Subcellular localization of Bax. Neutrophils (3 x 108 cells) were held at 15 °C for 18 h. 108 cells were incubated at 15 °C for 5 h (lanes 
1-3); 106 cells were cultured for a further 2 h at 15 °C before warming to 37 °C for 3 h (lanes 4 -6) and 106 cells were treated for 2 h at 15 °C with 
100 µm zVAD-fink before warming to 37 °C for 3 h (T18: lanes 10 -12). One sample of 106 freshly isolated neutrophils was treated with 100 µM 
zVAD -fmk at 15 °C for 20 h and then warmed to 37 °C for 3 h (lanes 7 -9). Post -nuclear supernatants (post -nuclear supernatants: lanes 1, 4, 7, and 
10) were fractionated into membrane (M: lanes 2, 5, 8, and 11) and cytosol (C: lanes 3, 6, 9, and 12) by ultracentrifugation, the membrane fractions 
being re- homogenized to their original volume in buffer. The fractions were immunoblotted with antibodies to Bax (upper panel) and procaspase -3 
(lower panel). 
procaspase -3 was still present in the cytosol (Fig. 8, lower 
panel, lane 12). However, when freshly isolated neutrophils were 
treated with 100 µM zVAD-fink at 15 °C for 20 h prior to warming 
to 37 °C, Bax remained in the cytosol fraction (Fig. 8, upper 
panel, lane 9) with procaspase -3 (Fig. 8, lower panel, lane 9). The 
Bax present in the membrane fraction (Fig. 8, upper panel, lane 
8) can be accounted for by the apoptotic cells (12 %) present. These 
results suggest that during incubation at 15 °C, caspase activity 
may prepare Bax for translocation from the cytosol to mitochon- 
dria and insertion into the mitochondrial membrane on warming 
to 37 °C. Caspase -8, a potential candidate for the indirect activa- 
tion of Bax, can be detected in neutrophil cytosols. However, 
procaspase -8 was not proteolytically cleaved during either incu- 
bations at 15 °C or during the warming of 15 °C cultured neutro- 
phils to 37 °C in the presence of zVAD -fmk (data not shown). 
The Translocation of Bax to Neutrophil Mitochondria -We 
followed the translocation of Bax from the cytoplasm to mito- 
chondria in apoptotic neutrophils by confocal microscopy. Im- 
munofluorescence staining of neutrophils with rabbit preim- 
mune sera and Alexa dye- tagged secondary antibodies showed 
nuclear staining in freshly isolated neutrophils (Fig. 9A) and no 
significant cytoplasmic staining. Anti -Bax polyclonal antibod- 
ies also showed nuclear staining (Fig. 9B), but similar staining 
in HeLa cells and Bax- deficient tumor cells suggested that this 
staining was nonspecific (72). In fresh preparations of neutro- 
phils the few constitutively apoptotic neutrophils showed Bax 
staining of large cytoplasmic structures (Fig. 9B, arrow). These 
cytoplasmic structures were also stained with polyclonal anti- 
bodies to ubiquinol cytochrome c oxidoreductase (complex III) 
that co- localized with mtHSP70 staining (Fig. 9C), whose ex- 
pression was increased in many preparations of 15 °C cultured 
neutrophils. Significantly, staining of 15 °C cultured neutro- 
phils with mtHSP70 (Fig. 9D) and Bax (Fig. 9E) showed co- 
localization (yellow staining) in merged images (Fig. 9F) of 
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FIG. 9. Intracellular localization of 
Bax by confocal microscopy. Freshly 
isolated neutrophils showed no signifi- 
cant cytoplasmic staining with rabbit pre - 
immune serum and anti- rabbit IgG -con- 
jugated to Alex® 568 (red) (A), with 
polyclonal antibodies against Bax (B) nor 
with monoclonal antibodies to the mito- 
chondrial marker mtHSP70 detected with 
anti -mouse IgG- conjugated to Alexam 488 
(green) (B). Nuclei were stained with 
TOPO -3410 and the cells were analyzed by 
confocal microscopy and single optical 
sections are shown. Apoptotic cells pres- 
ent in the freshly isolated cells, however, 
showed Bax staining (red) of large cyto- 
plasmic structures (arrow in B) that co- 
localized (yellow) with staining for both 
the mitochondrial markers mtHSP70 
(red) and complex III (green) (C). After 
culture for 20 h at 15 °C (D -F) neutrophils 
showed staining for cytoplasmic struc- 
tures with mtHSP70 (D) and Bax (E) that 
co- localized (yellow staining) in merged 
micrographs (F). When the 15 °C cultured 
neutrophils were warmed to 37 °C for 3 h 
(G -I), they showed staining of several dis- 
crete cytoplasmic structures. These were 
also stained for mtHSP70 (G) and Bax (H) 
and when the micrographs were merged 
(I) the Bax and mtHSP70 staining was 
mainly co- localized, although there were 
some structures that stained for only one 
or another of the antibodies. A control 
15 °C culture was warmed to 37 °C for 3 h 
and stained with rabbit preimmune (J). 
Freshly isolated neutrophils were treated 
for 20 h with 100 gm zVAD -fmk and then 
warmed to 37 °C for 3 h. The micrograph 
(K) shows the merged staining for Bax 
and mtHSP70. Neutrophils were cultured 
at 15 °C for 18 h and then treated at 15 °C 
for 2 h with 100 µht zVAD -fmk before 
warming to 37 °C for 3 h. The micrograph 
(L) again shows the merged staining for 
Bax and mtHSP70. The bar represents 
5 wt. 
cytoplasmic structures that were present in cells that showed 
none of the pyknotic nuclear morphology associated with neu- 
trophil apoptosis. Co- localization analysis, on single optical 
sections using Leica TCS software, confirmed the subcellular 
co- localization of Bax and mtHSP70 seen in the merged fluo- 
rescent micrographs (data not shown). Bax appeared therefore 
to translocate to mitochondria at 15 °C, without triggering 
apoptosis. The binding of Bax to mitochondria without inser- 
tion of its hydrophobic membrane -spanning domain would be 
consistent with Bax being peripherally associated with the 
mitochondrial membrane and redistributing to the cytosol frac- 
tion during homogenization and washing of the membrane 
fraction (Fig. 8, lane 3). After warming the 15 °C cultured 
neutrophils to 37 °C for 3 h, mtHSP70 staining (Fig. 9G) and 
Bax staining (Fig. 9H) were co- localized in the merged micro- 
graph (Fig. 91) with a small number of large, but discrete, 
cytoplasmic structures. Similar cytoplasmic structures have 
been identified in HeLa cells treated with staurosporine to 
induce apoptosis (72) and in cells overexpressing Bax (37, 38) 
as aggregates of mitochondria. Not all mitochondria stained for 
Bax and some Bax- stained structures did not stain with 
mtHSP70. There was therefore a differential response by mi- 
tochondria to apoptotic signals and Bax may also translocate to 
other membrane compartments. Neutrophils cultured at 15 °C 
for 20 h then warmed to 37 °C for 3 h showed no staining with 
rabbit preimmune sera (Fig. 9J). 
After culture of neutrophils at 15 °C for 20 h with zVAD -fmk 
and warming to 37 °C for 3 h there was no significant Bag 
staining of neutrophil mitochondria that showed non -apoptotic 
nuclear morphology (Fig. 9K). This was consistent with the 
immunoblotting data (Fig. 8, upper panel, lanes 7 -9) that 
showed no insertion of Bax into mitochondria. However, neu- 
trophils cultured at 15 °C for 18 h, then treated for 2 h with 
zVAD -fmk before warming to 37 °C for 3 h, did show significant 
Bag and mtHSP70 staining (Fig. 9L). This was consistent with 
immunoblotting data that showed that Bag had translocated to 
the membrane fraction (Fig. 8, upper panel, lanes 10 -12). 
While the nuclear morphology was significantly different from 
the nuclei of freshly isolated neutrophils under these condi- 
tions, the pyknotic nuclear morphology characteristic of apop- 
totic neutrophils was not detected and there was no fragmen- 
tation of DNA under these conditions (see Fig. 2, A -C). 
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DISCUSSION 
We have shown for the first time that culturing neutrophils 
at 15 °C reversibly arrests the induction of apoptosis, with 
subsequent warming to 37 °C triggering a burst of synchronous 
apoptosis. The molecular consequences of temperature reduc- 
tion on cells are poorly understood. However, between 10 and 
20 °C there is a reduction in membrane lipid fluidity, a de- 
crease in the rate of protein translation, and an inhibition of 
vesicular trafficking and neutrophil respiratory burst activity 
(67, 50, 51). Our results suggest that the arrest of apoptosis in 
neutrophils cultured at 15 °C may be due to the failure of the 
proapoptotic protein Bax to undergo the conformational 
changes necessary for it to insert into mitochondria. Once in 
the membrane Bax triggers the release of cytochrome c and the 
subsequent activation of caspase -3 that induces the execution 
phase of neutrophil apoptosis. 
Bax is a soluble protein located in the cytoplasm of freshly 
isolated neutrophils (10 -12). Our immunofluorescence studies 
on Bax localization in neutrophils cultured at 15 °C have 
shown that in addition to its cytoplasmic localization, Bax was 
also associated with mitochondria that showed signs of aggre- 
gation; both observations reported for many cell lines cultured 
at 37 °C (73). However, in neutrophils cultured at 15 °C Bax 
failed to undergo the conformational changes necessary for 
insertion of its C- terminal membrane -spanning domain into 
mitochondria (33). Bax was readily washed from membranes 
isolated from neutrophils cultured at 15 °C suggesting a pe- 
ripheral association with the membrane fraction. The N- termi- 
nal region of the Bax molecule may bind to and mask its 
C- terminal domain in the cytoplasm and the removal of the 
N- terminal domain leads to an autoactivation and constitutive 
insertion of the mutant protein into mitochondria (72). The 
cytoplasmic components that normally facilitate this unmask- 
ing of the C- terminal membrane -spanning domain and the 
conformational changes to neutrophil Bax are unknown. How- 
ever, in HeLa cells, for example, the proapoptotic protein Bid, 
can induce the insertion of Bax into membranes (22, 72) and 
may be one of a number of cytoplasmic factors that play a role 
in the release of cytochrome c from mitochondria (29). 
In many models of apoptosis the insertion of Bax into mito- 
chondria and the subsequent release of cytochrome c are not 
inhibited by the pan- caspase inhibitor zVAD -fink, while pro - 
teolytic cleavage of procaspase -3 is inhibited (28). Treatment of 
neutrophils, cultured at 15 °C for 18 h, with zVAD -fmk prior to 
triggering apoptosis by warming to 37 °C, also failed to inhibit 
Bax translocation to neutrophil membranes under conditions 
where procaspase -3 was not proteolytically cleaved, consistent 
with other models of apoptosis. However, when freshly isolated 
neutrophils were treated with zVAD -fmk at the beginning of 
the culture period at 15 °C, Bax failed to insert into mitochon- 
dria when the cells were warmed to 37 °C. Assuming the fidel- 
ity of zVAD -fmk for its caspase targets, these experiments 
suggested that caspase -mediated events were necessary for 
Bax insertion (74) but were not in themselves a sufficient 
trigger for the induction of Bax insertion into mitochondria at 
15 °C. Whatever the role the caspases play in preparing Bax, or 
in activating a putative effector protein necessary for the acti- 
vation of Bax binding and insertion once the neutrophils are 
warmed to 37 °C, we saw no evidence that Bax was proteolyti- 
cally cleaved at 15 °C. Activation of an effector protein and Bax 
binding at 15 °C would provide an explanation for the synchro- 
nization of apoptosis we observe on warming the cells to 37 °C 
after culture at 15 °C. Direct proteolytic cleavage of p21 Bax 
does not appear to be involved in the translocation of Bax to 
mitochondria (70, 71). However, caspases have been shown to 
activate the calcium- activated cysteine protease, calpain, that 
cleaves p21 Bax to p18 Bax at the mitochondrial membrane 
(70, 71). While this proteolytic processing by calpain augments 
the homodimerization of Bax and the release of cytochrome c it 
is a relatively late apoptotic event concomitant temporally with 
the cleavage of many other caspase -3 substrates and with DNA 
fragmentation (75, 76). 
The conformational changes necessary for neutrophil Bax to 
insert into the mitochondria) membrane were not only inhib- 
ited by low temperature, but also by clamping neutrophils at an 
acidic pH, during warming to 37 °C, a treatment that was 
dominant over the effect of temperature reduction. In FL5.12 
cells and Dl thymocyte cell lines transient increases in cyto- 
plasmic pHi have been correlated with pH- dependent confor- 
mational change in Bax, an effect that is also inhibited by acid 
pH (39, 64, 73). This observation may provide an explanation 
for the inhibition of neutrophil apoptosis observed at inflam- 
matory foci where an acid environment has developed (59). Our 
data are also consistent with the observation that tumor ne- 
crosis factor /cycloheximide- induced cytochrome c release is in- 
hibited by zVAD-fink (30) and that caspase -8 may trigger the 
release of cytochrome c (77). However, our preliminary data 
(not shown) have suggested that procaspase -8, like pro - 
caspase-3 is not proteolytically cleaved at 15 or at 37 °C in the 
presence of zVAD -fmk, under conditions where Bax insertion 
occurs. 
How cytochrome c is translocated across the outer membrane 
of mitochondria is not known (41, 68, 78, 79). Bax insertion may 
affect membrane channels by inducing permeability changes 
that result in the release of cytochrome c (78, 80 -82). Many 
cells that obtain their ATP by oxidative phosphorylation can 
still release cytochrome c from mitochondria at low tempera- 
ture (30, 81). It was possible that extended culture at low 
temperature would lead to collapse of the inner mitochondrial 
membrane potential (M',) and trigger the opening of the mi- 
tochondria) permeability transition pore in neutrophils, an 
event that correlates with the insertion of Bax and the induc- 
tion of apoptosis (27, 41, 68). In granulocytes, however, ATP is 
obtained predominantly by glycolysis and this may allow their 
mitochondria to use pyruvate to maintain their .6.111., at low 
temperature. Apoptosis triggered by warming 15 °C cultured 
neutrophils to 37 °C was not inhibited by preincubation with 50 
bongkrekic acid (data not shown), an inhibitor that blocks 
the permeability transition pore (37, 77). This experiment sug- 
gested that the collapse of the membrane potential might be an 
event triggered downstream of caspase -3 activation (28). 
The Bax- dependent release of cytochrome c from mitochon- 
dria in 15 °C cultured neutrophils, treated with zVAD -fink just 
before warming to 37 °C to inhibit caspase -3, triggered the 
activation of apoptosis inducing activities that led to the arrest 
of both secretion and phagocytosis (57). The externalization of 
phosphatidylserine on the cell surface was also induced and 
this may trigger recognition and phagocytosis of granulocytes 
by macrophages (55). We have established that mitochondria 
play a role in triggering neutrophil apoptosis. Our 15 °C cy- 
tosols will now enable us to investigate not only the zVAD -fmk 
sensitive activity that is required for Bax insertion into mito- 
chondria, but also the zVAD -fmk insensitive activities trig- 
gered during cytochrome c release, that lead to the apoptotic 
changes associated with the neutrophil plasma membrane. Fi- 
nally, the differential response of granulocytes and proliferat- 
ing cells to temperature reduction suggests that therapeutic 
targets specific for triggering of neutrophil apoptosis may pos- 
sibly be identified in this clinically relevant cellular model of 
apoptosis. 
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